ID	Gene Name	Species	BBID	BIOCARTA	COG_ONTOLOGY	GOTERM_BP_DIRECT	GOTERM_CC_DIRECT	GOTERM_MF_DIRECT	INTERPRO	KEGG_PATHWAY	OMIM_DISEASE	PIR_SUPERFAMILY	SMART	UP_KEYWORDS	UP_SEQ_FEATURE
ADAMTSL4	ADAMTS like 4(ADAMTSL4)	Homo sapiens				GO:0002064~epithelial cell development,GO:0006508~proteolysis,GO:0006915~apoptotic process,GO:0030198~extracellular matrix organization,GO:0036066~protein O-linked fucosylation,GO:0043065~positive regulation of apoptotic process,	GO:0005614~interstitial matrix,GO:0005788~endoplasmic reticulum lumen,GO:0031012~extracellular matrix,	GO:0002020~protease binding,GO:0004222~metalloendopeptidase activity,GO:0005515~protein binding,GO:0008233~peptidase activity,	IPR000884:Thrombospondin, type 1 repeat,IPR010294:ADAM-TS Spacer 1,IPR010909:PLAC,		225100~Ectopia lentis, isolated, autosomal recessive,225200~Ectopia lentis et pupillae,		SM00209:TSP1,	Alternative splicing,Apoptosis,Complete proteome,Extracellular matrix,Glycoprotein,Polymorphism,Reference proteome,Repeat,Secreted,Signal,	chain:ADAMTS-like protein 4,compositionally biased region:Pro-rich,domain:PLAC,domain:TSP type-1 1,domain:TSP type-1 2,domain:TSP type-1 3,domain:TSP type-1 4,domain:TSP type-1 5,domain:TSP type-1 6,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,splice variant,
ARL13B	ADP ribosylation factor like GTPase 13B(ARL13B)	Homo sapiens				GO:0001947~heart looping,GO:0007224~smoothened signaling pathway,GO:0007264~small GTPase mediated signal transduction,GO:0009953~dorsal/ventral pattern formation,GO:0021532~neural tube patterning,GO:0021830~interneuron migration from the subpallium to the cortex,GO:0021943~formation of radial glial scaffolds,GO:0035058~nonmotile primary cilium assembly,GO:0042384~cilium assembly,GO:0060271~cilium morphogenesis,GO:0070986~left/right axis specification,	GO:0005929~cilium,GO:0005930~axoneme,GO:0031514~motile cilium,GO:0060170~ciliary membrane,GO:0072372~primary cilium,	GO:0005515~protein binding,GO:0005525~GTP binding,	IPR005225:Small GTP-binding protein domain,IPR006689:Small GTPase superfamily, ARF/SAR type,IPR024156:Small GTPase superfamily, ARF type,IPR027417:P-loop containing nucleoside triphosphate hydrolase,		612291~Joubert syndrome 8,			Alternative splicing,Cell membrane,Cell projection,Ciliopathy,Cilium,Coiled coil,Complete proteome,Disease mutation,GTP-binding,Isopeptide bond,Joubert syndrome,Lipoprotein,Membrane,Nucleotide-binding,Palmitate,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation,	chain:ADP-ribosylation factor-like protein 13B,compositionally biased region:Pro-rich,nucleotide phosphate-binding region:GTP,sequence variant,splice variant,
AHCTF1	AT-hook containing transcription factor 1(AHCTF1)	Homo sapiens				GO:0000910~cytokinesis,GO:0006355~regulation of transcription, DNA-templated,GO:0007062~sister chromatid cohesion,GO:0015031~protein transport,GO:0051028~mRNA transport,GO:0051292~nuclear pore complex assembly,	GO:0000777~condensed chromosome kinetochore,GO:0000785~chromatin,GO:0005634~nucleus,GO:0005643~nuclear pore,GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0016363~nuclear matrix,GO:0031080~nuclear pore outer ring,GO:0031965~nuclear membrane,GO:0034399~nuclear periphery,GO:0070062~extracellular exosome,	GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,	IPR011047:Quinonprotein alcohol dehydrogenase-like superfamily,IPR025151:ELYS-like domain,					Alternative splicing,Cell cycle,Cell division,Centromere,Chromosome,Complete proteome,Cytoplasm,DNA-binding,Kinetochore,mRNA transport,Nuclear pore complex,Nucleus,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Translocation,Transport,	chain:Protein ELYS,DNA-binding region:A.T hook,modified residue,region of interest:Mediates transcriptional activity,region of interest:Necessary for cytoplasmic localization,region of interest:Necessary for nuclear localization,sequence conflict,sequence variant,splice variant,
ARID1A	AT-rich interaction domain 1A(ARID1A)	Homo sapiens		h_hSWI-SNFpathway:Chromatin Remodeling by hSWI/SNF ATP-dependent Complexes,h_vdrPathway:Control of Gene Expression by Vitamin D Receptor,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001843~neural tube closure,GO:0003205~cardiac chamber development,GO:0003408~optic cup formation involved in camera-type eye development,GO:0006337~nucleosome disassembly,GO:0006338~chromatin remodeling,GO:0006344~maintenance of chromatin silencing,GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0016569~covalent chromatin modification,GO:0030520~intracellular estrogen receptor signaling pathway,GO:0030521~androgen receptor signaling pathway,GO:0030900~forebrain development,GO:0042766~nucleosome mobilization,GO:0042921~glucocorticoid receptor signaling pathway,GO:0043044~ATP-dependent chromatin remodeling,GO:0045893~positive regulation of transcription, DNA-templated,GO:0048096~chromatin-mediated maintenance of transcription,GO:0055007~cardiac muscle cell differentiation,GO:0060674~placenta blood vessel development,GO:1901998~toxin transport,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0016514~SWI/SNF complex,GO:0071564~npBAF complex,GO:0071565~nBAF complex,GO:0090544~BAF-type complex,	GO:0003677~DNA binding,GO:0003713~transcription coactivator activity,GO:0005515~protein binding,GO:0016922~ligand-dependent nuclear receptor binding,GO:0031491~nucleosome binding,	IPR001606:ARID/BRIGHT DNA-binding domain,IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,IPR021906:Protein of unknown function DUF3518,		614607~Mental retardation, autosomal dominant 14,		SM00501:BRIGHT,	3D-structure,Acetylation,Alternative splicing,Chromatin regulator,Complete proteome,Direct protein sequencing,DNA-binding,Mental retardation,Methylation,Neurogenesis,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:AT-rich interactive domain-containing protein 1A,compositionally biased region:Gln-rich,compositionally biased region:Poly-Gln,compositionally biased region:Poly-Ser,domain:ARID,helix,modified residue,mutagenesis site,sequence conflict,short sequence motif:LXXLL,splice variant,strand,turn,
ARID1B	AT-rich interaction domain 1B(ARID1B)	Homo sapiens				GO:0006338~chromatin remodeling,GO:0006351~transcription, DNA-templated,GO:0007270~neuron-neuron synaptic transmission,GO:0007399~nervous system development,GO:0016569~covalent chromatin modification,GO:0048096~chromatin-mediated maintenance of transcription,GO:0060996~dendritic spine development,GO:0097026~dendritic cell dendrite assembly,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016514~SWI/SNF complex,GO:0071565~nBAF complex,GO:0090544~BAF-type complex,	GO:0003677~DNA binding,GO:0003713~transcription coactivator activity,GO:0005515~protein binding,	IPR001606:ARID/BRIGHT DNA-binding domain,IPR011989:Armadillo-like helical,IPR021906:Protein of unknown function DUF3518,		614562~Mental retardation, autosomal dominant 12,		SM00501:BRIGHT,	3D-structure,Acetylation,Alternative splicing,Chromatin regulator,Complete proteome,DNA-binding,Mental retardation,Methylation,Neurogenesis,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,Triplet repeat expansion,	chain:AT-rich interactive domain-containing protein 1B,compositionally biased region:Ala-rich,compositionally biased region:Gln-rich,compositionally biased region:Gly-rich,compositionally biased region:His-rich,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Pro,compositionally biased region:Poly-Ser,compositionally biased region:Pro-rich,compositionally biased region:Ser-rich,domain:ARID,helix,modified residue,sequence conflict,sequence variant,short sequence motif:LXXLL,splice variant,
ATM	ATM serine/threonine kinase(ATM)	Homo sapiens		h_atmPathway:ATM Signaling Pathway,h_atrbrcaPathway:Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility,H_cdc25Pathway:cdc25 and chk1 Regulatory Pathway in response to DNA damage,h_chemicalPathway:Apoptotic Signaling in Response to DNA Damage,h_g1Pathway:Cell Cycle: G1/S Check Point ,h_g2Pathway:Cell Cycle: G2/M Checkpoint,h_p53hypoxiaPathway:Hypoxia and p53 in the Cardiovascular system,h_p53Pathway:p53 Signaling Pathway,h_plk3Pathway:Regulation of cell cycle progression by Plk3,h_rbPathway:RB Tumor Suppressor/Checkpoint Signaling in response to DNA damage,		GO:0000077~DNA damage checkpoint,GO:0000723~telomere maintenance,GO:0000724~double-strand break repair via homologous recombination,GO:0000729~DNA double-strand break processing,GO:0000731~DNA synthesis involved in DNA repair,GO:0000732~strand displacement,GO:0001666~response to hypoxia,GO:0001756~somitogenesis,GO:0002331~pre-B cell allelic exclusion,GO:0006260~DNA replication,GO:0006281~DNA repair,GO:0006303~double-strand break repair via nonhomologous end joining,GO:0006468~protein phosphorylation,GO:0006974~cellular response to DNA damage stimulus,GO:0006975~DNA damage induced protein phosphorylation,GO:0006977~DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,GO:0007004~telomere maintenance via telomerase,GO:0007050~cell cycle arrest,GO:0007094~mitotic spindle assembly checkpoint,GO:0007131~reciprocal meiotic recombination,GO:0007165~signal transduction,GO:0007420~brain development,GO:0007507~heart development,GO:0008340~determination of adult lifespan,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0010212~response to ionizing radiation,GO:0010506~regulation of autophagy,GO:0016572~histone phosphorylation,GO:0018105~peptidyl-serine phosphorylation,GO:0030889~negative regulation of B cell proliferation,GO:0032212~positive regulation of telomere maintenance via telomerase,GO:0033129~positive regulation of histone phosphorylation,GO:0033151~V(D)J recombination,GO:0036092~phosphatidylinositol-3-phosphate biosynthetic process,GO:0036289~peptidyl-serine autophosphorylation,GO:0042159~lipoprotein catabolic process,GO:0042981~regulation of apoptotic process,GO:0043065~positive regulation of apoptotic process,GO:0043517~positive regulation of DNA damage response, signal transduction by p53 class mediator,GO:0043525~positive regulation of neuron apoptotic process,GO:0045141~meiotic telomere clustering,GO:0046777~protein autophosphorylation,GO:0048599~oocyte development,GO:0051402~neuron apoptotic process,GO:0051726~regulation of cell cycle,GO:0051972~regulation of telomerase activity,GO:0071044~histone mRNA catabolic process,GO:0071480~cellular response to gamma radiation,GO:0071481~cellular response to X-ray,GO:0071500~cellular response to nitrosative stress,GO:0072434~signal transduction involved in mitotic G2 DNA damage checkpoint,GO:0090399~replicative senescence,GO:0097694~establishment of RNA localization to telomere,GO:0097695~establishment of macromolecular complex localization to telomere,GO:1900034~regulation of cellular response to heat,GO:1901796~regulation of signal transduction by p53 class mediator,GO:1904262~negative regulation of TORC1 signaling,GO:1904354~negative regulation of telomere capping,GO:1904358~positive regulation of telomere maintenance via telomere lengthening,GO:1904884~positive regulation of telomerase catalytic core complex assembly,	GO:0000781~chromosome, telomeric region,GO:0000784~nuclear chromosome, telomeric region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005819~spindle,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0031410~cytoplasmic vesicle,GO:1990391~DNA repair complex,	GO:0003677~DNA binding,GO:0004674~protein serine/threonine kinase activity,GO:0004677~DNA-dependent protein kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016303~1-phosphatidylinositol-3-kinase activity,GO:0016740~transferase activity,GO:0032403~protein complex binding,GO:0046983~protein dimerization activity,GO:0047485~protein N-terminus binding,	IPR000403:Phosphatidylinositol 3-/4-kinase, catalytic domain,IPR003151:PIK-related kinase, FAT,IPR003152:PIK-related kinase, FATC,IPR011009:Protein kinase-like domain,IPR014009:PIK-related kinase,IPR015519:ATM/Tel1,IPR016024:Armadillo-type fold,IPR018936:Phosphatidylinositol 3/4-kinase, conserved site,IPR021668:Telomere-length maintenance and DNA damage repair,	hsa04064:NF-kappa B signaling pathway,hsa04068:FoxO signaling pathway,hsa04110:Cell cycle,hsa04115:p53 signaling pathway,hsa04210:Apoptosis,hsa05166:HTLV-I infection,hsa05202:Transcriptional misregulation in cancer,hsa05206:MicroRNAs in cancer,	114480~Breast cancer, susceptibility to,208900~Ataxia-telangiectasia,Lymphoma, B-cell non-Hodgkin, somatic~Lymphoma, B-cell non-Hodgkin, somatic,Lymphoma, mantle cell~Lymphoma, mantle cell,T-cell prolymphocytic leukemia, somatic~T-cell prolymphocytic leukemia, somatic,		SM00146:PI3Kc,SM01342:SM01342,SM01343:SM01343,	Acetylation,ATP-binding,Cell cycle,Complete proteome,Cytoplasmic vesicle,Disease mutation,DNA damage,DNA-binding,Kinase,Neurodegeneration,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transferase,Tumor suppressor,	chain:Serine-protein kinase ATM,domain:FAT,domain:FATC,domain:PI3K/PI4K,modified residue,mutagenesis site,region of interest:Interaction with ABL1,sequence conflict,sequence variant,splice variant,
ABCA10	ATP binding cassette subfamily A member 10(ABCA10)	Homo sapiens			Defense mechanisms,	GO:0006869~lipid transport,GO:0055085~transmembrane transport,	GO:0016021~integral component of membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0005215~transporter activity,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,	IPR003439:ABC transporter-like,IPR003593:AAA+ ATPase domain,IPR017871:ABC transporter, conserved site,IPR026082:ABC transporter A, ABCA,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa02010:ABC transporters,			SM00382:AAA,	Alternative splicing,ATP-binding,Complete proteome,Membrane,Nucleotide-binding,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transmembrane,Transmembrane helix,Transport,	chain:ATP-binding cassette sub-family A member 10,domain:ABC transporter 1,domain:ABC transporter 2,modified residue,nucleotide phosphate-binding region:ATP 1,nucleotide phosphate-binding region:ATP 2,sequence conflict,sequence variant,splice variant,transmembrane region,
ATP6V1C2	ATPase H+ transporting V1 subunit C2(ATP6V1C2)	Homo sapiens				GO:0008286~insulin receptor signaling pathway,GO:0015991~ATP hydrolysis coupled proton transport,GO:0016241~regulation of macroautophagy,GO:0030177~positive regulation of Wnt signaling pathway,GO:0033572~transferrin transport,GO:0034220~ion transmembrane transport,GO:0090383~phagosome acidification,	GO:0000221~vacuolar proton-transporting V-type ATPase, V1 domain,GO:0005765~lysosomal membrane,GO:0005829~cytosol,GO:0033180~proton-transporting V-type ATPase, V1 domain,GO:0070062~extracellular exosome,	GO:0008553~hydrogen-exporting ATPase activity, phosphorylative mechanism,GO:0015078~hydrogen ion transmembrane transporter activity,GO:0046961~proton-transporting ATPase activity, rotational mechanism,GO:0046983~protein dimerization activity,	IPR004907:ATPase, V1 complex, subunit C,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa04145:Phagosome,hsa04721:Synaptic vesicle cycle,hsa04966:Collecting duct acid secretion,hsa05110:Vibrio cholerae infection,hsa05120:Epithelial cell signaling in Helicobacter pylori infection,hsa05323:Rheumatoid arthritis,				Alternative splicing,Coiled coil,Complete proteome,Hydrogen ion transport,Ion transport,Polymorphism,Proteomics identification,Reference proteome,Transport,	chain:V-type proton ATPase subunit C 2,sequence variant,splice variant,
ATAD2	ATPase family, AAA domain containing 2(ATAD2)	Homo sapiens				GO:0006325~chromatin organization,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0031936~negative regulation of chromatin silencing,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0070062~extracellular exosome,	GO:0003682~chromatin binding,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0042393~histone binding,	IPR001487:Bromodomain,IPR003593:AAA+ ATPase domain,IPR003959:ATPase, AAA-type, core,IPR003960:ATPase, AAA-type, conserved site,IPR011989:Armadillo-like helical,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00297:BROMO,SM00382:AAA,	3D-structure,Activator,Alternative splicing,ATP-binding,Bromodomain,Coiled coil,Complete proteome,Hydrolase,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:ATPase family AAA domain-containing protein 2,compositionally biased region:Asp-rich,compositionally biased region:Poly-Ser,domain:Bromo,helix,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence variant,splice variant,turn,
ATRX	ATRX, chromatin remodeler(ATRX)	Homo sapiens				GO:0006281~DNA repair,GO:0006306~DNA methylation,GO:0006310~DNA recombination,GO:0006334~nucleosome assembly,GO:0006336~DNA replication-independent nucleosome assembly,GO:0006338~chromatin remodeling,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007283~spermatogenesis,GO:0010571~positive regulation of nuclear cell cycle DNA replication,GO:0016569~covalent chromatin modification,GO:0030330~DNA damage response, signal transduction by p53 class mediator,GO:0030900~forebrain development,GO:0031297~replication fork processing,GO:0032206~positive regulation of telomere maintenance,GO:0032508~DNA duplex unwinding,GO:0035128~post-embryonic forelimb morphogenesis,GO:0035264~multicellular organism growth,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0060009~Sertoli cell development,GO:0070198~protein localization to chromosome, telomeric region,GO:0072520~seminiferous tubule development,GO:0072711~cellular response to hydroxyurea,GO:1900112~regulation of histone H3-K9 trimethylation,GO:1901581~negative regulation of telomeric RNA transcription from RNA pol II promoter,GO:1901582~positive regulation of telomeric RNA transcription from RNA pol II promoter,GO:1904908~negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric,	GO:0000784~nuclear chromosome, telomeric region,GO:0005634~nucleus,GO:0005720~nuclear heterochromatin,GO:0005721~pericentric heterochromatin,GO:0016605~PML body,GO:0031933~telomeric heterochromatin,GO:0070603~SWI/SNF superfamily-type complex,GO:1990707~nuclear subtelomeric heterochromatin,	GO:0003677~DNA binding,GO:0003678~DNA helicase activity,GO:0003682~chromatin binding,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0015616~DNA translocase activity,GO:0035064~methylated histone binding,GO:0042393~histone binding,GO:0046872~metal ion binding,GO:0070087~chromo shadow domain binding,	IPR000330:SNF2-related,IPR001650:Helicase, C-terminal,IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR025766:ADD domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,		300448~Alpha-thalassemia myelodysplasia syndrome, somatic,301040~Alpha-thalassemia/mental retardation syndrome,309580~Mental retardation-hypotonic facies syndrome, X-linked,Mental retardation, X-linked 52~Mental retardation, X-linked 52,		SM00487:DEXDc,SM00490:HELICc,	3D-structure,Acetylation,Alternative splicing,ATP-binding,Chromatin regulator,Chromosome,Coiled coil,Complete proteome,Disease mutation,DNA damage,DNA repair,DNA-binding,Helicase,Hydrolase,Isopeptide bond,Mental retardation,Metal-binding,Methylation,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Telomere,Transcription,Transcription regulation,Ubl conjugation,Zinc,Zinc-finger,	chain:Transcriptional regulator ATRX,compositionally biased region:Poly-Asp,compositionally biased region:Poly-Gln,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Lys,compositionally biased region:Poly-Ser,domain:Helicase ATP-binding,domain:Helicase C-terminal,helix,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,short sequence motif:DEGH box,short sequence motif:PxVxL motif,splice variant,strand,turn,zinc finger region:GATA-type; atypical,zinc finger region:PHD-type,
BCL9	B-cell CLL/lymphoma 9(BCL9)	Homo sapiens				GO:0014908~myotube differentiation involved in skeletal muscle regeneration,GO:0017015~regulation of transforming growth factor beta receptor signaling pathway,GO:0035019~somatic stem cell population maintenance,GO:0035914~skeletal muscle cell differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0060070~canonical Wnt signaling pathway,GO:1904837~beta-catenin-TCF complex assembly,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005794~Golgi apparatus,GO:0005801~cis-Golgi network,	GO:0005515~protein binding,GO:0008013~beta-catenin binding,	IPR015668:B Cell Lymphoma 9,IPR024670:B-cell lymphoma 9, beta-catenin binding domain,					3D-structure,Acetylation,Chromosomal rearrangement,Complete proteome,Methylation,Nucleus,Phosphoprotein,Polymorphism,Proto-oncogene,Reference proteome,Wnt signaling pathway,	chain:B-cell CLL/lymphoma 9 protein,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Pro,compositionally biased region:Pro-rich,helix,modified residue,region of interest:CTNNB1-binding,sequence conflict,sequence variant,strand,
BCL9L	B-cell CLL/lymphoma 9-like(BCL9L)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0010718~positive regulation of epithelial to mesenchymal transition,GO:0022604~regulation of cell morphogenesis,GO:0030512~negative regulation of transforming growth factor beta receptor signaling pathway,GO:0035019~somatic stem cell population maintenance,GO:0035914~skeletal muscle cell differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0060070~canonical Wnt signaling pathway,GO:1904837~beta-catenin-TCF complex assembly,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,	GO:0003713~transcription coactivator activity,GO:0008013~beta-catenin binding,	IPR015668:B Cell Lymphoma 9,IPR024670:B-cell lymphoma 9, beta-catenin binding domain,					3D-structure,Acetylation,Activator,Alternative splicing,Complete proteome,Methylation,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:B-cell CLL/lymphoma 9-like protein,compositionally biased region:Met-rich,compositionally biased region:Pro-rich,modified residue,region of interest:Necessary for interaction with CTNNB1,splice variant,
BCOR	BCL6 corepressor(BCOR)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000415~negative regulation of histone H3-K36 methylation,GO:0006351~transcription, DNA-templated,GO:0007507~heart development,GO:0030502~negative regulation of bone mineralization,GO:0035518~histone H2A monoubiquitination,GO:0042476~odontogenesis,GO:0045892~negative regulation of transcription, DNA-templated,GO:0051572~negative regulation of histone H3-K4 methylation,GO:0060021~palate development,GO:0065001~specification of axis polarity,GO:0070171~negative regulation of tooth mineralization,	GO:0005634~nucleus,GO:0005739~mitochondrion,GO:0031519~PcG protein complex,	GO:0003714~transcription corepressor activity,GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0031072~heat shock protein binding,GO:0042826~histone deacetylase binding,GO:0044212~transcription regulatory region DNA binding,	IPR002110:Ankyrin repeat,IPR020683:Ankyrin repeat-containing domain,		300166~Microphthalmia, syndromic 2,		SM00248:ANK,	3D-structure,Acetylation,Alternative splicing,ANK repeat,Chromatin regulator,Complete proteome,Disease mutation,Microphthalmia,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,	chain:BCL-6 corepressor,compositionally biased region:Poly-Asp,compositionally biased region:Pro-rich,modified residue,mutagenesis site,region of interest:Interaction with BCL6,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,sequence conflict,sequence variant,splice variant,strand,
BCORL1	BCL6 corepressor-like 1(BCORL1)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0016569~covalent chromatin modification,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005886~plasma membrane,		IPR002110:Ankyrin repeat,IPR020683:Ankyrin repeat-containing domain,				SM00248:ANK,	3D-structure,Alternative splicing,ANK repeat,Chromatin regulator,Complete proteome,Isopeptide bond,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,Ubl conjugation,	chain:BCL-6 corepressor-like protein 1,compositionally biased region:Pro-rich,modified residue,mutagenesis site,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,sequence conflict,sequence variant,short sequence motif:Nuclear localization signal,splice variant,
BRCA2	BRCA2, DNA repair associated(BRCA2)	Homo sapiens		h_atrbrcaPathway:Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility,		GO:0000722~telomere maintenance via recombination,GO:0000724~double-strand break repair via homologous recombination,GO:0000731~DNA synthesis involved in DNA repair,GO:0000732~strand displacement,GO:0000910~cytokinesis,GO:0001556~oocyte maturation,GO:0001833~inner cell mass cell proliferation,GO:0006289~nucleotide-excision repair,GO:0006302~double-strand break repair,GO:0006978~DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,GO:0007141~male meiosis I,GO:0007283~spermatogenesis,GO:0007420~brain development,GO:0007569~cell aging,GO:0008585~female gonad development,GO:0010165~response to X-ray,GO:0010225~response to UV-C,GO:0010332~response to gamma radiation,GO:0030097~hemopoiesis,GO:0031052~chromosome breakage,GO:0032465~regulation of cytokinesis,GO:0033600~negative regulation of mammary gland epithelial cell proliferation,GO:0042771~intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,GO:0043966~histone H3 acetylation,GO:0043967~histone H4 acetylation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045931~positive regulation of mitotic cell cycle,GO:0048478~replication fork protection,GO:0051298~centrosome duplication,GO:0070200~establishment of protein localization to telomere,GO:1990426~mitotic recombination-dependent replication fork processing,	GO:0000784~nuclear chromosome, telomeric region,GO:0000800~lateral element,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0016021~integral component of membrane,GO:0030141~secretory granule,GO:0033593~BRCA2-MAGE-D1 complex,GO:0043234~protein complex,	GO:0002020~protease binding,GO:0003697~single-stranded DNA binding,GO:0004402~histone acetyltransferase activity,GO:0005515~protein binding,GO:0008022~protein C-terminus binding,GO:0010484~H3 histone acetyltransferase activity,GO:0010485~H4 histone acetyltransferase activity,GO:0043015~gamma-tubulin binding,	IPR002093:BRCA2 repeat,IPR012340:Nucleic acid-binding, OB-fold,IPR015187:BRCA2, oligonucleotide/oligosaccharide-binding 1,IPR015188:BRCA2, oligonucleotide/oligosaccharide-binding 3,IPR015205:Tower,IPR015252:DNA recombination/repair protein BRCA2, helical domain,IPR015525:Breast cancer type 2 susceptibility protein,	hsa03440:Homologous recombination,hsa03460:Fanconi anemia pathway,hsa05200:Pathways in cancer,hsa05212:Pancreatic cancer,	114480~Breast cancer, male, susceptibility to,155255~Medulloblastoma,176807~Prostate cancer,194070~Wilms tumor,605724~Fanconi anemia, complementation group D1,612555~Breast-ovarian cancer, familial, 2,613029~Glioblastoma 3,613347~Pancreatic cancer 2,	PIRSF002397:DNA recombination repair protein, BRCA2 type,	SM01341:SM01341,	3D-structure,Cell cycle,Complete proteome,Cytoplasm,Cytoskeleton,Disease mutation,DNA damage,DNA recombination,DNA repair,DNA-binding,Fanconi anemia,Membrane,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transmembrane,Transmembrane helix,Tumor suppressor,Ubl conjugation,	chain:Breast cancer type 2 susceptibility protein,helix,modified residue,region of interest:Interaction with FANCD2,region of interest:Interaction with PALB2,repeat:BRCA2 1,repeat:BRCA2 2,repeat:BRCA2 3,repeat:BRCA2 4,repeat:BRCA2 5,repeat:BRCA2 6,repeat:BRCA2 7,repeat:BRCA2 8,sequence conflict,sequence variant,turn,
BTBD7	BTB domain containing 7(BTBD7)	Homo sapiens				GO:0007275~multicellular organism development,GO:0060693~regulation of branching involved in salivary gland morphogenesis,	GO:0005634~nucleus,		IPR000210:BTB/POZ-like,IPR011333:BTB/POZ fold,IPR011705:BTB/Kelch-associated,				SM00225:BTB,SM00875:SM00875,	Alternative splicing,Complete proteome,Developmental protein,Lipoprotein,Myristate,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,	chain:BTB/POZ domain-containing protein 7,compositionally biased region:Poly-Ala,compositionally biased region:Pro-rich,domain:BTB 1,domain:BTB 2,modified residue,sequence conflict,splice variant,
CCR4	C-C motif chemokine receptor 4(CCR4)	Homo sapiens	14.chemokine_receptor-ligand,15.T-cell_polarization-chemokine_receptors,16.Chemokines-rec-T-cells,	h_nktPathway:Selective expression of chemokine receptors during T-cell polarization,		GO:0001764~neuron migration,GO:0002507~tolerance induction,GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0009314~response to radiation,GO:0009617~response to bacterium,GO:0046677~response to antibiotic,GO:0048872~homeostasis of number of cells,GO:0050927~positive regulation of positive chemotaxis,GO:0070098~chemokine-mediated signaling pathway,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009897~external side of plasma membrane,GO:0016021~integral component of membrane,GO:0043025~neuronal cell body,	GO:0004950~chemokine receptor activity,GO:0016493~C-C chemokine receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000355:Chemokine receptor family,IPR002239:CC chemokine receptor 4,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,hsa05203:Viral carcinogenesis,			SM01381:SM01381,	Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:C-C chemokine receptor type 4,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
DAZAP1	DAZ associated protein 1(DAZAP1)	Homo sapiens				GO:0001893~maternal placenta development,GO:0007283~spermatogenesis,GO:0008283~cell proliferation,GO:0030154~cell differentiation,GO:0048026~positive regulation of mRNA splicing, via spliceosome,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0035613~RNA stem-loop binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,	hsa03015:mRNA surveillance pathway,			SM00360:RRM,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Developmental protein,Differentiation,Direct protein sequencing,Methylation,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Repeat,RNA-binding,Spermatogenesis,	chain:DAZ-associated protein 1,compositionally biased region:Pro-rich,domain:RRM 1,domain:RRM 2,helix,modified residue,sequence conflict,sequence variant,splice variant,strand,turn,
DDX27	DEAD-box helicase 27(DDX27)	Homo sapiens				GO:0006364~rRNA processing,GO:0010501~RNA secondary structure unwinding,	GO:0005694~chromosome,GO:0005730~nucleolus,	GO:0003676~nucleic acid binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0044822~poly(A) RNA binding,	IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site,IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00487:DEXDc,SM00490:HELICc,	ATP-binding,Chromosome,Coiled coil,Complete proteome,Helicase,Hydrolase,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ribosome biogenesis,rRNA processing,	chain:Probable ATP-dependent RNA helicase DDX27,compositionally biased region:Asp/Glu/Lys-rich,domain:Helicase ATP-binding,domain:Helicase C-terminal,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,short sequence motif:DEAD box,short sequence motif:Nuclear localization signal,short sequence motif:Q motif,
DEPDC5	DEP domain containing 5(DEPDC5)	Homo sapiens				GO:0010506~regulation of autophagy,GO:0032007~negative regulation of TOR signaling,GO:0034198~cellular response to amino acid starvation,GO:0035556~intracellular signal transduction,GO:0043547~positive regulation of GTPase activity,GO:1904262~negative regulation of TORC1 signaling,	GO:0005622~intracellular,GO:0005764~lysosome,GO:0005765~lysosomal membrane,GO:0005829~cytosol,GO:0048471~perinuclear region of cytoplasm,GO:1990130~Iml1 complex,	GO:0005096~GTPase activator activity,GO:0032403~protein complex binding,	IPR000591:DEP domain,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR027244:Vacuolar membrane-associated protein Iml1,		604364~Epilepsy, familial focal, with variable foci,		SM00049:DEP,	Alternative splicing,Complete proteome,Cytoplasm,Disease mutation,Epilepsy,GTPase activation,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:DEP domain-containing protein 5,domain:DEP,sequence conflict,sequence variant,splice variant,
DDX39B	DExD-box helicase 39B(DDX39B)	Homo sapiens				GO:0000245~spliceosomal complex assembly,GO:0000398~mRNA splicing, via spliceosome,GO:0001889~liver development,GO:0006369~termination of RNA polymerase II transcription,GO:0006405~RNA export from nucleus,GO:0006406~mRNA export from nucleus,GO:0008380~RNA splicing,GO:0010501~RNA secondary structure unwinding,GO:0031124~mRNA 3'-end processing,GO:0032786~positive regulation of DNA-templated transcription, elongation,GO:0045727~positive regulation of translation,GO:0046784~viral mRNA export from host cell nucleus,GO:0061051~positive regulation of cell growth involved in cardiac muscle cell development,GO:1904707~positive regulation of vascular smooth muscle cell proliferation,GO:2000002~negative regulation of DNA damage checkpoint,GO:2000573~positive regulation of DNA biosynthetic process,	GO:0000346~transcription export complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005687~U4 snRNP,GO:0005688~U6 snRNP,GO:0005737~cytoplasm,GO:0016363~nuclear matrix,GO:0016607~nuclear speck,GO:0043234~protein complex,	GO:0003676~nucleic acid binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008186~RNA-dependent ATPase activity,GO:0016887~ATPase activity,GO:0017070~U6 snRNA binding,GO:0030621~U4 snRNA binding,GO:0032403~protein complex binding,GO:0042802~identical protein binding,GO:0043008~ATP-dependent protein binding,GO:0044822~poly(A) RNA binding,	IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa03013:RNA transport,hsa03015:mRNA surveillance pathway,hsa03040:Spliceosome,hsa05164:Influenza A,			SM00487:DEXDc,SM00490:HELICc,	3D-structure,Acetylation,Alternative splicing,ATP-binding,Complete proteome,Cytoplasm,Helicase,Hydrolase,Isopeptide bond,mRNA processing,mRNA splicing,mRNA transport,Nucleotide-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,RNA-binding,Spliceosome,Transport,Ubl conjugation,	chain:Spliceosome RNA helicase BAT1,domain:Helicase ATP-binding,domain:Helicase C-terminal,helix,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence conflict,short sequence motif:DECD box,short sequence motif:Q motif,splice variant,strand,turn,
DNMT3A	DNA methyltransferase 3 alpha(DNMT3A)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000278~mitotic cell cycle,GO:0006306~DNA methylation,GO:0006346~methylation-dependent chromatin silencing,GO:0006349~regulation of gene expression by genetic imprinting,GO:0007283~spermatogenesis,GO:0007568~aging,GO:0009636~response to toxic substance,GO:0010212~response to ionizing radiation,GO:0010288~response to lead ion,GO:0010424~DNA methylation on cytosine within a CG sequence,GO:0010468~regulation of gene expression,GO:0010942~positive regulation of cell death,GO:0030182~neuron differentiation,GO:0032355~response to estradiol,GO:0033189~response to vitamin A,GO:0042220~response to cocaine,GO:0042493~response to drug,GO:0043045~DNA methylation involved in embryo development,GO:0043046~DNA methylation involved in gamete generation,GO:0044027~hypermethylation of CpG island,GO:0045814~negative regulation of gene expression, epigenetic,GO:0046498~S-adenosylhomocysteine metabolic process,GO:0046499~S-adenosylmethioninamine metabolic process,GO:0071230~cellular response to amino acid stimulus,GO:0071361~cellular response to ethanol,GO:0071456~cellular response to hypoxia,GO:0090116~C-5 methylation of cytosine,GO:0097284~hepatocyte apoptotic process,	GO:0000775~chromosome, centromeric region,GO:0000791~euchromatin,GO:0001741~XY body,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005720~nuclear heterochromatin,GO:0005737~cytoplasm,GO:0016363~nuclear matrix,	GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003886~DNA (cytosine-5-)-methyltransferase activity,GO:0005515~protein binding,GO:0009008~DNA-methyltransferase activity,GO:0042802~identical protein binding,GO:0045322~unmethylated CpG binding,GO:0046872~metal ion binding,GO:0051718~DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates,	IPR000313:PWWP,IPR001525:C-5 cytosine methyltransferase,IPR018117:DNA methylase, C-5 cytosine-specific, active site,IPR025766:ADD domain,	hsa00270:Cysteine and methionine metabolism,hsa01100:Metabolic pathways,hsa05206:MicroRNAs in cancer,	615879~Tatton-Brown-Rahman syndrome,		SM00293:PWWP,	3D-structure,Alternative promoter usage,Alternative splicing,Chromatin regulator,Complete proteome,Cytoplasm,Disease mutation,DNA-binding,Mental retardation,Metal-binding,Methylation,Methyltransferase,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repressor,S-adenosyl-L-methionine,Transferase,Ubl conjugation,Zinc,Zinc-finger,	chain:DNA (cytosine-5)-methyltransferase 3A,domain:PWWP,helix,modified residue,mutagenesis site,region of interest:Interaction with DNMT1 and DNMT3B,region of interest:Interaction with the PRC2/EED-EZH2 complex,splice variant,strand,turn,zinc finger region:ADD-type,
POLQ	DNA polymerase theta(POLQ)	Homo sapiens			DNA replication, recombination, and repair,	GO:0000724~double-strand break repair via homologous recombination,GO:0006261~DNA-dependent DNA replication,GO:0006281~DNA repair,GO:0006284~base-excision repair,GO:0006302~double-strand break repair,GO:0006974~cellular response to DNA damage stimulus,GO:0016446~somatic hypermutation of immunoglobulin genes,GO:0051260~protein homooligomerization,GO:0071897~DNA biosynthetic process,GO:0097681~double-strand break repair via alternative nonhomologous end joining,GO:2000042~negative regulation of double-strand break repair via homologous recombination,	GO:0005654~nucleoplasm,GO:0005694~chromosome,	GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003684~damaged DNA binding,GO:0003887~DNA-directed DNA polymerase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0043142~single-stranded DNA-dependent ATPase activity,GO:0051575~5'-deoxyribose-5-phosphate lyase activity,	IPR001098:DNA-directed DNA polymerase, family A, palm domain,IPR001650:Helicase, C-terminal,IPR002298:DNA polymerase A,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR012337:Ribonuclease H-like domain,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR019760:DNA-directed DNA polymerase, family A, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00482:POLAc,SM00487:DEXDc,SM00490:HELICc,	3D-structure,Acetylation,Alternative splicing,ATP-binding,Chromosome,Coiled coil,Complete proteome,DNA damage,DNA repair,DNA-directed DNA polymerase,Nucleotide-binding,Nucleotidyltransferase,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Transferase,
DNAJC11	DnaJ heat shock protein family (Hsp40) member C11(DNAJC11)	Homo sapiens					GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0070062~extracellular exosome,	GO:0005515~protein binding,	IPR001623:DnaJ domain,IPR018253:DnaJ domain, conserved site,IPR024586:DnaJ-like protein C11, C-terminal,				SM00271:DnaJ,	Acetylation,Alternative splicing,Chaperone,Coiled coil,Complete proteome,Mitochondrion,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:DnaJ homolog subfamily C member 11,domain:J,sequence conflict,sequence variant,splice variant,
FBXW7	F-box and WD repeat domain containing 7(FBXW7)	Homo sapiens		h_fbw7Pathway:Cyclin E Destruction Pathway,		GO:0000209~protein polyubiquitination,GO:0001944~vasculature development,GO:0006974~cellular response to DNA damage stimulus,GO:0007062~sister chromatid cohesion,GO:0010868~negative regulation of triglyceride biosynthetic process,GO:0010883~regulation of lipid storage,GO:0016032~viral process,GO:0016567~protein ubiquitination,GO:0031146~SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,GO:0031398~positive regulation of protein ubiquitination,GO:0032876~negative regulation of DNA endoreduplication,GO:0032880~regulation of protein localization,GO:0034644~cellular response to UV,GO:0045741~positive regulation of epidermal growth factor-activated receptor activity,GO:0045746~negative regulation of Notch signaling pathway,GO:0050821~protein stabilization,GO:0051443~positive regulation of ubiquitin-protein transferase activity,GO:0055088~lipid homeostasis,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:1901800~positive regulation of proteasomal protein catabolic process,GO:1902806~regulation of cell cycle G1/S phase transition,GO:1903146~regulation of mitophagy,GO:1903378~positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,GO:1903955~positive regulation of protein targeting to mitochondrion,GO:2000060~positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,GO:2000346~negative regulation of hepatocyte proliferation,GO:2000639~negative regulation of SREBP signaling pathway,	GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0019005~SCF ubiquitin ligase complex,GO:0043234~protein complex,GO:1990452~Parkin-FBXW7-Cul1 ubiquitin ligase complex,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0030332~cyclin binding,GO:0030674~protein binding, bridging,GO:0031625~ubiquitin protein ligase binding,GO:0042802~identical protein binding,GO:0050816~phosphothreonine binding,GO:0097027~ubiquitin-protein transferase activator activity,	IPR001680:WD40 repeat,IPR001810:F-box domain, cyclin-like,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,IPR020472:G-protein beta WD-40 repeat,	hsa04120:Ubiquitin mediated proteolysis,			SM00256:FBOX,SM00320:WD40,	3D-structure,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Host-virus interaction,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,Ubl conjugation,Ubl conjugation pathway,WD repeat,	chain:F-box/WD repeat-containing protein 7,domain:F-box,helix,modified residue,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,repeat:WD 7,sequence conflict,sequence variant,splice variant,strand,turn,
FXR1	FMR1 autosomal homolog 1(FXR1)	Homo sapiens				GO:0006915~apoptotic process,GO:0007517~muscle organ development,GO:0017148~negative regulation of translation,GO:0030154~cell differentiation,GO:2000637~positive regulation of gene silencing by miRNA,	GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005844~polysome,GO:0016020~membrane,GO:0030424~axon,GO:0035770~ribonucleoprotein granule,GO:0043034~costamere,GO:0043197~dendritic spine,GO:0048471~perinuclear region of cytoplasm,	GO:0002151~G-quadruplex RNA binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0005515~protein binding,GO:0033592~RNA strand annealing activity,GO:0042803~protein homodimerization activity,GO:0044822~poly(A) RNA binding,GO:0046982~protein heterodimerization activity,	IPR004087:K Homology domain,IPR004088:K Homology domain, type 1,IPR008395:Agenet-like domain,IPR022034:Fragile X mental retardation protein family,	hsa03013:RNA transport,			SM00322:KH,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Developmental protein,Differentiation,Direct protein sequencing,Myogenesis,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,RNA-binding,Signal,	chain:Fragile X mental retardation syndrome- related protein 1,compositionally biased region:Poly-Arg,compositionally biased region:Poly-Pro,domain:KH 1,domain:KH 2,helix,modified residue,region of interest:RNA-binding RGG-box,sequence conflict,sequence variant,splice variant,strand,turn,
GPS2	G protein pathway suppressor 2(GPS2)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000188~inactivation of MAPK activity,GO:0007049~cell cycle,GO:0007254~JNK cascade,GO:0034260~negative regulation of GTPase activity,GO:0046329~negative regulation of JNK cascade,	GO:0005654~nucleoplasm,GO:0017053~transcriptional repressor complex,	GO:0003714~transcription corepressor activity,GO:0005095~GTPase inhibitor activity,GO:0005515~protein binding,	IPR026094:G protein pathway suppressor 2,	hsa05166:HTLV-I infection,				3D-structure,Alternative splicing,Coiled coil,Complete proteome,Methylation,Polymorphism,Proteomics identification,Reference proteome,	chain:G protein pathway suppressor 2,compositionally biased region:Poly-Glu,sequence variant,
GRK4	G protein-coupled receptor kinase 4(GRK4)	Homo sapiens		h_agpcrPathway:Attenuation of GPCR Signaling,		GO:0002031~G-protein coupled receptor internalization,GO:0006468~protein phosphorylation,GO:0007165~signal transduction,GO:0008277~regulation of G-protein coupled receptor protein signaling pathway,GO:0022400~regulation of rhodopsin mediated signaling pathway,GO:0031623~receptor internalization,	GO:0005829~cytosol,GO:0005938~cell cortex,GO:0030425~dendrite,GO:0043025~neuronal cell body,GO:0097381~photoreceptor disc membrane,	GO:0004703~G-protein coupled receptor kinase activity,GO:0005524~ATP binding,GO:0050254~rhodopsin kinase activity,	IPR000239:GPCR kinase,IPR000719:Protein kinase, catalytic domain,IPR000961:AGC-kinase, C-terminal,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR016137:Regulator of G protein signalling superfamily,IPR017441:Protein kinase, ATP binding site,	hsa04062:Chemokine signaling pathway,hsa04144:Endocytosis,hsa05032:Morphine addiction,			SM00133:S_TK_X,SM00220:S_TKc,SM00315:RGS,	3D-structure,Acetylation,Alternative splicing,ATP-binding,Complete proteome,Cytoplasm,Kinase,Lipoprotein,Nucleotide-binding,Palmitate,Phosphoprotein,Polymorphism,Reference proteome,Serine/threonine-protein kinase,Transferase,	active site:Proton acceptor,binding site:ATP,chain:G protein-coupled receptor kinase 4,domain:AGC-kinase C-terminal,domain:Protein kinase,domain:RGS,nucleotide phosphate-binding region:ATP,region of interest:N-terminal,sequence conflict,sequence variant,splice variant,
GATA3	GATA binding protein 3(GATA3)	Homo sapiens	78.B_Cell_Development,80.T_cell_Activation,89.CD4_T_Cell_Differentiation,	h_gata3Pathway:GATA3 participate in activating the Th2 cytokine genes expression,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001701~in utero embryonic development,GO:0001709~cell fate determination,GO:0001764~neuron migration,GO:0001806~type IV hypersensitivity,GO:0001822~kidney development,GO:0001823~mesonephros development,GO:0002088~lens development in camera-type eye,GO:0002572~pro-T cell differentiation,GO:0003180~aortic valve morphogenesis,GO:0003215~cardiac right ventricle morphogenesis,GO:0003281~ventricular septum development,GO:0006338~chromatin remodeling,GO:0006366~transcription from RNA polymerase II promoter,GO:0006952~defense response,GO:0006959~humoral immune response,GO:0007165~signal transduction,GO:0007411~axon guidance,GO:0007507~heart development,GO:0007596~blood coagulation,GO:0008285~negative regulation of cell proliferation,GO:0008584~male gonad development,GO:0009615~response to virus,GO:0009653~anatomical structure morphogenesis,GO:0009791~post-embryonic development,GO:0009887~organ morphogenesis,GO:0009967~positive regulation of signal transduction,GO:0010332~response to gamma radiation,GO:0010595~positive regulation of endothelial cell migration,GO:0010975~regulation of neuron projection development,GO:0014065~phosphatidylinositol 3-kinase signaling,GO:0030218~erythrocyte differentiation,GO:0031929~TOR signaling,GO:0032689~negative regulation of interferon-gamma production,GO:0032703~negative regulation of interleukin-2 production,GO:0032753~positive regulation of interleukin-4 production,GO:0033600~negative regulation of mammary gland epithelial cell proliferation,GO:0035162~embryonic hemopoiesis,GO:0035457~cellular response to interferon-alpha,GO:0035799~ureter maturation,GO:0035898~parathyroid hormone secretion,GO:0042035~regulation of cytokine biosynthetic process,GO:0042421~norepinephrine biosynthetic process,GO:0042472~inner ear morphogenesis,GO:0042493~response to drug,GO:0043370~regulation of CD4-positive, alpha-beta T cell differentiation,GO:0043523~regulation of neuron apoptotic process,GO:0043583~ear development,GO:0043627~response to estrogen,GO:0045061~thymic T cell selection,GO:0045064~T-helper 2 cell differentiation,GO:0045087~innate immune response,GO:0045165~cell fate commitment,GO:0045471~response to ethanol,GO:0045582~positive regulation of T cell differentiation,GO:0045599~negative regulation of fat cell differentiation,GO:0045786~negative regulation of cell cycle,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048469~cell maturation,GO:0048485~sympathetic nervous system development,GO:0048538~thymus development,GO:0048565~digestive tract development,GO:0048589~developmental growth,GO:0048646~anatomical structure formation involved in morphogenesis,GO:0050728~negative regulation of inflammatory response,GO:0050852~T cell receptor signaling pathway,GO:0051569~regulation of histone H3-K4 methylation,GO:0051897~positive regulation of protein kinase B signaling,GO:0060017~parathyroid gland development,GO:0060037~pharyngeal system development,GO:0060065~uterus development,GO:0060231~mesenchymal to epithelial transition,GO:0060374~mast cell differentiation,GO:0060676~ureteric bud formation,GO:0061085~regulation of histone H3-K27 methylation,GO:0061290~canonical Wnt signaling pathway involved in metanephric kidney development,GO:0071353~cellular response to interleukin-4,GO:0071356~cellular response to tumor necrosis factor,GO:0071442~positive regulation of histone H3-K14 acetylation,GO:0071599~otic vesicle development,GO:0071773~cellular response to BMP stimulus,GO:0072107~positive regulation of ureteric bud formation,GO:0072178~nephric duct morphogenesis,GO:0072179~nephric duct formation,GO:0072182~regulation of nephron tubule epithelial cell differentiation,GO:0072602~interleukin-4 secretion,GO:0072643~interferon-gamma secretion,GO:0072676~lymphocyte migration,GO:0090102~cochlea development,GO:1901536~negative regulation of DNA demethylation,GO:2000114~regulation of establishment of cell polarity,GO:2000146~negative regulation of cell motility,GO:2000352~negative regulation of endothelial cell apoptotic process,GO:2000553~positive regulation of T-helper 2 cell cytokine production,GO:2000607~negative regulation of cell proliferation involved in mesonephros development,GO:2000611~positive regulation of thyroid hormone generation,GO:2000617~positive regulation of histone H3-K9 acetylation,GO:2000664~positive regulation of interleukin-5 secretion,GO:2000667~positive regulation of interleukin-13 secretion,GO:2000679~positive regulation of transcription regulatory region DNA binding,GO:2000683~regulation of cellular response to X-ray,GO:2000703~negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,GO:2000734~negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005730~nucleolus,	GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000979~RNA polymerase II core promoter sequence-specific DNA binding,GO:0000987~core promoter proximal region sequence-specific DNA binding,GO:0001046~core promoter sequence-specific DNA binding,GO:0001071~nucleic acid binding transcription factor activity,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001078~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001085~RNA polymerase II transcription factor binding,GO:0001158~enhancer sequence-specific DNA binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003713~transcription coactivator activity,GO:0005134~interleukin-2 receptor binding,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0008270~zinc ion binding,GO:0044212~transcription regulatory region DNA binding,GO:0046983~protein dimerization activity,GO:0070888~E-box binding,GO:0071837~HMG box domain binding,	IPR000679:Zinc finger, GATA-type,IPR013088:Zinc finger, NHR/GATA-type,IPR016374:Transcription factor, GATA-1/2/3,		146255~Hypoparathyroidism, sensorineural deafness, and renal dysplasia,	PIRSF003027:transcription factor, GATA-1/2/3 types,	SM00401:ZnF_GATA,	3D-structure,Activator,Alternative splicing,Complete proteome,Deafness,Disease mutation,DNA-binding,Immunity,Innate immunity,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Trans-acting T-cell-specific transcription factor GATA-3,compositionally biased region:Poly-Ser,compositionally biased region:Poly-Thr,modified residue,sequence conflict,sequence variant,splice variant,zinc finger region:GATA-type 1,zinc finger region:GATA-type 2,
GCC2	GRIP and coiled-coil domain containing 2(GCC2)	Homo sapiens				GO:0000042~protein targeting to Golgi,GO:0006622~protein targeting to lysosome,GO:0031023~microtubule organizing center organization,GO:0034067~protein localization to Golgi apparatus,GO:0034453~microtubule anchoring,GO:0034499~late endosome to Golgi transport,GO:0042147~retrograde transport, endosome to Golgi,GO:0043001~Golgi to plasma membrane protein transport,GO:0070861~regulation of protein exit from endoplasmic reticulum,GO:0071955~recycling endosome to Golgi transport,GO:0090161~Golgi ribbon formation,	GO:0005622~intracellular,GO:0005794~Golgi apparatus,GO:0005802~trans-Golgi network,GO:0005829~cytosol,GO:0016020~membrane,	GO:0005515~protein binding,GO:0042802~identical protein binding,	IPR000237:GRIP,				SM00755:Grip,	3D-structure,Acetylation,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Golgi apparatus,Membrane,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Transport,	chain:GRIP and coiled-coil domain-containing protein 2,compositionally biased region:Glu-rich,domain:GRIP,helix,modified residue,mutagenesis site,sequence conflict,sequence variant,splice variant,
IWS1	IWS1, SUPT6H interacting protein(IWS1)	Homo sapiens			General function prediction only,	GO:0006351~transcription, DNA-templated,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0010793~regulation of mRNA export from nucleus,GO:0032784~regulation of DNA-templated transcription, elongation,GO:0050684~regulation of mRNA processing,GO:0051028~mRNA transport,GO:0090239~regulation of histone H4 acetylation,GO:2001253~regulation of histone H3-K36 trimethylation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0003677~DNA binding,GO:0005515~protein binding,	IPR017923:Transcription factor IIS, N-terminal,					Acetylation,Alternative splicing,Complete proteome,mRNA processing,mRNA splicing,mRNA transport,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Transport,	chain:Protein IWS1 homolog,compositionally biased region:Glu-rich,domain:TFIIS N-terminal,modified residue,region of interest:3 X approximate tandem repeats,repeat:1,repeat:2,repeat:3; half-length,sequence conflict,sequence variant,splice variant,
LARP1	La ribonucleoprotein domain family member 1(LARP1)	Homo sapiens			Posttranslational modification, protein turnover, chaperones / Translation, ribosomal structure and biogenesis,	GO:0006413~translational initiation,GO:0008283~cell proliferation,GO:0016239~positive regulation of macroautophagy,GO:0031929~TOR signaling,GO:0045070~positive regulation of viral genome replication,GO:0045727~positive regulation of translation,GO:0098609~cell-cell adhesion,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005913~cell-cell adherens junction,GO:0016020~membrane,GO:0031931~TORC1 complex,	GO:0000339~RNA cap binding,GO:0003730~mRNA 3'-UTR binding,GO:0005515~protein binding,GO:0008190~eukaryotic initiation factor 4E binding,GO:0008494~translation activator activity,GO:0031369~translation initiation factor binding,GO:0044822~poly(A) RNA binding,GO:0048027~mRNA 5'-UTR binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR006607:Protein of unknown function DM15,IPR006630:RNA-binding protein Lupus La,IPR011991:Winged helix-turn-helix DNA-binding domain,				SM00684:DM15,SM00715:LA,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Direct protein sequencing,Isopeptide bond,Methylation,Phosphoprotein,Protein biosynthesis,Proteomics identification,Reference proteome,RNA-binding,Ubl conjugation,	chain:La-related protein 1,compositionally biased region:Poly-Gly,domain:HTH La-type RNA-binding,modified residue,sequence conflict,splice variant,
LARP4B	La ribonucleoprotein domain family member 4B(LARP4B)	Homo sapiens				GO:0045727~positive regulation of translation,	GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0010494~cytoplasmic stress granule,GO:0016020~membrane,GO:0042788~polysomal ribosome,	GO:0000166~nucleotide binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR006630:RNA-binding protein Lupus La,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR012677:Nucleotide-binding, alpha-beta plait,				SM00715:LA,	3D-structure,Acetylation,Complete proteome,Cytoplasm,Methylation,Phosphoprotein,Proteomics identification,Reference proteome,RNA-binding,Translation regulation,	chain:La-related protein 4B,domain:HTH La-type RNA-binding,domain:RRM,modified residue,
MAP7D1	MAP7 domain containing 1(MAP7D1)	Homo sapiens				GO:0000226~microtubule cytoskeleton organization,	GO:0005737~cytoplasm,GO:0005819~spindle,GO:0015630~microtubule cytoskeleton,	GO:0005198~structural molecule activity,	IPR008604:E-MAP-115,					Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Isopeptide bond,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:MAP7 domain-containing protein 1,compositionally biased region:Pro-rich,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),modified residue,sequence conflict,sequence variant,splice variant,
MGA	MGA, MAX dimerization protein(MGA)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0071339~MLL1 complex,	GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0046983~protein dimerization activity,	IPR001699:Transcription factor, T-box,IPR008967:p53-like transcription factor, DNA-binding,IPR011598:Myc-type, basic helix-loop-helix (bHLH) domain,IPR018186:Transcription factor, T-box, conserved site,				SM00353:HLH,SM00425:TBOX,	Alternative splicing,Coiled coil,Complete proteome,DNA-binding,Isopeptide bond,Methylation,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,Ubl conjugation,	chain:MAX gene-associated protein,compositionally biased region:Gln-rich,compositionally biased region:Poly-Ser,compositionally biased region:Thr-rich,DNA-binding region:Basic motif,DNA-binding region:T-box,domain:Helix-loop-helix motif,modified residue,sequence conflict,sequence variant,splice variant,
MIS18BP1	MIS18 binding protein 1(MIS18BP1)	Homo sapiens				GO:0007067~mitotic nuclear division,GO:0034080~CENP-A containing nucleosome assembly,GO:0051301~cell division,	GO:0000778~condensed nuclear chromosome kinetochore,GO:0005654~nucleoplasm,	GO:0003677~DNA binding,GO:0005515~protein binding,	IPR001005:SANT/Myb domain,IPR009057:Homeodomain-like,IPR015216:SANT associated,IPR017884:SANT domain,				SM00717:SANT,	3D-structure,Alternative splicing,Cell cycle,Cell division,Centromere,Chromosome,Complete proteome,DNA-binding,Isopeptide bond,Mitosis,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation,	chain:Kinetochore-associated protein KNL-2 homolog,compositionally biased region:Poly-Asp,domain:SANT,helix,modified residue,sequence conflict,sequence variant,splice variant,strand,turn,
MORC4	MORC family CW-type zinc finger 4(MORC4)	Homo sapiens					GO:0005654~nucleoplasm,	GO:0005515~protein binding,GO:0008270~zinc ion binding,	IPR003594:Histidine kinase-like ATPase, ATP-binding domain,IPR011124:Zinc finger, CW-type,					Alternative splicing,Coiled coil,Complete proteome,Metal-binding,Nucleus,Polymorphism,Reference proteome,Zinc,Zinc-finger,	chain:MORC family CW-type zinc finger protein 4,modified residue,sequence conflict,sequence variant,zinc finger region:CW-type,
NFKBIA	NFKB inhibitor alpha(NFKBIA)	Homo sapiens	17.Activators-CAM,77.IkBa_Kinase_JNK_MEKK1,90.IB_and-cat-Arm_processing_of_Ci,	h_41BBPathway:The 4-1BB-dependent immune response,h_aktPathway:AKT Signaling Pathway,h_atmPathway:ATM Signaling Pathway,h_cd40Pathway:CD40L Signaling Pathway,h_cdmacPathway:Cadmium induces DNA synthesis and proliferation in macrophages,h_deathPathway:Induction of apoptosis through DR3 and DR4/5 Death Receptors ,h_eponfkbPathway:Erythropoietin mediated neuroprotection through NF-kB,h_fmlpPathway:fMLP induced chemokine gene expression in HMC-1 cells,h_hivnefPathway:HIV-I Nef: negative effector of Fas and TNF,h_il1rPathway:Signal transduction through IL1R,h_keratinocytePathway:Keratinocyte Differentiation,h_mapkPathway:MAPKinase Signaling Pathway,h_nfkbPathway:NF-kB Signaling Pathway,h_nthiPathway:NFkB activation by Nontypeable Hemophilus influenzae,h_pkcPathway:Activation of PKC through G protein coupled receptor,h_PparaPathway:Mechanism of Gene Regulation by Peroxisome Proliferators via PPARa(alpha),h_raccycdPathway:Influence of Ras and Rho proteins on G1 to S Transition,h_relaPathway:Acetylation and Deacetylation of RelA in The Nucleus,h_rnaPathway:Double Stranded RNA Induced Gene Expression,h_stressPathway:TNF/Stress Related Signaling,h_tcrPathway:T Cell Receptor Signaling Pathway,h_tidPathway:Chaperones modulate interferon Signaling Pathway,h_tnfr2Pathway:TNFR2 Signaling Pathway,h_tollPathway:Toll-Like Receptor Pathway,h_vipPathway:Neuropeptides VIP and PACAP inhibit the apoptosis of activated T cells,		GO:0000060~protein import into nucleus, translocation,GO:0002223~stimulatory C-type lectin receptor signaling pathway,GO:0006915~apoptotic process,GO:0007253~cytoplasmic sequestering of NF-kappaB,GO:0010745~negative regulation of macrophage derived foam cell differentiation,GO:0010875~positive regulation of cholesterol efflux,GO:0010888~negative regulation of lipid storage,GO:0016032~viral process,GO:0031663~lipopolysaccharide-mediated signaling pathway,GO:0032088~negative regulation of NF-kappaB transcription factor activity,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032495~response to muramyl dipeptide,GO:0034142~toll-like receptor 4 signaling pathway,GO:0035994~response to muscle stretch,GO:0038095~Fc-epsilon receptor signaling pathway,GO:0042127~regulation of cell proliferation,GO:0042345~regulation of NF-kappaB import into nucleus,GO:0042994~cytoplasmic sequestering of transcription factor,GO:0043066~negative regulation of apoptotic process,GO:0043330~response to exogenous dsRNA,GO:0043392~negative regulation of DNA binding,GO:0045638~negative regulation of myeloid cell differentiation,GO:0045746~negative regulation of Notch signaling pathway,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0050852~T cell receptor signaling pathway,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0070417~cellular response to cold,GO:0070427~nucleotide-binding oligomerization domain containing 1 signaling pathway,GO:0070431~nucleotide-binding oligomerization domain containing 2 signaling pathway,GO:0071345~cellular response to cytokine stimulus,GO:0071407~cellular response to organic cyclic compound,GO:0097421~liver regeneration,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0033256~I-kappaB/NF-kappaB complex,	GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0008139~nuclear localization sequence binding,GO:0019899~enzyme binding,GO:0031072~heat shock protein binding,GO:0031625~ubiquitin protein ligase binding,GO:0032403~protein complex binding,GO:0042802~identical protein binding,GO:0051059~NF-kappaB binding,	IPR002110:Ankyrin repeat,IPR020683:Ankyrin repeat-containing domain,	hsa04024:cAMP signaling pathway,hsa04062:Chemokine signaling pathway,hsa04064:NF-kappa B signaling pathway,hsa04210:Apoptosis,hsa04380:Osteoclast differentiation,hsa04620:Toll-like receptor signaling pathway,hsa04621:NOD-like receptor signaling pathway,hsa04622:RIG-I-like receptor signaling pathway,hsa04623:Cytosolic DNA-sensing pathway,hsa04660:T cell receptor signaling pathway,hsa04662:B cell receptor signaling pathway,hsa04668:TNF signaling pathway,hsa04722:Neurotrophin signaling pathway,hsa04920:Adipocytokine signaling pathway,hsa04931:Insulin resistance,hsa05120:Epithelial cell signaling in Helicobacter pylori infection,hsa05131:Shigellosis,hsa05134:Legionellosis,hsa05140:Leishmaniasis,hsa05142:Chagas disease (American trypanosomiasis),hsa05145:Toxoplasmosis,hsa05160:Hepatitis C,hsa05161:Hepatitis B,hsa05162:Measles,hsa05164:Influenza A,hsa05166:HTLV-I infection,hsa05168:Herpes simplex infection,hsa05169:Epstein-Barr virus infection,hsa05200:Pathways in cancer,hsa05203:Viral carcinogenesis,hsa05215:Prostate cancer,hsa05220:Chronic myeloid leukemia,hsa05222:Small cell lung cancer,	612132~Ectodermal dysplasia, anhidrotic, with T-cell immunodeficiency,		SM00248:ANK,	3D-structure,ANK repeat,Complete proteome,Cytoplasm,Disease mutation,Ectodermal dysplasia,Host-virus interaction,Hydroxylation,Isopeptide bond,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Ubl conjugation,	chain:NF-kappa-B inhibitor alpha,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),helix,modified residue,mutagenesis site,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,repeat:ANK 4,repeat:ANK 5,sequence variant,short sequence motif:Nuclear export signal,short sequence motif:Nuclear import signal,strand,turn,
NIPBL	NIPBL, cohesin loading factor(NIPBL)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001656~metanephros development,GO:0003007~heart morphogenesis,GO:0003151~outflow tract morphogenesis,GO:0006974~cellular response to DNA damage stimulus,GO:0007064~mitotic sister chromatid cohesion,GO:0007420~brain development,GO:0007605~sensory perception of sound,GO:0010468~regulation of gene expression,GO:0019827~stem cell population maintenance,GO:0031065~positive regulation of histone deacetylation,GO:0034088~maintenance of mitotic sister chromatid cohesion,GO:0034613~cellular protein localization,GO:0035115~embryonic forelimb morphogenesis,GO:0035136~forelimb morphogenesis,GO:0035261~external genitalia morphogenesis,GO:0040018~positive regulation of multicellular organism growth,GO:0042471~ear morphogenesis,GO:0042634~regulation of hair cycle,GO:0045444~fat cell differentiation,GO:0045778~positive regulation of ossification,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0045995~regulation of embryonic development,GO:0048557~embryonic digestive tract morphogenesis,GO:0048589~developmental growth,GO:0048592~eye morphogenesis,GO:0048638~regulation of developmental growth,GO:0048703~embryonic viscerocranium morphogenesis,GO:0050890~cognition,GO:0060325~face morphogenesis,GO:0061010~gall bladder development,GO:0061038~uterus morphogenesis,GO:0071481~cellular response to X-ray,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0032116~SMC loading complex,GO:0070062~extracellular exosome,	GO:0003682~chromatin binding,GO:0005515~protein binding,GO:0008022~protein C-terminus binding,GO:0036033~mediator complex binding,GO:0042826~histone deacetylase binding,GO:0047485~protein N-terminus binding,GO:0070087~chromo shadow domain binding,	IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,IPR024986:Sister chromatid cohesion C-terminal domain,IPR026003:HEAT repeat associated with sister chromatid cohesion protein,		122470~Cornelia de Lange syndrome 1,			Acetylation,Alternative splicing,Cell cycle,Complete proteome,Disease mutation,Mental retardation,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:Nipped-B-like protein,compositionally biased region:Gln-rich,modified residue,repeat:HEAT 1,repeat:HEAT 2,repeat:HEAT 3,repeat:HEAT 4,repeat:HEAT 5,sequence conflict,sequence variant,short sequence motif:PxVxL motif,splice variant,
PAN3	PAN3 poly(A) specific ribonuclease subunit(PAN3)	Homo sapiens				GO:0000289~nuclear-transcribed mRNA poly(A) tail shortening,GO:0000290~deadenylation-dependent decapping of nuclear-transcribed mRNA,GO:0006397~mRNA processing,GO:0006468~protein phosphorylation,GO:0006605~protein targeting,GO:0010606~positive regulation of cytoplasmic mRNA processing body assembly,GO:0090503~RNA phosphodiester bond hydrolysis, exonucleolytic,	GO:0000932~cytoplasmic mRNA processing body,GO:0005829~cytosol,GO:0031251~PAN complex,	GO:0004535~poly(A)-specific ribonuclease activity,GO:0004672~protein kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR000571:Zinc finger, CCCH-type,IPR000719:Protein kinase, catalytic domain,IPR011009:Protein kinase-like domain,	hsa03018:RNA degradation,			SM00356:ZnF_C3H1,	Alternative splicing,ATP-binding,Coiled coil,Complete proteome,Cytoplasm,Metal-binding,mRNA processing,Nucleotide-binding,Phosphoprotein,Proteomics identification,Reference proteome,Zinc,Zinc-finger,	chain:PAB-dependent poly(A)-specific ribonuclease subunit 3,domain:Protein kinase,region of interest:Interaction with PAN2,region of interest:Interaction with polyadenylate-binding protein,sequence conflict,splice variant,
PSIP1	PC4 and SFRS1 interacting protein 1(PSIP1)	Homo sapiens				GO:0000395~mRNA 5'-splice site recognition,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006979~response to oxidative stress,GO:0009408~response to heat,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051169~nuclear transport,GO:0075713~establishment of integrated proviral latency,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005720~nuclear heterochromatin,GO:0005829~cytosol,GO:0034399~nuclear periphery,GO:0035327~transcriptionally active chromatin,	GO:0001105~RNA polymerase II transcription coactivator activity,GO:0003682~chromatin binding,GO:0005515~protein binding,GO:0033613~activating transcription factor binding,GO:0044822~poly(A) RNA binding,GO:0097100~supercoiled DNA binding,	IPR000313:PWWP,IPR017859:Treacle-like, Treacher Collins Syndrome,IPR021567:Lens epithelium-derived growth factor (LEDGF),				SM00293:PWWP,	3D-structure,Alternative splicing,Chromosomal rearrangement,Citrullination,Coiled coil,Complete proteome,Direct protein sequencing,DNA-binding,Host-virus interaction,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:PC4 and SFRS1-interacting protein,domain:PWWP,helix,modified residue,mutagenesis site,sequence conflict,short sequence motif:Nuclear localization signal,splice variant,
PDS5B	PDS5 cohesin associated factor B(PDS5B)	Homo sapiens				GO:0006281~DNA repair,GO:0007062~sister chromatid cohesion,GO:0007064~mitotic sister chromatid cohesion,GO:0008283~cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0042127~regulation of cell proliferation,GO:0051301~cell division,	GO:0000775~chromosome, centromeric region,GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005829~cytosol,	GO:0003677~DNA binding,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,					3D-structure,Acetylation,Alternative splicing,Cell cycle,Cell division,Complete proteome,Mitosis,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,	chain:Sister chromatid cohesion protein PDS5 homolog B,DNA-binding region:A.T hook 1,DNA-binding region:A.T hook 2,DNA-binding region:A.T hook 3,modified residue,repeat:HEAT,sequence conflict,splice variant,
PHF10	PHD finger protein 10(PHF10)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007399~nervous system development,	GO:0005634~nucleus,GO:0071564~npBAF complex,	GO:0008270~zinc ion binding,	IPR001965:Zinc finger, PHD-type,IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR019787:Zinc finger, PHD-finger,				SM00249:PHD,	Acetylation,Alternative splicing,Complete proteome,Isopeptide bond,Metal-binding,Neurogenesis,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Ubl conjugation,Zinc,Zinc-finger,	chain:PHD finger protein 10,modified residue,region of interest:Essential to induce neural progenitor proliferation,region of interest:SAY,sequence conflict,splice variant,zinc finger region:PHD-type 1; degenerate,zinc finger region:PHD-type 2; degenerate,
PHF14	PHD finger protein 14(PHF14)	Homo sapiens			General function prediction only,	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0048286~lung alveolus development,GO:2000584~negative regulation of platelet-derived growth factor receptor-alpha signaling pathway,GO:2000791~negative regulation of mesenchymal cell proliferation involved in lung development,	GO:0005634~nucleus,	GO:0008270~zinc ion binding,	IPR001965:Zinc finger, PHD-type,IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR019786:Zinc finger, PHD-type, conserved site,IPR019787:Zinc finger, PHD-finger,				SM00249:PHD,	Alternative initiation,Alternative splicing,Coiled coil,Complete proteome,Metal-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Zinc,Zinc-finger,	chain:PHD finger protein 14,compositionally biased region:Glu/Lys-rich,modified residue,sequence conflict,sequence variant,splice variant,zinc finger region:PHD-type 1,zinc finger region:PHD-type 2,
PNISR	PNN interacting serine and arginine rich protein(PNISR)	Homo sapiens					GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016607~nuclear speck,	GO:0044822~poly(A) RNA binding,						Alternative splicing,Coiled coil,Complete proteome,Isopeptide bond,Nucleus,Phosphoprotein,Reference proteome,Ubl conjugation,	chain:Splicing factor, arginine/serine-rich 18,compositionally biased region:Gln-rich,compositionally biased region:Pro-rich,compositionally biased region:Ser-rich,modified residue,sequence conflict,splice variant,
QKI	QKI, KH domain containing RNA binding(QKI)	Homo sapiens				GO:0001570~vasculogenesis,GO:0006397~mRNA processing,GO:0007286~spermatid development,GO:0008380~RNA splicing,GO:0010628~positive regulation of gene expression,GO:0042552~myelination,GO:0042692~muscle cell differentiation,GO:0042759~long-chain fatty acid biosynthetic process,GO:0051028~mRNA transport,GO:0061158~3'-UTR-mediated mRNA destabilization,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0005515~protein binding,GO:0017124~SH3 domain binding,GO:0044822~poly(A) RNA binding,	IPR004087:K Homology domain,IPR004088:K Homology domain, type 1,				SM00322:KH,	3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Developmental protein,Differentiation,Methylation,mRNA processing,mRNA splicing,mRNA transport,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,RNA-binding,SH3-binding,Translation regulation,Transport,	chain:Protein quaking,domain:KH,sequence conflict,sequence variant,short sequence motif:Nuclear localization signal,short sequence motif:SH3-binding,splice variant,
RAD50	RAD50 double strand break repair protein(RAD50)	Homo sapiens		h_atmPathway:ATM Signaling Pathway,h_atrbrcaPathway:Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility,		GO:0000019~regulation of mitotic recombination,GO:0000722~telomere maintenance via recombination,GO:0000723~telomere maintenance,GO:0000724~double-strand break repair via homologous recombination,GO:0000729~DNA double-strand break processing,GO:0000731~DNA synthesis involved in DNA repair,GO:0000732~strand displacement,GO:0006260~DNA replication,GO:0006281~DNA repair,GO:0006302~double-strand break repair,GO:0006303~double-strand break repair via nonhomologous end joining,GO:0006310~DNA recombination,GO:0006974~cellular response to DNA damage stimulus,GO:0007004~telomere maintenance via telomerase,GO:0007131~reciprocal meiotic recombination,GO:0016032~viral process,GO:0031860~telomeric 3' overhang formation,GO:0031954~positive regulation of protein autophosphorylation,GO:0032206~positive regulation of telomere maintenance,GO:0032508~DNA duplex unwinding,GO:0033674~positive regulation of kinase activity,GO:0046939~nucleotide phosphorylation,GO:0070192~chromosome organization involved in meiotic cell cycle,GO:0090305~nucleic acid phosphodiester bond hydrolysis,GO:1901796~regulation of signal transduction by p53 class mediator,GO:1904354~negative regulation of telomere capping,	GO:0000784~nuclear chromosome, telomeric region,GO:0000790~nuclear chromatin,GO:0000794~condensed nuclear chromosome,GO:0005654~nucleoplasm,GO:0016020~membrane,GO:0030870~Mre11 complex,GO:0035861~site of double-strand break,	GO:0000014~single-stranded DNA endodeoxyribonuclease activity,GO:0003677~DNA binding,GO:0003691~double-stranded telomeric DNA binding,GO:0004003~ATP-dependent DNA helicase activity,GO:0004017~adenylate kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008408~3'-5' exonuclease activity,GO:0016887~ATPase activity,GO:0030674~protein binding, bridging,GO:0043047~single-stranded telomeric DNA binding,GO:0046872~metal ion binding,GO:0051880~G-quadruplex DNA binding,	IPR004584:DNA repair protein Rad50,IPR013134:Zinc hook, Rad50,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa03440:Homologous recombination,hsa03450:Non-homologous end-joining,	613078~Nijmegen breakage syndrome-like disorder,			Acetylation,Alternative splicing,ATP-binding,Cell cycle,Chromosome,Coiled coil,Complete proteome,DNA damage,DNA repair,Host-virus interaction,Hydrolase,Meiosis,Metal-binding,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Telomere,Zinc,	chain:DNA repair protein RAD50,compositionally biased region:Ala/Asp-rich (DA-box),domain:Zinc-hook,metal ion-binding site:Zinc,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,
RASA1	RAS p21 protein activator 1(RASA1)	Homo sapiens		h_egfPathway:EGF Signaling Pathway,h_hivnefPathway:HIV-I Nef: negative effector of Fas and TNF,h_igf1Pathway:IGF-1 Signaling Pathway,h_insulinPathway:Insulin Signaling Pathway,h_metPathway:Signaling of Hepatocyte Growth Factor Receptor,h_pdgfPathway:PDGF Signaling Pathway,h_sam68Pathway:Regulation of Splicing through Sam68,h_spryPathway:Sprouty regulation of tyrosine kinase signals,h_tcrPathway:T Cell Receptor Signaling Pathway,h_tpoPathway:TPO Signaling Pathway,		GO:0000165~MAPK cascade,GO:0000281~mitotic cytokinesis,GO:0001570~vasculogenesis,GO:0001953~negative regulation of cell-matrix adhesion,GO:0007162~negative regulation of cell adhesion,GO:0007165~signal transduction,GO:0008360~regulation of cell shape,GO:0009790~embryo development,GO:0030833~regulation of actin filament polymerization,GO:0035556~intracellular signal transduction,GO:0043524~negative regulation of neuron apoptotic process,GO:0043547~positive regulation of GTPase activity,GO:0046580~negative regulation of Ras protein signal transduction,GO:0048013~ephrin receptor signaling pathway,GO:0048514~blood vessel morphogenesis,GO:0051252~regulation of RNA metabolic process,	GO:0001726~ruffle,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0031235~intrinsic component of the cytoplasmic side of the plasma membrane,	GO:0001948~glycoprotein binding,GO:0005096~GTPase activator activity,GO:0005102~receptor binding,GO:0005515~protein binding,GO:0019870~potassium channel inhibitor activity,GO:0051020~GTPase binding,	IPR000008:C2 calcium-dependent membrane targeting,IPR000980:SH2 domain,IPR001452:Src homology-3 domain,IPR001849:Pleckstrin homology domain,IPR001936:Ras GTPase-activating protein,IPR008936:Rho GTPase activation protein,IPR011993:Pleckstrin homology-like domain,IPR023152:Ras GTPase-activating protein, conserved site,	hsa04010:MAPK signaling pathway,hsa04014:Ras signaling pathway,hsa04360:Axon guidance,	605462~Basal cell carcinoma, somatic,608354~Capillary malformation-arteriovenous malformation,608355~Parkes Weber syndrome,		SM00233:PH,SM00239:C2,SM00252:SH2,SM00323:RasGAP,SM00326:SH3,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Direct protein sequencing,Disease mutation,GTPase activation,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,SH2 domain,SH3 domain,Tumor suppressor,	chain:Ras GTPase-activating protein 1,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Gly,compositionally biased region:Poly-Pro,domain:C2,domain:PH,domain:Ras-GAP,domain:SH2 1,domain:SH2 2,domain:SH3,helix,modified residue,sequence conflict,sequence variant,splice variant,strand,turn,
RB1	RB transcriptional corepressor 1(RB1)	Homo sapiens	94.E2F_transcriptional_activity_cell_cycle,	h_arfPathway:Tumor Suppressor Arf Inhibits Ribosomal Biogenesis,h_btg2Pathway:BTG family proteins and cell cycle regulation,h_cellcyclePathway:Cyclins and Cell Cycle Regulation,h_fasPathway:FAS signaling pathway ( CD95 ),h_fbw7Pathway:Cyclin E Destruction Pathway,h_g1Pathway:Cell Cycle: G1/S Check Point ,h_hcmvPathway:Human Cytomegalovirus and Map Kinase Pathways,h_hivnefPathway:HIV-I Nef: negative effector of Fas and TNF,h_p27Pathway:Regulation of p27 Phosphorylation during Cell Cycle Progression,h_p53Pathway:p53 Signaling Pathway,h_pmlPathway:Regulation of transcriptional activity by PML,h_PparaPathway:Mechanism of Gene Regulation by Peroxisome Proliferators via PPARa(alpha),h_raccycdPathway:Influence of Ras and Rho proteins on G1 to S Transition,h_rbPathway:RB Tumor Suppressor/Checkpoint Signaling in response to DNA damage,h_skp2e2fPathway:E2F1 Destruction Pathway,h_telPathway:Telomeres, Telomerase, Cellular Aging, and  Immortality,h_tercPathway:Overview of telomerase RNA component gene hTerc Transcriptional Regulation,h_tidPathway:Chaperones modulate interferon Signaling Pathway,h_tnfr1Pathway:TNFR1 Signaling Pathway,		GO:0000075~cell cycle checkpoint,GO:0000082~G1/S transition of mitotic cell cycle,GO:0000083~regulation of transcription involved in G1/S transition of mitotic cell cycle,GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001558~regulation of cell growth,GO:0001894~tissue homeostasis,GO:0006338~chromatin remodeling,GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006469~negative regulation of protein kinase activity,GO:0006915~apoptotic process,GO:0007050~cell cycle arrest,GO:0007070~negative regulation of transcription from RNA polymerase II promoter during mitosis,GO:0007093~mitotic cell cycle checkpoint,GO:0007265~Ras protein signal transduction,GO:0007346~regulation of mitotic cell cycle,GO:0008285~negative regulation of cell proliferation,GO:0010629~negative regulation of gene expression,GO:0016032~viral process,GO:0016569~covalent chromatin modification,GO:0030521~androgen receptor signaling pathway,GO:0031134~sister chromatid biorientation,GO:0031175~neuron projection development,GO:0034088~maintenance of mitotic sister chromatid cohesion,GO:0034349~glial cell apoptotic process,GO:0035914~skeletal muscle cell differentiation,GO:0042551~neuron maturation,GO:0043353~enucleate erythrocyte differentiation,GO:0043433~negative regulation of sequence-specific DNA binding transcription factor activity,GO:0043550~regulation of lipid kinase activity,GO:0045445~myoblast differentiation,GO:0045651~positive regulation of macrophage differentiation,GO:0045842~positive regulation of mitotic metaphase/anaphase transition,GO:0045879~negative regulation of smoothened signaling pathway,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048565~digestive tract development,GO:0048667~cell morphogenesis involved in neuron differentiation,GO:0050680~negative regulation of epithelial cell proliferation,GO:0051146~striated muscle cell differentiation,GO:0051301~cell division,GO:0051402~neuron apoptotic process,GO:0051726~regulation of cell cycle,GO:0071459~protein localization to chromosome, centromeric region,GO:0071466~cellular response to xenobiotic stimulus,GO:0071922~regulation of cohesin loading,GO:0071930~negative regulation of transcription involved in G1/S transition of mitotic cell cycle,GO:0090230~regulation of centromere complex assembly,GO:0097284~hepatocyte apoptotic process,GO:2000134~negative regulation of G1/S transition of mitotic cell cycle,GO:2000679~positive regulation of transcription regulatory region DNA binding,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005819~spindle,GO:0008024~cyclin/CDK positive transcription elongation factor complex,GO:0016514~SWI/SNF complex,GO:0016605~PML body,GO:0035189~Rb-E2F complex,	GO:0001047~core promoter binding,GO:0001102~RNA polymerase II activating transcription factor binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003713~transcription coactivator activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0019900~kinase binding,GO:0031625~ubiquitin protein ligase binding,GO:0042802~identical protein binding,GO:0050681~androgen receptor binding,GO:0051219~phosphoprotein binding,	IPR002719:Retinoblastoma-associated protein, B-box,IPR002720:Retinoblastoma-associated protein, A-box,IPR013763:Cyclin-like,IPR015030:Rb C-terminal,IPR024599:Domain of unknown function DUF3452, retinoblastoma-associated,	hsa04110:Cell cycle,hsa05161:Hepatitis B,hsa05166:HTLV-I infection,hsa05169:Epstein-Barr virus infection,hsa05200:Pathways in cancer,hsa05203:Viral carcinogenesis,hsa05212:Pancreatic cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05218:Melanoma,hsa05219:Bladder cancer,hsa05220:Chronic myeloid leukemia,hsa05222:Small cell lung cancer,hsa05223:Non-small cell lung cancer,	109800~Bladder cancer, somatic,180200~Retinoblastoma,180200~Retinoblastoma, trilateral,182280~Small cell cancer of the lung, somatic,259500~Osteosarcoma, somatic,		SM00385:CYCLIN,SM01367:SM01367,SM01368:SM01368,SM01369:SM01369,	3D-structure,Acetylation,Cell cycle,Chromatin regulator,Complete proteome,Direct protein sequencing,Disease mutation,DNA-binding,Host-virus interaction,Methylation,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,Tumor suppressor,	chain:Retinoblastoma-associated protein,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Pro,helix,modified residue,mutagenesis site,region of interest:Domain A,region of interest:Domain B,region of interest:Domain C; mediates interaction with E4F1,region of interest:Interaction with LIMD1,region of interest:Pocket; binds T and E1A,region of interest:Spacer,sequence conflict,sequence variant,short sequence motif:Nuclear localization signal,strand,turn,
RBM6	RNA binding motif protein 6(RBM6)	Homo sapiens			Function unknown,	GO:0006396~RNA processing,	GO:0005634~nucleus,	GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR000467:G-patch domain,IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,				SM00360:RRM,SM00443:G_patch,	Alternative splicing,Coiled coil,Complete proteome,Isopeptide bond,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,RNA-binding,Ubl conjugation,	chain:RNA-binding protein 6,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Pro,domain:G-patch,domain:RRM,modified residue,sequence conflict,sequence variant,
RBMX	RNA binding motif protein, X-linked(RBMX)	Homo sapiens				GO:0000381~regulation of alternative mRNA splicing, via spliceosome,GO:0000398~mRNA splicing, via spliceosome,GO:0001649~osteoblast differentiation,GO:0006366~transcription from RNA polymerase II promoter,GO:0006376~mRNA splice site selection,GO:0006509~membrane protein ectodomain proteolysis,GO:0010467~gene expression,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048025~negative regulation of mRNA splicing, via spliceosome,GO:0048026~positive regulation of mRNA splicing, via spliceosome,GO:0051260~protein homooligomerization,GO:0071347~cellular response to interleukin-1,	GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005719~nuclear euchromatin,GO:0016020~membrane,GO:0030529~intracellular ribonucleoprotein complex,GO:0044530~supraspliceosomal complex,GO:0070062~extracellular exosome,GO:0071013~catalytic step 2 spliceosome,	GO:0000166~nucleotide binding,GO:0001047~core promoter binding,GO:0003676~nucleic acid binding,GO:0003682~chromatin binding,GO:0003723~RNA binding,GO:0003727~single-stranded RNA binding,GO:0003729~mRNA binding,GO:0005515~protein binding,GO:0042802~identical protein binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR003954:RNA recognition motif domain, eukaryote,IPR012604:RBM1CTR,IPR012677:Nucleotide-binding, alpha-beta plait,	hsa03040:Spliceosome,	300238~Mental retardation, X-linked, syndromic 11, Shashi type,		SM00360:RRM,SM00361:RRM_1,	3D-structure,Acetylation,Activator,Alternative splicing,Complete proteome,Direct protein sequencing,Glycoprotein,Isopeptide bond,Mental retardation,Methylation,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repressor,Ribonucleoprotein,RNA-binding,Spliceosome,Transcription,Tumor suppressor,Ubl conjugation,	chain:Heterogeneous nuclear ribonucleoprotein G,chain:Heterogeneous nuclear ribonucleoprotein G, N-terminally processed,domain:RRM,modified residue,sequence conflict,
RIN2	Ras and Rab interactor 2(RIN2)	Homo sapiens				GO:0006897~endocytosis,GO:0007165~signal transduction,GO:0007264~small GTPase mediated signal transduction,GO:0043547~positive regulation of GTPase activity,	GO:0005737~cytoplasm,	GO:0005096~GTPase activator activity,GO:0017112~Rab guanyl-nucleotide exchange factor activity,GO:0030695~GTPase regulator activity,	IPR000159:Ras-association,IPR000980:SH2 domain,IPR003123:Vacuolar sorting protein 9,		613075~Macrocephaly, alopecia, cutis laxa, and scoliosis,		SM00167:VPS9,SM00314:RA,	Alternative splicing,Complete proteome,Cytoplasm,Endocytosis,GTPase activation,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,SH2 domain,	chain:Ras and Rab interactor 2,compositionally biased region:Poly-Pro,domain:Ras-associating,domain:SH2,domain:VPS9,modified residue,sequence conflict,sequence variant,splice variant,
ARHGAP35	Rho GTPase activating protein 35(ARHGAP35)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001843~neural tube closure,GO:0006351~transcription, DNA-templated,GO:0007264~small GTPase mediated signal transduction,GO:0007411~axon guidance,GO:0007413~axonal fasciculation,GO:0008064~regulation of actin polymerization or depolymerization,GO:0008360~regulation of cell shape,GO:0010976~positive regulation of neuron projection development,GO:0016477~cell migration,GO:0021955~central nervous system neuron axonogenesis,GO:0030879~mammary gland development,GO:0030900~forebrain development,GO:0030950~establishment or maintenance of actin cytoskeleton polarity,GO:0031668~cellular response to extracellular stimulus,GO:0032956~regulation of actin cytoskeleton organization,GO:0035024~negative regulation of Rho protein signal transduction,GO:0043010~camera-type eye development,GO:0043116~negative regulation of vascular permeability,GO:0043547~positive regulation of GTPase activity,GO:0044319~wound healing, spreading of cells,GO:0045724~positive regulation of cilium assembly,GO:0045892~negative regulation of transcription, DNA-templated,GO:0050770~regulation of axonogenesis,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0097485~neuron projection guidance,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0015629~actin cytoskeleton,GO:0036064~ciliary basal body,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0001227~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0003714~transcription corepressor activity,GO:0005096~GTPase activator activity,GO:0005525~GTP binding,GO:0005543~phospholipid binding,	IPR000198:Rho GTPase-activating protein domain,IPR001806:Small GTPase superfamily,IPR002713:FF domain,IPR008936:Rho GTPase activation protein,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04510:Focal adhesion,hsa04611:Platelet activation,hsa04670:Leukocyte transendothelial migration,hsa04810:Regulation of actin cytoskeleton,			SM00324:RhoGAP,SM00441:FF,	3D-structure,Cell membrane,Cell projection,Complete proteome,Cytoplasm,Cytoskeleton,DNA-binding,GTPase activation,Membrane,Nucleus,Phosphoprotein,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,	chain:Glucocorticoid receptor DNA-binding factor 1,compositionally biased region:Pro-rich,domain:FF 1,domain:FF 2,domain:FF 3,domain:FF 4,domain:Rho-GAP,helix,modified residue,sequence conflict,splice variant,strand,turn,
SEC31A	SEC31 homolog A, COPII coat complex component(SEC31A)	Homo sapiens				GO:0002474~antigen processing and presentation of peptide antigen via MHC class I,GO:0006888~ER to Golgi vesicle-mediated transport,GO:0015031~protein transport,GO:0019886~antigen processing and presentation of exogenous peptide antigen via MHC class II,GO:0036498~IRE1-mediated unfolded protein response,GO:0048208~COPII vesicle coating,GO:0051592~response to calcium ion,	GO:0000139~Golgi membrane,GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005829~cytosol,GO:0012507~ER to Golgi transport vesicle membrane,GO:0030120~vesicle coat,GO:0030127~COPII vesicle coat,GO:0030134~ER to Golgi transport vesicle,GO:0043231~intracellular membrane-bounded organelle,GO:0048471~perinuclear region of cytoplasm,GO:0070971~endoplasmic reticulum exit site,	GO:0005515~protein binding,GO:0048306~calcium-dependent protein binding,	IPR001680:WD40 repeat,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,	hsa04141:Protein processing in endoplasmic reticulum,			SM00320:WD40,	3D-structure,Alternative splicing,Chromosomal rearrangement,Complete proteome,Cytoplasm,Cytoplasmic vesicle,Endoplasmic reticulum,ER-Golgi transport,Isopeptide bond,Membrane,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Proto-oncogene,Reference proteome,Repeat,Signal,Transport,Ubl conjugation,WD repeat,	chain:Protein transport protein Sec31A,compositionally biased region:Pro-rich,modified residue,region of interest:Interaction with PDCD6,region of interest:Interaction with SEC13,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,repeat:WD 7,sequence conflict,sequence variant,splice variant,
SEC63	SEC63 homolog, protein translocation regulator(SEC63)	Homo sapiens				GO:0001889~liver development,GO:0006612~protein targeting to membrane,GO:0006614~SRP-dependent cotranslational protein targeting to membrane,GO:0006620~posttranslational protein targeting to membrane,GO:0006807~nitrogen compound metabolic process,GO:0010259~multicellular organism aging,GO:0036498~IRE1-mediated unfolded protein response,GO:0072001~renal system development,	GO:0005622~intracellular,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005829~cytosol,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0004872~receptor activity,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR000008:C2 calcium-dependent membrane targeting,IPR001623:DnaJ domain,IPR004179:Sec63 domain,IPR014756:Immunoglobulin E-set,	hsa03060:Protein export,hsa04141:Protein processing in endoplasmic reticulum,	174050~Polycystic liver disease,		SM00271:DnaJ,SM00973:SM00973,	Chaperone,Coiled coil,Complete proteome,Disease mutation,Endoplasmic reticulum,Membrane,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Repeat,Transmembrane,Transmembrane helix,Transport,	chain:Translocation protein SEC63 homolog,compositionally biased region:Asp/Glu-rich (highly acidic),domain:J,domain:SEC63 1,domain:SEC63 2,modified residue,sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
SETD2	SET domain containing 2(SETD2)	Homo sapiens				GO:0001525~angiogenesis,GO:0001763~morphogenesis of a branching structure,GO:0001843~neural tube closure,GO:0006298~mismatch repair,GO:0006355~regulation of transcription, DNA-templated,GO:0006368~transcription elongation from RNA polymerase II promoter,GO:0010793~regulation of mRNA export from nucleus,GO:0030900~forebrain development,GO:0034728~nucleosome organization,GO:0035441~cell migration involved in vasculogenesis,GO:0048332~mesoderm morphogenesis,GO:0048701~embryonic cranial skeleton morphogenesis,GO:0048864~stem cell development,GO:0060039~pericardium development,GO:0060669~embryonic placenta morphogenesis,GO:0060977~coronary vasculature morphogenesis,GO:0097198~histone H3-K36 trimethylation,GO:0097676~histone H3-K36 dimethylation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,	GO:0005515~protein binding,GO:0018024~histone-lysine N-methyltransferase activity,GO:0046975~histone methyltransferase activity (H3-K36 specific),	IPR001202:WW domain,IPR001214:SET domain,IPR003616:Post-SET domain,IPR006560:AWS,IPR009078:Ferritin-like superfamily,IPR013257:SRI, Set2 Rpb1 interacting,	hsa00310:Lysine degradation,			SM00317:SET,SM00456:WW,SM00508:PostSET,SM00570:AWS,	3D-structure,Activator,Alternative splicing,Autism spectrum disorder,Chromatin regulator,Chromosome,Coiled coil,Complete proteome,Isopeptide bond,Mental retardation,Methyltransferase,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,S-adenosyl-L-methionine,Transcription,Transcription regulation,Transferase,Ubl conjugation,	chain:Histone-lysine N-methyltransferase SETD2,compositionally biased region:Arg-rich,compositionally biased region:Gln-rich,compositionally biased region:Pro-rich,domain:AWS,domain:Post-SET,domain:SET,domain:WW,helix,modified residue,mutagenesis site,region of interest:Interaction with POLR2A,region of interest:Low charge region,sequence conflict,sequence variant,splice variant,strand,turn,
SHC1	SHC adaptor protein 1(SHC1)	Homo sapiens	101.Gprot_coupled_Rec_MAP_Kinase,	h_at1rPathway:Angiotensin II mediated activation of JNK Pathway via Pyk2 dependent signaling,h_bcrPathway:BCR Signaling Pathway,h_biopeptidesPathway:Bioactive Peptide Induced Signaling Pathway,h_ecmPathway:Erk and PI-3 Kinase Are Necessary for Collagen Binding in Corneal Epithelia,h_egfPathway:EGF Signaling Pathway,h_epoPathway:EPO Signaling Pathway,h_erk5Pathway:Role of Erk5 in Neuronal Survival,h_erkPathway:Erk1/Erk2 Mapk Signaling pathway,h_fcer1Pathway:Fc Epsilon Receptor I Signaling in Mast Cells,h_ghPathway:Growth Hormone Signaling Pathway,h_hbxPathway:Calcium Signaling by HBx of Hepatitis B virus,h_her2Pathway:Role of ERBB2 in Signal Transduction and Oncology,h_igf1Pathway:IGF-1 Signaling Pathway,h_igf1rPathway:Multiple antiapoptotic pathways from IGF-1R signaling lead to BAD phosphorylation,h_il2Pathway:IL 2 signaling pathway,h_il2rbPathway:IL-2 Receptor Beta Chain in T cell Activation,h_il3Pathway:IL 3 signaling pathway,h_il4Pathway:IL 4 signaling pathway,h_il6Pathway:IL 6 signaling pathway,h_insulinPathway:Insulin Signaling Pathway,h_integrinPathway:Integrin Signaling Pathway,h_longevityPathway:The IGF-1 Receptor and Longevity,h_mapkPathway:MAPKinase Signaling Pathway,h_ngfPathway:Nerve growth factor pathway (NGF),h_p38mapkPathway:p38 MAPK Signaling Pathway ,h_pdgfPathway:PDGF Signaling Pathway,h_ptenPathway:PTEN dependent cell cycle arrest and apoptosis,h_pyk2Pathway:Links between Pyk2 and Map Kinases,h_spryPathway:Sprouty regulation of tyrosine kinase signals,h_tcrPathway:T Cell Receptor Signaling Pathway,h_tffPathway:Trefoil Factors Initiate  Mucosal Healing,h_tpoPathway:TPO Signaling Pathway,h_trkaPathway:Trka Receptor Signaling Pathway,h_vegfPathway:VEGF, Hypoxia, and Angiogenesis,		GO:0000165~MAPK cascade,GO:0000187~activation of MAPK activity,GO:0001525~angiogenesis,GO:0007165~signal transduction,GO:0007173~epidermal growth factor receptor signaling pathway,GO:0007176~regulation of epidermal growth factor-activated receptor activity,GO:0007265~Ras protein signal transduction,GO:0007507~heart development,GO:0008284~positive regulation of cell proliferation,GO:0008286~insulin receptor signaling pathway,GO:0016032~viral process,GO:0016337~single organismal cell-cell adhesion,GO:0031532~actin cytoskeleton reorganization,GO:0035556~intracellular signal transduction,GO:0036498~IRE1-mediated unfolded protein response,GO:0038095~Fc-epsilon receptor signaling pathway,GO:0038128~ERBB2 signaling pathway,GO:0040008~regulation of growth,GO:0043547~positive regulation of GTPase activity,GO:0045740~positive regulation of DNA replication,GO:0050900~leukocyte migration,GO:0071363~cellular response to growth factor stimulus,	GO:0005622~intracellular,GO:0005759~mitochondrial matrix,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0070435~Shc-EGFR complex,	GO:0005068~transmembrane receptor protein tyrosine kinase adaptor activity,GO:0005088~Ras guanyl-nucleotide exchange factor activity,GO:0005154~epidermal growth factor receptor binding,GO:0005158~insulin receptor binding,GO:0005159~insulin-like growth factor receptor binding,GO:0005168~neurotrophin TRKA receptor binding,GO:0005515~protein binding,GO:0005543~phospholipid binding,GO:0046875~ephrin receptor binding,GO:0048408~epidermal growth factor binding,	IPR000980:SH2 domain,IPR006019:Phosphotyrosine interaction (PID/PI),IPR006020:Phosphotyrosine interaction domain,IPR011993:Pleckstrin homology-like domain,	hsa04012:ErbB signaling pathway,hsa04014:Ras signaling pathway,hsa04062:Chemokine signaling pathway,hsa04510:Focal adhesion,hsa04650:Natural killer cell mediated cytotoxicity,hsa04722:Neurotrophin signaling pathway,hsa04910:Insulin signaling pathway,hsa04915:Estrogen signaling pathway,hsa04917:Prolactin signaling pathway,hsa05034:Alcoholism,hsa05100:Bacterial invasion of epithelial cells,hsa05206:MicroRNAs in cancer,hsa05214:Glioma,hsa05220:Chronic myeloid leukemia,			SM00252:SH2,SM00462:PTB,	3D-structure,Acetylation,Alternative promoter usage,Alternative splicing,Angiogenesis,Complete proteome,Cytoplasm,Growth regulation,Host-virus interaction,Mitochondrion,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,SH2 domain,	chain:SHC-transforming protein 1,compositionally biased region:Pro-rich,domain:PID,domain:SH2,helix,modified residue,region of interest:CH1,sequence conflict,sequence variant,splice variant,strand,turn,
SIN3A	SIN3 transcription regulator family member A(SIN3A)	Homo sapiens		h_etsPathway:METS affect on Macrophage Differentiation,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001701~in utero embryonic development,GO:0002218~activation of innate immune response,GO:0002230~positive regulation of defense response to virus by host,GO:0002244~hematopoietic progenitor cell differentiation,GO:0006260~DNA replication,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006476~protein deacetylation,GO:0007568~aging,GO:0010817~regulation of hormone levels,GO:0010971~positive regulation of G2/M transition of mitotic cell cycle,GO:0016575~histone deacetylation,GO:0031937~positive regulation of chromatin silencing,GO:0034613~cellular protein localization,GO:0042754~negative regulation of circadian rhythm,GO:0043066~negative regulation of apoptotic process,GO:0043619~regulation of transcription from RNA polymerase II promoter in response to oxidative stress,GO:0044255~cellular lipid metabolic process,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048511~rhythmic process,GO:0051595~response to methylglyoxal,GO:0071333~cellular response to glucose stimulus,GO:1900181~negative regulation of protein localization to nucleus,GO:1901675~negative regulation of histone H3-K27 acetylation,GO:1903351~cellular response to dopamine,GO:2000678~negative regulation of transcription regulatory region DNA binding,	GO:0000776~kinetochore,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0016580~Sin3 complex,GO:0017053~transcriptional repressor complex,GO:0045171~intercellular bridge,	GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0001102~RNA polymerase II activating transcription factor binding,GO:0001103~RNA polymerase II repressing transcription factor binding,GO:0001106~RNA polymerase II transcription corepressor activity,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003723~RNA binding,GO:0004407~histone deacetylase activity,GO:0005515~protein binding,GO:0032403~protein complex binding,GO:0033558~protein deacetylase activity,	IPR003822:Paired amphipathic helix,IPR013194:Histone deacetylase interacting,	hsa04919:Thyroid hormone signaling pathway,hsa05016:Huntington's disease,hsa05202:Transcriptional misregulation in cancer,			SM00761:HDAC_interact,	3D-structure,Acetylation,Biological rhythms,Coiled coil,Complete proteome,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,Ubl conjugation,	chain:Paired amphipathic helix protein Sin3a,modified residue,region of interest:Interaction with HCFC1,region of interest:Interaction with NCOR1,region of interest:Interaction with REST,region of interest:Interaction with SAP30,region of interest:Interactions with HDAC1 and ARID4B,region of interest:Interactions with SUDS3 and SAP130,repeat:PAH 1,repeat:PAH 2,repeat:PAH 3,sequence conflict,sequence variant,
SRGAP3	SLIT-ROBO Rho GTPase activating protein 3(SRGAP3)	Homo sapiens				GO:0007165~signal transduction,GO:0030336~negative regulation of cell migration,GO:0043547~positive regulation of GTPase activity,GO:0051056~regulation of small GTPase mediated signal transduction,	GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0005096~GTPase activator activity,GO:0005515~protein binding,GO:0048365~Rac GTPase binding,	IPR000198:Rho GTPase-activating protein domain,IPR001060:FCH domain,IPR001452:Src homology-3 domain,IPR008936:Rho GTPase activation protein,	hsa04360:Axon guidance,			SM00055:FCH,SM00324:RhoGAP,SM00326:SH3,	Alternative splicing,Chromosomal rearrangement,Coiled coil,Complete proteome,GTPase activation,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,SH3 domain,	chain:SLIT-ROBO Rho GTPase-activating protein 3,domain:FCH,domain:Rho-GAP,domain:SH3,modified residue,sequence variant,splice variant,
SMAD7	SMAD family member 7(SMAD7)	Homo sapiens		h_tgfbPathway:TGF beta signaling pathway,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001657~ureteric bud development,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0010717~regulation of epithelial to mesenchymal transition,GO:0010719~negative regulation of epithelial to mesenchymal transition,GO:0010801~negative regulation of peptidyl-threonine phosphorylation,GO:0010944~negative regulation of transcription by competitive promoter binding,GO:0017015~regulation of transforming growth factor beta receptor signaling pathway,GO:0022409~positive regulation of cell-cell adhesion,GO:0030336~negative regulation of cell migration,GO:0030509~BMP signaling pathway,GO:0030512~negative regulation of transforming growth factor beta receptor signaling pathway,GO:0030514~negative regulation of BMP signaling pathway,GO:0031397~negative regulation of protein ubiquitination,GO:0031398~positive regulation of protein ubiquitination,GO:0032436~positive regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0032925~regulation of activin receptor signaling pathway,GO:0033137~negative regulation of peptidyl-serine phosphorylation,GO:0034333~adherens junction assembly,GO:0034616~response to laminar fluid shear stress,GO:0034629~cellular protein complex localization,GO:0043433~negative regulation of sequence-specific DNA binding transcription factor activity,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048844~artery morphogenesis,GO:0050821~protein stabilization,GO:0051444~negative regulation of ubiquitin-protein transferase activity,GO:0055010~ventricular cardiac muscle tissue morphogenesis,GO:0055117~regulation of cardiac muscle contraction,GO:0060373~regulation of ventricular cardiac muscle cell membrane depolarization,GO:0060389~pathway-restricted SMAD protein phosphorylation,GO:0060394~negative regulation of pathway-restricted SMAD protein phosphorylation,GO:0060412~ventricular septum morphogenesis,GO:0071560~cellular response to transforming growth factor beta stimulus,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005913~cell-cell adherens junction,GO:0016342~catenin complex,GO:0043234~protein complex,	GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0005518~collagen binding,GO:0008013~beta-catenin binding,GO:0030617~transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity,GO:0031625~ubiquitin protein ligase binding,GO:0034713~type I transforming growth factor beta receptor binding,GO:0044212~transcription regulatory region DNA binding,GO:0046872~metal ion binding,GO:0048185~activin binding,GO:0070411~I-SMAD binding,	IPR001132:SMAD domain, Dwarfin-type,IPR003619:MAD homology 1, Dwarfin-type,IPR008984:SMAD/FHA domain,IPR013019:MAD homology, MH1,IPR013790:Dwarfin,IPR017855:SMAD domain-like,	hsa04350:TGF-beta signaling pathway,	612229~Colorectal cancer, susceptibility to, 3,		SM00523:DWA,SM00524:DWB,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Cytoplasm,DNA-binding,Isopeptide bond,Metal-binding,Nucleus,Phosphoprotein,Reference proteome,Transcription,Transcription regulation,Ubl conjugation,Zinc,	chain:Mothers against decapentaplegic homolog 7,compositionally biased region:Poly-Gly,compositionally biased region:Poly-Pro,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate,domain:MH1,domain:MH2,modified residue,mutagenesis site,region of interest:Important for interaction with SMURF2,sequence conflict,short sequence motif:PY-motif,strand,
SP140	SP140 nuclear body protein(SP140)	Homo sapiens				GO:0006355~regulation of transcription, DNA-templated,GO:0006952~defense response,	GO:0005634~nucleus,GO:0005635~nuclear envelope,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005739~mitochondrion,GO:0016605~PML body,	GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,	IPR000770:SAND domain,IPR001487:Bromodomain,IPR001965:Zinc finger, PHD-type,IPR004865:Sp100,IPR010919:SAND domain-like,IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR019786:Zinc finger, PHD-type, conserved site,IPR019787:Zinc finger, PHD-finger,				SM00249:PHD,SM00258:SAND,SM00297:BROMO,	3D-structure,Alternative splicing,Bromodomain,Complete proteome,Cytoplasm,DNA-binding,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Zinc,Zinc-finger,	chain:Nuclear body protein SP140,compositionally biased region:Poly-Tyr,domain:Bromo,domain:HSR,domain:SAND,sequence conflict,sequence variant,short sequence motif:Nuclear localization signal,splice variant,zinc finger region:PHD-type,
SCAF4	SR-related CTD associated factor 4(SCAF4)	Homo sapiens					GO:0005654~nucleoplasm,	GO:0000166~nucleotide binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR006569:CID domain,IPR006903:RNA polymerase II-binding domain,IPR008942:ENTH/VHS,IPR012677:Nucleotide-binding, alpha-beta plait,				SM00360:RRM,SM00582:RPR,	Acetylation,Alternative splicing,Complete proteome,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,RNA-binding,	chain:Splicing factor, arginine/serine-rich 15,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Gln,compositionally biased region:Poly-Pro,domain:CID,domain:RRM,modified residue,sequence conflict,sequence variant,splice variant,
SOX9	SRY-box 9(SOX9)	Homo sapiens				GO:0001501~skeletal system development,GO:0001502~cartilage condensation,GO:0001503~ossification,GO:0001658~branching involved in ureteric bud morphogenesis,GO:0001708~cell fate specification,GO:0001837~epithelial to mesenchymal transition,GO:0001894~tissue homeostasis,GO:0001934~positive regulation of protein phosphorylation,GO:0001942~hair follicle development,GO:0002053~positive regulation of mesenchymal cell proliferation,GO:0002683~negative regulation of immune system process,GO:0003170~heart valve development,GO:0003179~heart valve morphogenesis,GO:0003188~heart valve formation,GO:0003203~endocardial cushion morphogenesis,GO:0003413~chondrocyte differentiation involved in endochondral bone morphogenesis,GO:0003415~chondrocyte hypertrophy,GO:0006334~nucleosome assembly,GO:0006338~chromatin remodeling,GO:0006366~transcription from RNA polymerase II promoter,GO:0006461~protein complex assembly,GO:0007010~cytoskeleton organization,GO:0007165~signal transduction,GO:0007173~epidermal growth factor receptor signaling pathway,GO:0007219~Notch signaling pathway,GO:0007283~spermatogenesis,GO:0008284~positive regulation of cell proliferation,GO:0008584~male gonad development,GO:0010564~regulation of cell cycle process,GO:0010634~positive regulation of epithelial cell migration,GO:0014032~neural crest cell development,GO:0014068~positive regulation of phosphatidylinositol 3-kinase signaling,GO:0016337~single organismal cell-cell adhesion,GO:0019100~male germ-line sex determination,GO:0019933~cAMP-mediated signaling,GO:0030155~regulation of cell adhesion,GO:0030198~extracellular matrix organization,GO:0030279~negative regulation of ossification,GO:0030502~negative regulation of bone mineralization,GO:0030850~prostate gland development,GO:0030857~negative regulation of epithelial cell differentiation,GO:0030858~positive regulation of epithelial cell differentiation,GO:0030879~mammary gland development,GO:0030903~notochord development,GO:0030916~otic vesicle formation,GO:0031018~endocrine pancreas development,GO:0032331~negative regulation of chondrocyte differentiation,GO:0032332~positive regulation of chondrocyte differentiation,GO:0032808~lacrimal gland development,GO:0034504~protein localization to nucleus,GO:0035019~somatic stem cell population maintenance,GO:0035622~intrahepatic bile duct development,GO:0042127~regulation of cell proliferation,GO:0042981~regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0043491~protein kinase B signaling,GO:0045662~negative regulation of myoblast differentiation,GO:0045732~positive regulation of protein catabolic process,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046533~negative regulation of photoreceptor cell differentiation,GO:0048709~oligodendrocyte differentiation,GO:0050679~positive regulation of epithelial cell proliferation,GO:0050680~negative regulation of epithelial cell proliferation,GO:0051216~cartilage development,GO:0060008~Sertoli cell differentiation,GO:0060009~Sertoli cell development,GO:0060018~astrocyte fate commitment,GO:0060041~retina development in camera-type eye,GO:0060174~limb bud formation,GO:0060221~retinal rod cell differentiation,GO:0060441~epithelial tube branching involved in lung morphogenesis,GO:0060487~lung epithelial cell differentiation,GO:0060517~epithelial cell proliferation involved in prostatic bud elongation,GO:0060532~bronchus cartilage development,GO:0060534~trachea cartilage development,GO:0060729~intestinal epithelial structure maintenance,GO:0060784~regulation of cell proliferation involved in tissue homeostasis,GO:0061036~positive regulation of cartilage development,GO:0061046~regulation of branching involved in lung morphogenesis,GO:0061138~morphogenesis of a branching epithelium,GO:0061145~lung smooth muscle development,GO:0070168~negative regulation of biomineral tissue development,GO:0070371~ERK1 and ERK2 cascade,GO:0070384~Harderian gland development,GO:0071260~cellular response to mechanical stimulus,GO:0071300~cellular response to retinoic acid,GO:0071347~cellular response to interleukin-1,GO:0071364~cellular response to epidermal growth factor stimulus,GO:0071504~cellular response to heparin,GO:0071560~cellular response to transforming growth factor beta stimulus,GO:0072034~renal vesicle induction,GO:0072190~ureter urothelium development,GO:0072193~ureter smooth muscle cell differentiation,GO:0072197~ureter morphogenesis,GO:0072289~metanephric nephron tubule formation,GO:0090090~negative regulation of canonical Wnt signaling pathway,GO:0090103~cochlea morphogenesis,GO:0090184~positive regulation of kidney development,GO:0090190~positive regulation of branching involved in ureteric bud morphogenesis,GO:1901203~positive regulation of extracellular matrix assembly,GO:1902894~negative regulation of pri-miRNA transcription from RNA polymerase II promoter,GO:2000020~positive regulation of male gonad development,GO:2000138~positive regulation of cell proliferation involved in heart morphogenesis,GO:2000741~positive regulation of mesenchymal stem cell differentiation,GO:2000794~regulation of epithelial cell proliferation involved in lung morphogenesis,GO:2001054~negative regulation of mesenchymal cell apoptotic process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0043234~protein complex,GO:0044798~nuclear transcription factor complex,	GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001046~core promoter sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001158~enhancer sequence-specific DNA binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003705~transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding,GO:0004672~protein kinase activity,GO:0005515~protein binding,GO:0008013~beta-catenin binding,GO:0034236~protein kinase A catalytic subunit binding,GO:0035326~enhancer binding,GO:0043425~bHLH transcription factor binding,GO:0046982~protein heterodimerization activity,GO:0097157~pre-mRNA intronic binding,	IPR009071:High mobility group (HMG) box domain,IPR022151:Sox developmental protein N-terminal,	hsa04024:cAMP signaling pathway,	114290~Acampomelic campomelic dysplasia,114290~Campomelic dysplasia,114290~Campomelic dysplasia with autosomal sex reversal,		SM00398:HMG,	3D-structure,Complete proteome,Disease mutation,DNA-binding,Nucleus,Reference proteome,Transcription,Transcription regulation,	chain:Transcription factor SOX-9,compositionally biased region:Gln/Pro-rich,compositionally biased region:Poly-Pro,DNA-binding region:HMG box,helix,sequence variant,strand,
SUZ12	SUZ12 polycomb repressive complex 2 subunit(SUZ12)	Homo sapiens		h_prc2Pathway:The PRC2 Complex Sets Long-term Gene Silencing Through Modification of Histone Tails,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0008284~positive regulation of cell proliferation,GO:0016571~histone methylation,GO:0016574~histone ubiquitination,GO:0045596~negative regulation of cell differentiation,GO:0045814~negative regulation of gene expression, epigenetic,	GO:0001739~sex chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0016586~RSC complex,GO:0032993~protein-DNA complex,GO:0035098~ESC/E(Z) complex,	GO:0000979~RNA polymerase II core promoter sequence-specific DNA binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0031490~chromatin DNA binding,GO:0035064~methylated histone binding,GO:0042054~histone methyltransferase activity,GO:0046872~metal ion binding,	IPR019135:Polycomb protein, VEFS-Box,					3D-structure,Chromatin regulator,Chromosomal rearrangement,Complete proteome,Isopeptide bond,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Proto-oncogene,Reference proteome,Repressor,Transcription,Transcription regulation,Ubl conjugation,Zinc,Zinc-finger,	chain:Polycomb protein SUZ12,compositionally biased region:Gly-rich,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Ser,modified residue,region of interest:VEFS-box,sequence variant,site:Breakpoint for translocation to form JAZF1-SUZ12 oncogene,zinc finger region:C2H2-type,
SMARCC2	SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 2(SMARCC2)	Homo sapiens		h_hSWI-SNFpathway:Chromatin Remodeling by hSWI/SNF ATP-dependent Complexes,h_vdrPathway:Control of Gene Expression by Vitamin D Receptor,	Chromatin structure and dynamics / Transcription,General function prediction only,	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006337~nucleosome disassembly,GO:0006338~chromatin remodeling,GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0016569~covalent chromatin modification,GO:0021882~regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment,GO:0043044~ATP-dependent chromatin remodeling,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,	GO:0000790~nuclear chromatin,GO:0005654~nucleoplasm,GO:0016514~SWI/SNF complex,GO:0017053~transcriptional repressor complex,GO:0043234~protein complex,GO:0071564~npBAF complex,GO:0071565~nBAF complex,GO:0090544~BAF-type complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000980~RNA polymerase II distal enhancer sequence-specific DNA binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003713~transcription coactivator activity,GO:0005515~protein binding,GO:0031492~nucleosomal DNA binding,	IPR000953:Chromo domain/shadow,IPR001005:SANT/Myb domain,IPR001357:BRCT domain,IPR007526:SWIRM domain,IPR009057:Homeodomain-like,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR017884:SANT domain,				SM00298:CHROMO,SM00717:SANT,	Acetylation,Alternative splicing,Chromatin regulator,Coiled coil,Complete proteome,Isopeptide bond,Neurogenesis,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Transcription,Transcription regulation,Ubl conjugation,	chain:SWI/SNF complex subunit SMARCC2,compositionally biased region:Glu-rich,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Gln,compositionally biased region:Poly-Glu,compositionally biased region:Pro-rich,domain:SANT,domain:SWIRM,modified residue,sequence conflict,splice variant,
SRCAP	Snf2 related CREBBP activator protein(SRCAP)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0016032~viral process,GO:0016573~histone acetylation,	GO:0005634~nucleus,GO:0005794~Golgi apparatus,GO:0043234~protein complex,GO:0048471~perinuclear region of cytoplasm,	GO:0003677~DNA binding,GO:0003713~transcription coactivator activity,GO:0004386~helicase activity,GO:0004402~histone acetyltransferase activity,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR000330:SNF2-related,IPR001650:Helicase, C-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014012:Helicase/SANT-associated, DNA binding,IPR017956:AT hook, DNA-binding motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,		136140~Floating-Harbor syndrome,		SM00384:AT_hook,SM00487:DEXDc,SM00490:HELICc,SM00573:HSA,	Activator,Alternative splicing,ATP-binding,Chromatin regulator,Coiled coil,Complete proteome,DNA-binding,Helicase,Host-virus interaction,Hydrolase,Nucleotide-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,	chain:Helicase SRCAP,compositionally biased region:Glu-rich,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Pro,compositionally biased region:Pro-rich,DNA-binding region:A.T hook 1,DNA-binding region:A.T hook 2,DNA-binding region:A.T hook 3,domain:Helicase ATP-binding,domain:Helicase C-terminal,domain:HSA,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,splice variant,
SP3	Sp3 transcription factor(SP3)	Homo sapiens		h_calcineurinPathway:Effects of calcineurin in Keratinocyte Differentiation,h_tercPathway:Overview of telomerase RNA component gene hTerc Transcriptional Regulation,h_tertPathway:Overview of telomerase protein component gene hTert Transcriptional Regulation ,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001503~ossification,GO:0001779~natural killer cell differentiation,GO:0001829~trophectodermal cell differentiation,GO:0001889~liver development,GO:0001892~embryonic placenta development,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0016925~protein sumoylation,GO:0030183~B cell differentiation,GO:0030217~T cell differentiation,GO:0030219~megakaryocyte differentiation,GO:0030224~monocyte differentiation,GO:0030324~lung development,GO:0030851~granulocyte differentiation,GO:0043353~enucleate erythrocyte differentiation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048596~embryonic camera-type eye morphogenesis,GO:0048706~embryonic skeletal system development,GO:0060136~embryonic process involved in female pregnancy,GO:0060216~definitive hemopoiesis,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0016605~PML body,GO:0017053~transcriptional repressor complex,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000979~RNA polymerase II core promoter sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0000987~core promoter proximal region sequence-specific DNA binding,GO:0001078~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003676~nucleic acid binding,GO:0003682~chromatin binding,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,	Acetylation,Activator,Alternative initiation,Alternative splicing,Complete proteome,DNA-binding,Isopeptide bond,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,Ubl conjugation,Zinc,Zinc-finger,	chain:Transcription factor Sp3,compositionally biased region:Ala-rich,compositionally biased region:Poly-Gln,compositionally biased region:Poly-Gly,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate,modified residue,mutagenesis site,region of interest:Repressor domain,region of interest:Transactivation domain (Gln-rich),sequence conflict,sequence variant,splice variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,
TBX3	T-box 3(TBX3)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001501~skeletal system development,GO:0001568~blood vessel development,GO:0001701~in utero embryonic development,GO:0001947~heart looping,GO:0003151~outflow tract morphogenesis,GO:0003167~atrioventricular bundle cell differentiation,GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007569~cell aging,GO:0008284~positive regulation of cell proliferation,GO:0008595~anterior/posterior axis specification, embryo,GO:0009887~organ morphogenesis,GO:0010159~specification of organ position,GO:0019827~stem cell population maintenance,GO:0021761~limbic system development,GO:0030539~male genitalia development,GO:0030540~female genitalia development,GO:0030857~negative regulation of epithelial cell differentiation,GO:0030879~mammary gland development,GO:0032275~luteinizing hormone secretion,GO:0035115~embryonic forelimb morphogenesis,GO:0035116~embryonic hindlimb morphogenesis,GO:0035136~forelimb morphogenesis,GO:0042733~embryonic digit morphogenesis,GO:0043066~negative regulation of apoptotic process,GO:0045662~negative regulation of myoblast differentiation,GO:0045787~positive regulation of cell cycle,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0046884~follicle-stimulating hormone secretion,GO:0048332~mesoderm morphogenesis,GO:0060021~palate development,GO:0060412~ventricular septum morphogenesis,GO:0060444~branching involved in mammary gland duct morphogenesis,GO:0060596~mammary placode formation,GO:0060923~cardiac muscle cell fate commitment,GO:0060931~sinoatrial node cell development,GO:0090398~cellular senescence,GO:2000648~positive regulation of stem cell proliferation,	GO:0005634~nucleus,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001078~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001085~RNA polymerase II transcription factor binding,GO:0001102~RNA polymerase II activating transcription factor binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0043565~sequence-specific DNA binding,	IPR001699:Transcription factor, T-box,IPR002070:Transcription factor, Brachyury,IPR008967:p53-like transcription factor, DNA-binding,IPR018186:Transcription factor, T-box, conserved site,IPR022582:Transcription factor, T-box, region of unknown function,	hsa04550:Signaling pathways regulating pluripotency of stem cells,	181450~Ulnar-mammary syndrome,		SM00425:TBOX,	3D-structure,Alternative splicing,Complete proteome,Developmental protein,Disease mutation,DNA-binding,Nucleus,Phosphoprotein,Reference proteome,Repressor,Transcription,Transcription regulation,	chain:T-box transcription factor TBX3,DNA-binding region:T-box; first part,DNA-binding region:T-box; second part,helix,modified residue,region of interest:Transcription repression,sequence conflict,sequence variant,splice variant,strand,
TEAD2	TEA domain transcription factor 2(TEAD2)	Homo sapiens				GO:0001570~vasculogenesis,GO:0001843~neural tube closure,GO:0003143~embryonic heart tube morphogenesis,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0030903~notochord development,GO:0035329~hippo signaling,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048339~paraxial mesoderm development,GO:0048368~lateral mesoderm development,GO:0060548~negative regulation of cell death,GO:0071300~cellular response to retinoic acid,GO:2000736~regulation of stem cell differentiation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,	GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003705~transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding,GO:0005515~protein binding,	IPR000818:TEA/ATTS,IPR016361:Transcriptional enhancer factor,	hsa04390:Hippo signaling pathway,		PIRSF002603:transcriptional enhancer factor,	SM00426:TEA,	3D-structure,Activator,Alternative splicing,Complete proteome,DNA-binding,Nucleus,Reference proteome,Transcription,Transcription regulation,	chain:Transcriptional enhancer factor TEF-4,compositionally biased region:Pro-rich,DNA-binding region:TEA,region of interest:Transcriptional activation,sequence conflict,
TGIF1	TGFB induced factor homeobox 1(TGIF1)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007275~multicellular organism development,GO:0042493~response to drug,GO:0071363~cellular response to growth factor stimulus,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001078~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0070410~co-SMAD binding,	IPR001356:Homeodomain,IPR008422:Homeobox KN domain,IPR009057:Homeodomain-like,	hsa04350:TGF-beta signaling pathway,	142946~Holoprosencephaly-4,		SM00389:HOX,	3D-structure,Alternative splicing,Complete proteome,Disease mutation,DNA-binding,Holoprosencephaly,Homeobox,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,	chain:Homeobox protein TGIF1,compositionally biased region:Poly-Arg,DNA-binding region:Homeobox; TALE-type,sequence conflict,sequence variant,short sequence motif:CTBP-binding motif,splice variant,
TTK	TTK protein kinase(TTK)	Homo sapiens				GO:0007051~spindle organization,GO:0007052~mitotic spindle organization,GO:0007093~mitotic cell cycle checkpoint,GO:0007094~mitotic spindle assembly checkpoint,GO:0008284~positive regulation of cell proliferation,GO:0010862~positive regulation of pathway-restricted SMAD protein phosphorylation,GO:0016321~female meiosis chromosome segregation,GO:0018105~peptidyl-serine phosphorylation,GO:0018107~peptidyl-threonine phosphorylation,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0033316~meiotic spindle assembly checkpoint,GO:0034501~protein localization to kinetochore,GO:0046777~protein autophosphorylation,GO:0051304~chromosome separation,GO:1903096~protein localization to meiotic spindle midzone,	GO:0000776~kinetochore,GO:0005737~cytoplasm,GO:0005819~spindle,GO:0016020~membrane,	GO:0004674~protein serine/threonine kinase activity,GO:0004712~protein serine/threonine/tyrosine kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0042803~protein homodimerization activity,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR011990:Tetratricopeptide-like helical,IPR017441:Protein kinase, ATP binding site,IPR027084:Dual specificity protein kinase TTK,	hsa04110:Cell cycle,			SM00220:S_TKc,	3D-structure,Acetylation,Alternative splicing,ATP-binding,Complete proteome,Kinase,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transferase,Tyrosine-protein kinase,	active site:Proton acceptor,binding site:ATP,chain:Dual specificity protein kinase TTK,domain:Protein kinase,helix,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,strand,turn,
TWISTNB	TWIST neighbor(TWISTNB)	Homo sapiens				GO:0006361~transcription initiation from RNA polymerase I promoter,GO:0006362~transcription elongation from RNA polymerase I promoter,GO:0006363~termination of RNA polymerase I transcription,GO:0045815~positive regulation of gene expression, epigenetic,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005736~DNA-directed RNA polymerase I complex,GO:0015630~microtubule cytoskeleton,	GO:0001054~RNA polymerase I activity,GO:0003899~DNA-directed RNA polymerase activity,	IPR005576:RNA polymerase Rpb7, N-terminal,	hsa00230:Purine metabolism,hsa00240:Pyrimidine metabolism,hsa01100:Metabolic pathways,hsa03020:RNA polymerase,				Complete proteome,DNA-directed RNA polymerase,Nucleus,Phosphoprotein,Reference proteome,Transcription,	chain:DNA-directed RNA polymerase I subunit rpa43,compositionally biased region:Lys-rich,modified residue,
WAC	WW domain containing adaptor with coiled-coil(WAC)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006974~cellular response to DNA damage stimulus,GO:0010390~histone monoubiquitination,GO:0016239~positive regulation of macroautophagy,GO:0032435~negative regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0044783~G1 DNA damage checkpoint,GO:0045893~positive regulation of transcription, DNA-templated,GO:0071894~histone H2B conserved C-terminal lysine ubiquitination,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0016607~nuclear speck,	GO:0000993~RNA polymerase II core binding,GO:0003682~chromatin binding,GO:0005515~protein binding,	IPR001202:WW domain,				SM00456:WW,	Acetylation,Alternative splicing,Chromatin regulator,Coiled coil,Complete proteome,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:WW domain-containing adapter protein with coiled-coil,domain:WW,modified residue,sequence conflict,sequence variant,splice variant,
WT1	Wilms tumor 1(WT1)	Homo sapiens		h_tertPathway:Overview of telomerase protein component gene hTert Transcriptional Regulation ,h_tidPathway:Chaperones modulate interferon Signaling Pathway,	General function prediction only,Transcription / Cell division and chromosome partitioning,	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001570~vasculogenesis,GO:0001657~ureteric bud development,GO:0001658~branching involved in ureteric bud morphogenesis,GO:0001822~kidney development,GO:0003156~regulation of organ formation,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0007281~germ cell development,GO:0007356~thorax and anterior abdomen determination,GO:0007507~heart development,GO:0007530~sex determination,GO:0008285~negative regulation of cell proliferation,GO:0008380~RNA splicing,GO:0008406~gonad development,GO:0008584~male gonad development,GO:0009888~tissue development,GO:0017148~negative regulation of translation,GO:0030308~negative regulation of cell growth,GO:0030325~adrenal gland development,GO:0030539~male genitalia development,GO:0030855~epithelial cell differentiation,GO:0032835~glomerulus development,GO:0032836~glomerular basement membrane development,GO:0035802~adrenal cortex formation,GO:0043010~camera-type eye development,GO:0043065~positive regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0060231~mesenchymal to epithelial transition,GO:0060421~positive regulation of heart growth,GO:0060539~diaphragm development,GO:0060923~cardiac muscle cell fate commitment,GO:0061032~visceral serous pericardium development,GO:0071320~cellular response to cAMP,GO:0071371~cellular response to gonadotropin stimulus,GO:0072075~metanephric mesenchyme development,GO:0072112~glomerular visceral epithelial cell differentiation,GO:0072166~posterior mesonephric tubule development,GO:0072207~metanephric epithelium development,GO:0072284~metanephric S-shaped body morphogenesis,GO:0072302~negative regulation of metanephric glomerular mesangial cell proliferation,GO:2000020~positive regulation of male gonad development,GO:2000195~negative regulation of female gonad development,GO:2001076~positive regulation of metanephric ureteric bud development,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0016607~nuclear speck,	GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003676~nucleic acid binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0010385~double-stranded methylated DNA binding,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,GO:0044729~hemi-methylated DNA-binding,GO:0046872~metal ion binding,GO:0070742~C2H2 zinc finger domain binding,	IPR000976:Wilm's tumour protein, N-terminal,IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,IPR017987:Wilm's tumour protein,	hsa05202:Transcriptional misregulation in cancer,	136680~Frasier syndrome,156240~Mesothelioma, somatic,194070~Wilms tumor, type 1,194080~Denys-Drash syndrome,256370~Nephrotic syndrome, type 4,608978~Meacham syndrome,		SM00355:ZnF_C2H2,	3D-structure,Alternative initiation,Alternative splicing,Chromosomal rearrangement,Complete proteome,Cytoplasm,Disease mutation,DNA-binding,Isopeptide bond,Metal-binding,Nucleus,Proteomics identification,Reference proteome,Repeat,RNA editing,RNA-binding,Signal,Transcription,Transcription regulation,Tumor suppressor,Ubl conjugation,Zinc,Zinc-finger,	chain:Wilms tumor protein,compositionally biased region:Pro-rich,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),helix,mutagenesis site,region of interest:Important for interaction with target DNA,sequence conflict,sequence variant,short sequence motif:KTS motif,site:Important for interaction with target DNA,splice variant,strand,turn,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,
YTHDC2	YTH domain containing 2(YTHDC2)	Homo sapiens				GO:0006396~RNA processing,GO:0034612~response to tumor necrosis factor,GO:0044829~positive regulation by host of viral genome replication,GO:0070555~response to interleukin-1,	GO:0005634~nucleus,GO:0005783~endoplasmic reticulum,	GO:0003676~nucleic acid binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008186~RNA-dependent ATPase activity,GO:0044822~poly(A) RNA binding,GO:0070063~RNA polymerase binding,GO:1990247~N6-methyladenosine-containing RNA binding,	IPR001374:Single-stranded nucleic acid binding R3H,IPR001650:Helicase, C-terminal,IPR002110:Ankyrin repeat,IPR007275:YTH domain,IPR007502:Helicase-associated domain,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR011709:Domain of unknown function DUF1605,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR020683:Ankyrin repeat-containing domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00393:R3H,SM00487:DEXDc,SM00490:HELICc,SM00847:SM00847,	3D-structure,ANK repeat,ATP-binding,Complete proteome,Helicase,Hydrolase,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,RNA-binding,	chain:Probable ATP-dependent RNA helicase YTHDC2,compositionally biased region:Gly-rich,compositionally biased region:Ser-rich,domain:Helicase ATP-binding,domain:Helicase C-terminal,domain:R3H,domain:YTH,helix,modified residue,nucleotide phosphate-binding region:ATP,repeat:ANK 1,repeat:ANK 2,sequence conflict,sequence variant,short sequence motif:DEAH box,strand,
AIM2	absent in melanoma 2(AIM2)	Homo sapiens				GO:0002218~activation of innate immune response,GO:0002230~positive regulation of defense response to virus by host,GO:0006915~apoptotic process,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0032088~negative regulation of NF-kappaB transcription factor activity,GO:0032461~positive regulation of protein oligomerization,GO:0032731~positive regulation of interleukin-1 beta production,GO:0033209~tumor necrosis factor-mediated signaling pathway,GO:0035458~cellular response to interferon-beta,GO:0035690~cellular response to drug,GO:0045087~innate immune response,GO:0050702~interleukin-1 beta secretion,GO:0050718~positive regulation of interleukin-1 beta secretion,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0070269~pyroptosis,GO:2001056~positive regulation of cysteine-type endopeptidase activity,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0097169~AIM2 inflammasome complex,	GO:0003690~double-stranded DNA binding,GO:0005515~protein binding,GO:0042802~identical protein binding,	IPR004020:DAPIN domain,IPR004021:HIN-200/IF120x,IPR011029:Death-like domain,	hsa04623:Cytosolic DNA-sensing pathway,			SM01289:SM01289,	3D-structure,Apoptosis,Complete proteome,Cytoplasm,DNA-binding,Immunity,Inflammatory response,Innate immunity,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Tumor suppressor,	chain:Interferon-inducible protein AIM2,compositionally biased region:Poly-Ile,domain:DAPIN,domain:HIN-200,sequence conflict,sequence variant,
ATF7IP	activating transcription factor 7 interacting protein(ATF7IP)	Homo sapiens			General function prediction only,	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006306~DNA methylation,GO:0006351~transcription, DNA-templated,GO:0016032~viral process,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045898~regulation of RNA polymerase II transcriptional preinitiation complex assembly,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005737~cytoplasm,	GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0016887~ATPase activity,	IPR003961:Fibronectin, type III,IPR013783:Immunoglobulin-like fold,IPR026085:Activating transcription factor 7-interacting protein,					3D-structure,Acetylation,Activator,Alternative splicing,Coiled coil,Complete proteome,Host-virus interaction,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,	chain:Activating transcription factor 7- interacting protein 1,compositionally biased region:Glu-rich,domain:Fibronectin type-III,modified residue,mutagenesis site,region of interest:Interaction with MBD1,region of interest:Interaction with SETDB1,region of interest:Interaction with SUMO,sequence conflict,sequence variant,short sequence motif:Nuclear localization signal,splice variant,
ACVR1B	activin A receptor type 1B(ACVR1B)	Homo sapiens				GO:0000082~G1/S transition of mitotic cell cycle,GO:0001701~in utero embryonic development,GO:0001942~hair follicle development,GO:0006355~regulation of transcription, DNA-templated,GO:0006468~protein phosphorylation,GO:0007165~signal transduction,GO:0007178~transmembrane receptor protein serine/threonine kinase signaling pathway,GO:0007417~central nervous system development,GO:0010629~negative regulation of gene expression,GO:0010862~positive regulation of pathway-restricted SMAD protein phosphorylation,GO:0018107~peptidyl-threonine phosphorylation,GO:0023014~signal transduction by protein phosphorylation,GO:0030308~negative regulation of cell growth,GO:0032924~activin receptor signaling pathway,GO:0032927~positive regulation of activin receptor signaling pathway,GO:0038092~nodal signaling pathway,GO:0045648~positive regulation of erythrocyte differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046545~development of primary female sexual characteristics,GO:0046777~protein autophosphorylation,GO:0097191~extrinsic apoptotic signaling pathway,GO:1901165~positive regulation of trophoblast cell migration,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,GO:0043235~receptor complex,GO:0048179~activin receptor complex,GO:0070062~extracellular exosome,	GO:0004674~protein serine/threonine kinase activity,GO:0004675~transmembrane receptor protein serine/threonine kinase activity,GO:0004702~receptor signaling protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016361~activin receptor activity, type I,GO:0017002~activin-activated receptor activity,GO:0019838~growth factor binding,GO:0031625~ubiquitin protein ligase binding,GO:0034711~inhibin binding,GO:0046332~SMAD binding,GO:0046872~metal ion binding,GO:0048185~activin binding,	IPR000333:Activin type II/Transforming growth factor-beta II receptor,IPR000472:TGF-beta receptor/activin receptor, type I/II,IPR000719:Protein kinase, catalytic domain,IPR003605:TGF beta receptor, GS motif,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,	hsa04060:Cytokine-cytokine receptor interaction,hsa04350:TGF-beta signaling pathway,hsa04550:Signaling pathways regulating pluripotency of stem cells,	Pancreatic cancer, somatic~Pancreatic cancer, somatic,		SM00220:S_TKc,SM00467:GS,	Alternative splicing,ATP-binding,Cell membrane,Complete proteome,Glycoprotein,Kinase,Magnesium,Manganese,Membrane,Metal-binding,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Serine/threonine-protein kinase,Signal,Transferase,Transmembrane,Transmembrane helix,Ubl conjugation,	active site:Proton acceptor,binding site:ATP,chain:Activin receptor type-1B,domain:GS,domain:Protein kinase,glycosylation site:N-linked (GlcNAc...),modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ADNP	activity dependent neuroprotector homeobox(ADNP)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007614~short-term memory,GO:0009743~response to carbohydrate,GO:0010035~response to inorganic substance,GO:0010629~negative regulation of gene expression,GO:0010835~regulation of protein ADP-ribosylation,GO:0030828~positive regulation of cGMP biosynthetic process,GO:0031668~cellular response to extracellular stimulus,GO:0032091~negative regulation of protein binding,GO:0032147~activation of protein kinase activity,GO:0033484~nitric oxide homeostasis,GO:0043524~negative regulation of neuron apoptotic process,GO:0044849~estrous cycle,GO:0045773~positive regulation of axon extension,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0050805~negative regulation of synaptic transmission,GO:0051965~positive regulation of synapse assembly,	GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0030424~axon,GO:0030425~dendrite,GO:0043025~neuronal cell body,	GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0005507~copper ion binding,GO:0005515~protein binding,GO:0042277~peptide binding,GO:0046872~metal ion binding,GO:0048487~beta-tubulin binding,	IPR001356:Homeodomain,IPR007087:Zinc finger, C2H2,IPR009057:Homeodomain-like,IPR015880:Zinc finger, C2H2-like,		615873~Helsmoortel-van der Aa syndrome,		SM00355:ZnF_C2H2,SM00389:HOX,	Acetylation,Autism spectrum disorder,Complete proteome,DNA-binding,Homeobox,Isopeptide bond,Mental retardation,Metal-binding,Methylation,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Ubl conjugation,Zinc,Zinc-finger,	chain:Activity-dependent neuroprotector homeobox protein,DNA-binding region:Homeobox,modified residue,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2; atypical,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5; atypical,zinc finger region:C2H2-type 6; atypical,zinc finger region:C2H2-type 7,zinc finger region:C2H2-type 8; atypical,zinc finger region:C2H2-type 9; atypical,
ASXL1	additional sex combs like 1, transcriptional regulator(ASXL1)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0003007~heart morphogenesis,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0032526~response to retinoic acid,GO:0035359~negative regulation of peroxisome proliferator activated receptor signaling pathway,GO:0035522~monoubiquitinated histone H2A deubiquitination,GO:0045599~negative regulation of fat cell differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048386~positive regulation of retinoic acid receptor signaling pathway,GO:0048387~negative regulation of retinoic acid receptor signaling pathway,GO:0060348~bone development,GO:0060430~lung saccule development,	GO:0000790~nuclear chromatin,GO:0035517~PR-DUB complex,GO:0070062~extracellular exosome,	GO:0003677~DNA binding,GO:0003713~transcription coactivator activity,GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0042974~retinoic acid receptor binding,GO:0042975~peroxisome proliferator activated receptor binding,GO:0046872~metal ion binding,	IPR007759:DNA-directed RNA polymerase delta subunit,IPR024811:Polycomb protein ASX/ASX-like,IPR024815:ASX-like protein 1,IPR026905:Protein ASX-like, PHD domain,		605039~Bohring-Opitz syndrome,614286~Myelodysplastic syndrome, somatic,			Alternative splicing,Chromatin regulator,Complete proteome,Craniosynostosis,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:Putative Polycomb group protein ASXL1,compositionally biased region:Gly-rich,compositionally biased region:Poly-Lys,compositionally biased region:Poly-Ser,modified residue,sequence conflict,sequence variant,short sequence motif:LXXLL motif,short sequence motif:Nuclear localization signal 1,short sequence motif:Nuclear localization signal 2,splice variant,zinc finger region:PHD-type; atypical,
ASXL2	additional sex combs like 2, transcriptional regulator(ASXL2)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0035360~positive regulation of peroxisome proliferator activated receptor signaling pathway,GO:0045600~positive regulation of fat cell differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005654~nucleoplasm,	GO:0003677~DNA binding,GO:0042975~peroxisome proliferator activated receptor binding,GO:0046872~metal ion binding,	IPR007759:DNA-directed RNA polymerase delta subunit,IPR024811:Polycomb protein ASX/ASX-like,IPR024817:ASX-like protein 2,IPR026905:Protein ASX-like, PHD domain,					Alternative splicing,Chromosomal rearrangement,Complete proteome,Metal-binding,Methylation,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Putative Polycomb group protein ASXL2,compositionally biased region:Ala-rich,compositionally biased region:Gly-rich,compositionally biased region:Poly-Leu,compositionally biased region:Poly-Ser,compositionally biased region:Ser-rich,modified residue,sequence conflict,sequence variant,short sequence motif:LXXLL motif 1,short sequence motif:LXXLL motif 2,short sequence motif:Nuclear localization signal,site:Breakpoint for translocation to form MYST3-ASXL2 protein,splice variant,zinc finger region:PHD-type; atypical,
ADRB3	adrenoceptor beta 3(ADRB3)	Homo sapiens				GO:0001659~temperature homeostasis,GO:0002024~diet induced thermogenesis,GO:0002025~vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure,GO:0002032~desensitization of G-protein coupled receptor protein signaling pathway by arrestin,GO:0005975~carbohydrate metabolic process,GO:0006091~generation of precursor metabolites and energy,GO:0006112~energy reserve metabolic process,GO:0006898~receptor-mediated endocytosis,GO:0007187~G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,GO:0007188~adenylate cyclase-modulating G-protein coupled receptor signaling pathway,GO:0007189~adenylate cyclase-activating G-protein coupled receptor signaling pathway,GO:0007190~activation of adenylate cyclase activity,GO:0007267~cell-cell signaling,GO:0007568~aging,GO:0009409~response to cold,GO:0031649~heat generation,GO:0040015~negative regulation of multicellular organism growth,GO:0042755~eating behavior,GO:0043410~positive regulation of MAPK cascade,GO:0046677~response to antibiotic,GO:0050873~brown fat cell differentiation,GO:0071880~adenylate cyclase-activating adrenergic receptor signaling pathway,	GO:0005634~nucleus,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0043235~receptor complex,	GO:0004939~beta-adrenergic receptor activity,GO:0005515~protein binding,GO:0015052~beta3-adrenergic receptor activity,GO:0031699~beta-3 adrenergic receptor binding,GO:0042803~protein homodimerization activity,GO:0051379~epinephrine binding,GO:0051380~norepinephrine binding,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000681:Adrenergic receptor beta 3,IPR002233:Adrenergic receptor,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04020:Calcium signaling pathway,hsa04022:cGMP-PKG signaling pathway,hsa04080:Neuroactive ligand-receptor interaction,hsa04923:Regulation of lipolysis in adipocytes,hsa04924:Renin secretion,hsa04970:Salivary secretion,	601665~Obesity, susceptibility to,		SM01381:SM01381,	3D-structure,Cell membrane,Complete proteome,Diabetes mellitus,Disulfide bond,G-protein coupled receptor,Glycoprotein,Lipoprotein,Membrane,Obesity,Palmitate,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	binding site:Agonist or antagonist,chain:Beta-3 adrenergic receptor,disulfide bond,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:S-palmitoyl cysteine,region of interest:Agonist and antagonist binding,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
AASDH	aminoadipate-semialdehyde dehydrogenase(AASDH)	Homo sapiens			Function unknown,	GO:0006631~fatty acid metabolic process,GO:0008152~metabolic process,GO:0019482~beta-alanine metabolic process,GO:0043041~amino acid activation for nonribosomal peptide biosynthetic process,	GO:0016021~integral component of membrane,	GO:0003824~catalytic activity,GO:0005524~ATP binding,GO:0016878~acid-thiol ligase activity,	IPR000873:AMP-dependent synthetase/ligase,IPR002372:Pyrrolo-quinoline quinone repeat,IPR009081:Acyl carrier protein-like,IPR011047:Quinonprotein alcohol dehydrogenase-like superfamily,IPR018391:Pyrrolo-quinoline quinone beta-propeller repeat,IPR020845:AMP-binding, conserved site,IPR027295:Quinonprotein alcohol dehydrogenase-like domain,				SM00564:PQQ,	Alternative splicing,ATP-binding,Complete proteome,Fatty acid metabolism,Ligase,Lipid metabolism,Membrane,Nucleotide-binding,Phosphopantetheine,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	binding site:ATP,chain:Acyl-CoA synthetase family member 4,domain:Acyl carrier,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,
ASB10	ankyrin repeat and SOCS box containing 10(ASB10)	Homo sapiens				GO:0016567~protein ubiquitination,GO:0035556~intracellular signal transduction,	GO:0000151~ubiquitin ligase complex,GO:0005622~intracellular,GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0004842~ubiquitin-protein transferase activity,GO:0031625~ubiquitin protein ligase binding,	IPR001496:SOCS protein, C-terminal,IPR002110:Ankyrin repeat,IPR020683:Ankyrin repeat-containing domain,		603383~Glaucoma 1, open angle, F,		SM00248:ANK,SM00969:SM00969,	Alternative splicing,ANK repeat,Complete proteome,Cytoplasm,Disease mutation,Glaucoma,Nucleus,Polymorphism,Reference proteome,Repeat,Ubl conjugation pathway,	chain:Ankyrin repeat and SOCS box protein 10,domain:SOCS box,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,repeat:ANK 4,repeat:ANK 5,repeat:ANK 6,repeat:ANK 7,sequence variant,splice variant,
ACIN1	apoptotic chromatin condensation inducer 1(ACIN1)	Homo sapiens				GO:0006397~mRNA processing,GO:0006921~cellular component disassembly involved in execution phase of apoptosis,GO:0008380~RNA splicing,GO:0030218~erythrocyte differentiation,GO:0030263~apoptotic chromosome condensation,GO:0043065~positive regulation of apoptotic process,GO:0045657~positive regulation of monocyte differentiation,GO:0048025~negative regulation of mRNA splicing, via spliceosome,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016607~nuclear speck,GO:0061574~ASAP complex,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0005515~protein binding,GO:0016887~ATPase activity,GO:0019899~enzyme binding,GO:0044822~poly(A) RNA binding,	IPR003034:SAP domain,IPR012677:Nucleotide-binding, alpha-beta plait,	hsa03013:RNA transport,hsa03015:mRNA surveillance pathway,hsa03040:Spliceosome,			SM00513:SAP,	Acetylation,Alternative splicing,Apoptosis,Coiled coil,Complete proteome,Direct protein sequencing,Isopeptide bond,Methylation,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,RNA-binding,Ubl conjugation,	chain:Apoptotic chromatin condensation inducer in the nucleus,compositionally biased region:Arg/Asp/Glu/Lys-rich,compositionally biased region:Glu-rich,compositionally biased region:Pro-rich,compositionally biased region:Ser-rich,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),domain:SAP,modified residue,mutagenesis site,sequence conflict,sequence variant,site:Cleavage; by caspase-3,splice variant,
ASTE1	asteroid homolog 1 (Drosophila)(ASTE1)	Homo sapiens				GO:0006281~DNA repair,GO:0090305~nucleic acid phosphodiester bond hydrolysis,		GO:0004518~nuclease activity,GO:0005515~protein binding,	IPR006085:XPG N-terminal,IPR026832:Asteroid,					Alternative splicing,Complete proteome,Proteomics identification,Reference proteome,	chain:Protein asteroid homolog 1,sequence conflict,
AMBRA1	autophagy and beclin 1 regulator 1(AMBRA1)	Homo sapiens				GO:0008285~negative regulation of cell proliferation,GO:0016236~macroautophagy,GO:0021915~neural tube development,GO:0030154~cell differentiation,GO:0043524~negative regulation of neuron apoptotic process,GO:0043552~positive regulation of phosphatidylinositol 3-kinase activity,GO:0061734~parkin-mediated mitophagy in response to mitochondrial depolarization,GO:0098779~mitophagy in response to mitochondrial depolarization,GO:1903599~positive regulation of mitophagy,GO:2000785~regulation of autophagosome assembly,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005741~mitochondrial outer membrane,GO:0005776~autophagosome,GO:0005829~cytosol,GO:0005930~axoneme,GO:0045335~phagocytic vesicle,GO:0048471~perinuclear region of cytoplasm,	GO:0005515~protein binding,GO:0031625~ubiquitin protein ligase binding,	IPR001680:WD40 repeat,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,				SM00320:WD40,	Alternative splicing,Autophagy,Complete proteome,Cytoplasmic vesicle,Developmental protein,Differentiation,Methylation,Neurogenesis,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,WD repeat,	chain:Activating molecule in BECN1-regulated autophagy protein 1,compositionally biased region:Poly-Pro,compositionally biased region:Ser-rich,modified residue,repeat:WD 1,repeat:WD 2,repeat:WD 3,sequence conflict,splice variant,
B2M	beta-2-microglobulin(B2M)	Homo sapiens		h_ctlPathway:CTL mediated immune response against target cells ,h_mhcPathway:Antigen Processing and Presentation,h_nkcellsPathway:Ras-Independent pathway in NK cell-mediated cytotoxicity,		GO:0001895~retina homeostasis,GO:0001916~positive regulation of T cell mediated cytotoxicity,GO:0002474~antigen processing and presentation of peptide antigen via MHC class I,GO:0002479~antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,GO:0002480~antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent,GO:0002481~antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent,GO:0002726~positive regulation of T cell cytokine production,GO:0003254~regulation of membrane depolarization,GO:0006955~immune response,GO:0010977~negative regulation of neuron projection development,GO:0019731~antibacterial humoral response,GO:0019885~antigen processing and presentation of endogenous peptide antigen via MHC class I,GO:0032092~positive regulation of protein binding,GO:0033077~T cell differentiation in thymus,GO:0042026~protein refolding,GO:0042493~response to drug,GO:0044267~cellular protein metabolic process,GO:0045087~innate immune response,GO:0046686~response to cadmium ion,GO:0048260~positive regulation of receptor-mediated endocytosis,GO:0050690~regulation of defense response to virus by virus,GO:0050776~regulation of immune response,GO:0050829~defense response to Gram-negative bacterium,GO:0050830~defense response to Gram-positive bacterium,GO:0055072~iron ion homeostasis,GO:0060333~interferon-gamma-mediated signaling pathway,GO:0071222~cellular response to lipopolysaccharide,GO:0071281~cellular response to iron ion,GO:1900121~negative regulation of receptor binding,GO:1900122~positive regulation of receptor binding,GO:1903991~positive regulation of ferrous iron import into cell,GO:1904434~positive regulation of ferrous iron binding,GO:1904437~positive regulation of transferrin receptor binding,	GO:0000139~Golgi membrane,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0005788~endoplasmic reticulum lumen,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0009897~external side of plasma membrane,GO:0012507~ER to Golgi transport vesicle membrane,GO:0016020~membrane,GO:0030670~phagocytic vesicle membrane,GO:0031901~early endosome membrane,GO:0031905~early endosome lumen,GO:0042612~MHC class I protein complex,GO:0070062~extracellular exosome,GO:1990712~HFE-transferrin receptor complex,	GO:0001948~glycoprotein binding,GO:0005515~protein binding,GO:0042802~identical protein binding,	IPR003006:Immunoglobulin/major histocompatibility complex, conserved site,IPR003597:Immunoglobulin C1-set,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013106:Immunoglobulin V-set,IPR013783:Immunoglobulin-like fold,IPR015370:Domain of unknown function DUF1968,IPR015707:Beta-2-Microglobulin,	hsa04612:Antigen processing and presentation,	105200~Amyloidosis, familial visceral,241600~Immunodeficiency 43,		SM00406:IGv,SM00407:IGc1,SM00409:IG,	3D-structure,Amyloid,Amyloidosis,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Glycation,Glycoprotein,Immunity,Immunoglobulin domain,MHC I,Proteomics identification,Pyrrolidone carboxylic acid,Reference proteome,Secreted,Signal,	chain:Beta-2-microglobulin,chain:Beta-2-microglobulin form pI 5.3,disulfide bond,domain:Ig-like C1-type,glycosylation site:N-linked (Glc) (glycation); in hemodialysis-associated amyloidosis,glycosylation site:N-linked (Glc) (glycation); in vitro,modified residue,mutagenesis site,sequence conflict,sequence variant,signal peptide,strand,
BMPR2	bone morphogenetic protein receptor type 2(BMPR2)	Homo sapiens		h_alkPathway:ALK in cardiac myocytes,		GO:0001707~mesoderm formation,GO:0001893~maternal placenta development,GO:0001935~endothelial cell proliferation,GO:0001938~positive regulation of endothelial cell proliferation,GO:0001946~lymphangiogenesis,GO:0001974~blood vessel remodeling,GO:0002063~chondrocyte development,GO:0003085~negative regulation of systemic arterial blood pressure,GO:0003148~outflow tract septum morphogenesis,GO:0003151~outflow tract morphogenesis,GO:0003181~atrioventricular valve morphogenesis,GO:0003183~mitral valve morphogenesis,GO:0003186~tricuspid valve morphogenesis,GO:0003197~endocardial cushion development,GO:0003252~negative regulation of cell proliferation involved in heart valve morphogenesis,GO:0006366~transcription from RNA polymerase II promoter,GO:0007178~transmembrane receptor protein serine/threonine kinase signaling pathway,GO:0007420~brain development,GO:0009267~cellular response to starvation,GO:0009952~anterior/posterior pattern specification,GO:0010595~positive regulation of endothelial cell migration,GO:0010634~positive regulation of epithelial cell migration,GO:0010862~positive regulation of pathway-restricted SMAD protein phosphorylation,GO:0014916~regulation of lung blood pressure,GO:0023014~signal transduction by protein phosphorylation,GO:0030166~proteoglycan biosynthetic process,GO:0030308~negative regulation of cell growth,GO:0030501~positive regulation of bone mineralization,GO:0030509~BMP signaling pathway,GO:0030513~positive regulation of BMP signaling pathway,GO:0032924~activin receptor signaling pathway,GO:0042127~regulation of cell proliferation,GO:0045669~positive regulation of osteoblast differentiation,GO:0045778~positive regulation of ossification,GO:0045906~negative regulation of vasoconstriction,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048010~vascular endothelial growth factor receptor signaling pathway,GO:0048286~lung alveolus development,GO:0048738~cardiac muscle tissue development,GO:0048842~positive regulation of axon extension involved in axon guidance,GO:0060173~limb development,GO:0060350~endochondral bone morphogenesis,GO:0060412~ventricular septum morphogenesis,GO:0060413~atrial septum morphogenesis,GO:0060836~lymphatic endothelial cell differentiation,GO:0060840~artery development,GO:0060841~venous blood vessel development,GO:0061036~positive regulation of cartilage development,GO:0061298~retina vasculature development in camera-type eye,GO:0061626~pharyngeal arch artery morphogenesis,GO:0071773~cellular response to BMP stimulus,GO:0072577~endothelial cell apoptotic process,GO:1902731~negative regulation of chondrocyte proliferation,GO:2000279~negative regulation of DNA biosynthetic process,	GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005901~caveola,GO:0005911~cell-cell junction,GO:0009925~basal plasma membrane,GO:0009986~cell surface,GO:0014069~postsynaptic density,GO:0016324~apical plasma membrane,GO:0030425~dendrite,GO:0043025~neuronal cell body,GO:0044214~spanning component of plasma membrane,	GO:0004702~receptor signaling protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016362~activin receptor activity, type II,GO:0019838~growth factor binding,GO:0036122~BMP binding,GO:0046872~metal ion binding,GO:0098821~BMP receptor activity,	IPR000333:Activin type II/Transforming growth factor-beta II receptor,IPR000472:TGF-beta receptor/activin receptor, type I/II,IPR000719:Protein kinase, catalytic domain,IPR011009:Protein kinase-like domain,IPR015770:Bone morphogenic protein type II receptor,IPR017441:Protein kinase, ATP binding site,	hsa04060:Cytokine-cytokine receptor interaction,hsa04350:TGF-beta signaling pathway,hsa04390:Hippo signaling pathway,hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa05206:MicroRNAs in cancer,	178600~Pulmonary hypertension, familial primary, 1, with or without HHT,178600~Pulmonary hypertension, primary, fenfluramine or dexfenfluramine-associated,265450~Pulmonary venoocclusive disease 1,			3D-structure,Alternative splicing,ATP-binding,Cell membrane,Complete proteome,Disease mutation,Disulfide bond,Glycoprotein,Kinase,Magnesium,Manganese,Membrane,Metal-binding,Nucleotide-binding,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Serine/threonine-protein kinase,Signal,Transferase,Transmembrane,Transmembrane helix,	active site:Proton acceptor,binding site:ATP,chain:Bone morphogenetic protein receptor type- 2,compositionally biased region:Poly-Asn,compositionally biased region:Poly-Ser,compositionally biased region:Poly-Thr,disulfide bond,domain:Protein kinase,glycosylation site:N-linked (GlcNAc...),helix,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
CDH24	cadherin 24(CDH24)	Homo sapiens				GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,GO:0016337~single organismal cell-cell adhesion,GO:0034332~adherens junction organization,	GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0005509~calcium ion binding,GO:0008013~beta-catenin binding,GO:0045294~alpha-catenin binding,GO:0070097~delta-catenin binding,	IPR000233:Cadherin, cytoplasmic domain,IPR002126:Cadherin,IPR015919:Cadherin-like,IPR020894:Cadherin conserved site,IPR027397:Catenin binding domain,				SM00112:CA,	Alternative splicing,Calcium,Cell adhesion,Cell membrane,Cleavage on pair of basic residues,Complete proteome,Glycoprotein,Membrane,Metal-binding,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Cadherin-24,domain:Cadherin 1,domain:Cadherin 2,domain:Cadherin 3,domain:Cadherin 4,domain:Cadherin 5,glycosylation site:N-linked (GlcNAc...),signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
CA14	carbonic anhydrase 14(CA14)	Homo sapiens				GO:0015701~bicarbonate transport,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004089~carbonate dehydratase activity,GO:0046872~metal ion binding,	IPR001148:Alpha carbonic anhydrase,IPR018431:Carbonic anhydrase, CA-XIV,IPR023561:Carbonic anhydrase, alpha-class,	hsa00910:Nitrogen metabolism,			SM01057:SM01057,	3D-structure,Complete proteome,Disulfide bond,Glycoprotein,Lyase,Membrane,Metal-binding,Phosphoprotein,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,Zinc,	chain:Carbonic anhydrase 14,disulfide bond,glycosylation site:N-linked (GlcNAc...),metal ion-binding site:Zinc; catalytic,sequence conflict,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
CASP8	caspase 8(CASP8)	Homo sapiens	150.caspase_and_NFKB_activation,39.Deg_of_Chromosomal_DNA,40.Deg_of_Chrom_DNA_TNF-ind_apoptosis,44.Sig_Trans_TNFR1-DR3-DR4_DR5,46.P13K_PTEN,72.IAP_interaction_with_cell_death_pathways,86.Apoptosis_Nematode&_Vert,	h_caspasePathway:Caspase Cascade in Apoptosis,h_ceramidePathway:Ceramide Signaling Pathway,h_d4gdiPathway:D4-GDI Signaling Pathway,h_deathPathway:Induction of apoptosis through DR3 and DR4/5 Death Receptors ,h_fasPathway:FAS signaling pathway ( CD95 ),h_hivnefPathway:HIV-I Nef: negative effector of Fas and TNF,h_mitochondriaPathway:Role of Mitochondria in Apoptotic Signaling,h_soddPathway:SODD/TNFR1 Signaling Pathway,h_tnfr1Pathway:TNFR1 Signaling Pathway,		GO:0006508~proteolysis,GO:0006915~apoptotic process,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0006921~cellular component disassembly involved in execution phase of apoptosis,GO:0007166~cell surface receptor signaling pathway,GO:0009409~response to cold,GO:0010803~regulation of tumor necrosis factor-mediated signaling pathway,GO:0010939~regulation of necrotic cell death,GO:0030101~natural killer cell activation,GO:0030225~macrophage differentiation,GO:0032025~response to cobalt ion,GO:0032355~response to estradiol,GO:0032496~response to lipopolysaccharide,GO:0034612~response to tumor necrosis factor,GO:0035666~TRIF-dependent toll-like receptor signaling pathway,GO:0036462~TRAIL-activated apoptotic signaling pathway,GO:0039650~suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process,GO:0042110~T cell activation,GO:0042113~B cell activation,GO:0042981~regulation of apoptotic process,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043124~negative regulation of I-kappaB kinase/NF-kappaB signaling,GO:0045471~response to ethanol,GO:0045651~positive regulation of macrophage differentiation,GO:0045862~positive regulation of proteolysis,GO:0046677~response to antibiotic,GO:0051291~protein heterooligomerization,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0060715~syncytiotrophoblast cell differentiation involved in labyrinthine layer development,GO:0070423~nucleotide-binding oligomerization domain containing signaling pathway,GO:0071260~cellular response to mechanical stimulus,GO:0071407~cellular response to organic cyclic compound,GO:0071550~death-inducing signaling complex assembly,GO:0097190~apoptotic signaling pathway,GO:0097191~extrinsic apoptotic signaling pathway,GO:0097194~execution phase of apoptosis,GO:0097202~activation of cysteine-type endopeptidase activity,GO:0097296~activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,GO:1900740~positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,GO:1902041~regulation of extrinsic apoptotic signaling pathway via death domain receptors,GO:1902042~negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005741~mitochondrial outer membrane,GO:0005815~microtubule organizing center,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0031264~death-inducing signaling complex,GO:0031265~CD95 death-inducing signaling complex,GO:0043005~neuron projection,GO:0044297~cell body,GO:0045121~membrane raft,GO:0097342~ripoptosome,	GO:0004197~cysteine-type endopeptidase activity,GO:0005123~death receptor binding,GO:0005164~tumor necrosis factor receptor binding,GO:0005515~protein binding,GO:0008233~peptidase activity,GO:0008234~cysteine-type peptidase activity,GO:0031625~ubiquitin protein ligase binding,GO:0032403~protein complex binding,GO:0035877~death effector domain binding,GO:0042802~identical protein binding,GO:0097110~scaffold protein binding,GO:0097153~cysteine-type endopeptidase activity involved in apoptotic process,GO:0097199~cysteine-type endopeptidase activity involved in apoptotic signaling pathway,	IPR001309:Peptidase C14, ICE, catalytic subunit p20,IPR001875:Death effector domain,IPR002138:Peptidase C14, caspase non-catalytic subunit p10,IPR011029:Death-like domain,IPR015917:Peptidase C14, caspase precursor p45, core,IPR016129:Peptidase C14, ICE, catalytic subunit p20, active site,	hsa04115:p53 signaling pathway,hsa04210:Apoptosis,hsa04620:Toll-like receptor signaling pathway,hsa04621:NOD-like receptor signaling pathway,hsa04622:RIG-I-like receptor signaling pathway,hsa04668:TNF signaling pathway,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05010:Alzheimer's disease,hsa05016:Huntington's disease,hsa05134:Legionellosis,hsa05142:Chagas disease (American trypanosomiasis),hsa05145:Toxoplasmosis,hsa05152:Tuberculosis,hsa05161:Hepatitis B,hsa05168:Herpes simplex infection,hsa05200:Pathways in cancer,hsa05203:Viral carcinogenesis,hsa05416:Viral myocarditis,	114480~Breast cancer, protection against,114550~Hepatocellular carcinoma, somatic,211980~Lung cancer, protection against,607271~Autoimmune lymphoproliferative syndrome, type IIB,		SM00031:DED,SM00115:CASc,	3D-structure,Acetylation,Alternative splicing,Apoptosis,Complete proteome,Cytoplasm,Direct protein sequencing,Disease mutation,Host-virus interaction,Hydrolase,Phosphoprotein,Polymorphism,Protease,Proteomics identification,Reference proteome,Repeat,Thiol protease,Zymogen,	chain:Caspase-8 subunit p10,chain:Caspase-8 subunit p18,domain:DED 1,domain:DED 2,helix,modified residue,mutagenesis site,sequence conflict,sequence variant,splice variant,strand,turn,
CTNND1	catenin delta 1(CTNND1)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007155~cell adhesion,GO:0007420~brain development,GO:0016055~Wnt signaling pathway,GO:0016337~single organismal cell-cell adhesion,GO:0034332~adherens junction organization,GO:0090090~negative regulation of canonical Wnt signaling pathway,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0005913~cell-cell adherens junction,GO:0005915~zonula adherens,GO:0030027~lamellipodium,GO:0030426~growth cone,GO:0030496~midbody,GO:0043197~dendritic spine,GO:0070062~extracellular exosome,	GO:0005102~receptor binding,GO:0005515~protein binding,GO:0019901~protein kinase binding,GO:0045296~cadherin binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000225:Armadillo,IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,	hsa04015:Rap1 signaling pathway,hsa04520:Adherens junction,hsa04670:Leukocyte transendothelial migration,			SM00185:ARM,	3D-structure,Acetylation,Alternative initiation,Alternative splicing,Cell adhesion,Cell membrane,Coiled coil,Complete proteome,Cytoplasm,Membrane,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Wnt signaling pathway,	chain:Catenin delta-1,modified residue,repeat:ARM 1,repeat:ARM 10,repeat:ARM 2,repeat:ARM 3,repeat:ARM 4,repeat:ARM 5,repeat:ARM 6,repeat:ARM 7,repeat:ARM 8,repeat:ARM 9,sequence conflict,sequence variant,short sequence motif:Nuclear localization signal,splice variant,
CTSK	cathepsin K(CTSK)	Homo sapiens				GO:0001957~intramembranous ossification,GO:0002224~toll-like receptor signaling pathway,GO:0006508~proteolysis,GO:0022617~extracellular matrix disassembly,GO:0030574~collagen catabolic process,GO:0045453~bone resorption,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:1903146~regulation of mitophagy,GO:1903955~positive regulation of protein targeting to mitochondrion,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005764~lysosome,GO:0036021~endolysosome lumen,	GO:0001968~fibronectin binding,GO:0004197~cysteine-type endopeptidase activity,GO:0004252~serine-type endopeptidase activity,GO:0005515~protein binding,GO:0005518~collagen binding,GO:0008234~cysteine-type peptidase activity,GO:0043394~proteoglycan binding,	IPR000169:Cysteine peptidase, cysteine active site,IPR000668:Peptidase C1A, papain C-terminal,IPR013128:Peptidase C1A, papain,IPR013201:Proteinase inhibitor I29, cathepsin propeptide,IPR015644:Peptidase C1A, cathepsin K,IPR025660:Cysteine peptidase, histidine active site,IPR025661:Cysteine peptidase, asparagine active site,	hsa04142:Lysosome,hsa04380:Osteoclast differentiation,hsa04620:Toll-like receptor signaling pathway,hsa05323:Rheumatoid arthritis,	265800~Pycnodysostosis,		SM00645:Pept_C1,SM00848:SM00848,	3D-structure,Complete proteome,Disease mutation,Disulfide bond,Glycoprotein,Hydrolase,Lysosome,Protease,Proteomics identification,Reference proteome,Signal,Thiol protease,Zymogen,	chain:Cathepsin K,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,propeptide:Activation peptide,sequence conflict,sequence variant,signal peptide,strand,turn,
CGRRF1	cell growth regulator with ring finger domain 1(CGRRF1)	Homo sapiens				GO:0006950~response to stress,GO:0007050~cell cycle arrest,GO:0008285~negative regulation of cell proliferation,	GO:0005654~nucleoplasm,GO:0016021~integral component of membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0008270~zinc ion binding,	IPR001841:Zinc finger, RING-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,				SM00184:RING,	3D-structure,Cell cycle,Complete proteome,Growth arrest,Membrane,Metal-binding,Nucleus,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,Zinc,Zinc-finger,	chain:Cell growth regulator with RING finger domain protein 1,sequence conflict,sequence variant,strand,turn,zinc finger region:RING-type,
CNTRL	centriolin(CNTRL)	Homo sapiens			Cell division and chromosome partitioning,	GO:0000086~G2/M transition of mitotic cell cycle,GO:0000278~mitotic cell cycle,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0051301~cell division,	GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005829~cytosol,GO:0016020~membrane,	GO:0004713~protein tyrosine kinase activity,GO:0005515~protein binding,	IPR001611:Leucine-rich repeat,IPR003591:Leucine-rich repeat, typical subtype,				SM00369:LRR_TYP,	Alternative splicing,Cell cycle,Cell division,Chromosomal rearrangement,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Leucine-rich repeat,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:Centriolin,compositionally biased region:Poly-Lys,compositionally biased region:Poly-Pro,compositionally biased region:Pro-rich,modified residue,region of interest:Required for centrosome localization,region of interest:Sufficient for interaction with HOOK2,repeat:LRR 1,repeat:LRR 10,repeat:LRR 11,repeat:LRR 12,repeat:LRR 13,repeat:LRR 14,repeat:LRR 15,repeat:LRR 16,repeat:LRR 17,repeat:LRR 18,repeat:LRR 19,repeat:LRR 2,repeat:LRR 20,repeat:LRR 21,repeat:LRR 3,repeat:LRR 4,repeat:LRR 5,repeat:LRR 6,repeat:LRR 7,repeat:LRR 8,repeat:LRR 9,sequence conflict,sequence variant,site:Breakpoint for translocation to form CEP110-FGFR1,splice variant,
CCT3	chaperonin containing TCP1 subunit 3(CCT3)	Homo sapiens				GO:0006457~protein folding,GO:0007339~binding of sperm to zona pellucida,GO:0032212~positive regulation of telomere maintenance via telomerase,GO:0046931~pore complex assembly,GO:0050821~protein stabilization,GO:1901998~toxin transport,GO:1904871~positive regulation of protein localization to Cajal body,GO:1904874~positive regulation of telomerase RNA localization to Cajal body,	GO:0002199~zona pellucida receptor complex,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005832~chaperonin-containing T-complex,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0005886~plasma membrane,GO:0043209~myelin sheath,GO:0044297~cell body,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0005524~ATP binding,GO:0044183~protein binding involved in protein folding,GO:0044822~poly(A) RNA binding,GO:0051082~unfolded protein binding,	IPR002194:Chaperonin TCP-1, conserved site,IPR002423:Chaperonin Cpn60/TCP-1,IPR012719:T-complex protein 1, gamma subunit,IPR017998:Chaperone tailless complex polypeptide 1 (TCP-1),IPR027409:GroEL-like apical domain,IPR027410:TCP-1-like chaperonin intermediate domain,IPR027413:GroEL-like equatorial domain,					Acetylation,Alternative splicing,ATP-binding,Chaperone,Complete proteome,Cytoplasm,Direct protein sequencing,Disulfide bond,Isopeptide bond,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation,	chain:T-complex protein 1 subunit gamma,disulfide bond,modified residue,sequence conflict,sequence variant,
CHD2	chromodomain helicase DNA binding protein 2(CHD2)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006974~cellular response to DNA damage stimulus,GO:0007517~muscle organ development,GO:0016569~covalent chromatin modification,GO:0032508~DNA duplex unwinding,GO:0060218~hematopoietic stem cell differentiation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0043231~intracellular membrane-bounded organelle,GO:0070062~extracellular exosome,	GO:0001046~core promoter sequence-specific DNA binding,GO:0003677~DNA binding,GO:0004003~ATP-dependent DNA helicase activity,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0042393~histone binding,GO:0044822~poly(A) RNA binding,	IPR000330:SNF2-related,IPR000953:Chromo domain/shadow,IPR001650:Helicase, C-terminal,IPR009057:Homeodomain-like,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR016197:Chromo domain-like,IPR023779:Chromo domain, conserved site,IPR023780:Chromo domain,IPR025260:Domain of unknown function DUF4208,IPR027417:P-loop containing nucleoside triphosphate hydrolase,		615369~Epileptic encephalopathy, childhood-onset,		SM00298:CHROMO,SM00487:DEXDc,SM00490:HELICc,SM01176:SM01176,	Alternative splicing,ATP-binding,Chromatin regulator,Coiled coil,Complete proteome,Disease mutation,DNA-binding,Epilepsy,Helicase,Hydrolase,Myogenesis,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,	chain:Chromodomain-helicase-DNA-binding protein 2,compositionally biased region:Glu-rich,compositionally biased region:Ser-rich,domain:Chromo 1,domain:Chromo 2,domain:Helicase ATP-binding,domain:Helicase C-terminal,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,short sequence motif:DEAH box,splice variant,
C9orf84	chromosome 9 open reading frame 84(C9orf84)	Homo sapiens												Alternative splicing,Complete proteome,Polymorphism,Proteomics identification,Reference proteome,	chain:Uncharacterized protein C9orf84,sequence variant,splice variant,
CLOCK	clock circadian regulator(CLOCK)	Homo sapiens		h_circadianPathway:Circadian Rhythms,		GO:0000077~DNA damage checkpoint,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0007165~signal transduction,GO:0007283~spermatogenesis,GO:0007623~circadian rhythm,GO:0009648~photoperiodism,GO:0016573~histone acetylation,GO:0032922~circadian regulation of gene expression,GO:0042634~regulation of hair cycle,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0050729~positive regulation of inflammatory response,GO:0050796~regulation of insulin secretion,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0051775~response to redox state,GO:0071479~cellular response to ionizing radiation,GO:2000074~regulation of type B pancreatic cell development,GO:2000323~negative regulation of glucocorticoid receptor signaling pathway,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0033391~chromatoid body,GO:0043231~intracellular membrane-bounded organelle,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000982~transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001046~core promoter sequence-specific DNA binding,GO:0001047~core promoter binding,GO:0001190~transcriptional activator activity, RNA polymerase II transcription factor binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0004402~histone acetyltransferase activity,GO:0005515~protein binding,GO:0031490~chromatin DNA binding,GO:0043565~sequence-specific DNA binding,GO:0046983~protein dimerization activity,GO:0070888~E-box binding,	IPR000014:PAS domain,IPR001067:Nuclear translocator,IPR001610:PAC motif,IPR011598:Myc-type, basic helix-loop-helix (bHLH) domain,IPR013767:PAS fold,	hsa04710:Circadian rhythm,hsa04728:Dopaminergic synapse,hsa05168:Herpes simplex infection,			SM00086:PAC,SM00091:PAS,SM00353:HLH,	3D-structure,Activator,Acyltransferase,Biological rhythms,Coiled coil,Complete proteome,Cytoplasm,DNA damage,DNA-binding,Isopeptide bond,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Transferase,Ubl conjugation,	chain:Circadian locomoter output cycles protein kaput,compositionally biased region:Gln-rich,compositionally biased region:Poly-Gln,DNA-binding region:Basic motif,domain:Helix-loop-helix motif,domain:PAC,domain:PAS 1,domain:PAS 2,modified residue,mutagenesis site,region of interest:Implicated in the circadian rhythmicity,sequence conflict,sequence variant,
CNTN6	contactin 6(CNTN6)	Homo sapiens				GO:0007155~cell adhesion,GO:0007219~Notch signaling pathway,GO:0007417~central nervous system development,GO:0030182~neuron differentiation,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0031225~anchored component of membrane,	GO:0005112~Notch binding,	IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR003961:Fibronectin, type III,IPR007110:Immunoglobulin-like domain,IPR013098:Immunoglobulin I-set,IPR013783:Immunoglobulin-like fold,				SM00060:FN3,SM00408:IGc2,SM00409:IG,	Cell adhesion,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,GPI-anchor,Immunoglobulin domain,Lipoprotein,Membrane,Notch signaling pathway,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Contactin-6,disulfide bond,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Fibronectin type-III 3,domain:Fibronectin type-III 4,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,domain:Ig-like C2-type 4,domain:Ig-like C2-type 5,domain:Ig-like C2-type 6,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:GPI-anchor amidated serine,modified residue,propeptide:Removed in mature form,sequence variant,signal peptide,
COBLL1	cordon-bleu WH2 repeat protein like 1(COBLL1)	Homo sapiens				GO:0030041~actin filament polymerization,GO:0051639~actin filament network formation,GO:0098609~cell-cell adhesion,	GO:0005913~cell-cell adherens junction,GO:0070062~extracellular exosome,	GO:0003785~actin monomer binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR003124:WH2 domain,IPR019025:Cordon-bleu domain,					3D-structure,Alternative splicing,Complete proteome,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,	chain:Cordon-bleu protein-like 1,domain:WH2,helix,modified residue,sequence conflict,short sequence motif:KKRRAP 1,short sequence motif:KKRRAP 2,splice variant,strand,turn,
COBL	cordon-bleu WH2 repeat protein(COBL)	Homo sapiens				GO:0000578~embryonic axis specification,GO:0001757~somite specification,GO:0001843~neural tube closure,GO:0001889~liver development,GO:0030041~actin filament polymerization,GO:0030903~notochord development,GO:0033504~floor plate development,GO:0048565~digestive tract development,GO:0048669~collateral sprouting in absence of injury,GO:0051639~actin filament network formation,GO:1900006~positive regulation of dendrite development,GO:1900029~positive regulation of ruffle assembly,	GO:0001726~ruffle,GO:0005884~actin filament,GO:0005886~plasma membrane,GO:0005938~cell cortex,GO:0016020~membrane,GO:0030424~axon,GO:0030425~dendrite,GO:0043025~neuronal cell body,GO:0044294~dendritic growth cone,GO:0044295~axonal growth cone,GO:0048471~perinuclear region of cytoplasm,	GO:0003785~actin monomer binding,	IPR003124:WH2 domain,IPR019025:Cordon-bleu domain,				SM00246:WH2,	3D-structure,Actin-binding,Alternative splicing,Cell membrane,Cell projection,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:Protein cordon-bleu,compositionally biased region:Poly-Pro,compositionally biased region:Pro-rich,domain:WH2 1,domain:WH2 2,domain:WH2 3,modified residue,sequence conflict,sequence variant,short sequence motif:KKRRAP 1,short sequence motif:KKRRAP 2,splice variant,
CDKN2A	cyclin dependent kinase inhibitor 2A(CDKN2A)	Homo sapiens	1.RBphosphoE2F,26.cyclin-CDK_complexes,94.E2F_transcriptional_activity_cell_cycle,	h_arfPathway:Tumor Suppressor Arf Inhibits Ribosomal Biogenesis,h_cellcyclePathway:Cyclins and Cell Cycle Regulation,h_ctcfPathway:CTCF: First Multivalent Nuclear Factor,h_g1Pathway:Cell Cycle: G1/S Check Point ,		GO:0000082~G1/S transition of mitotic cell cycle,GO:0000209~protein polyubiquitination,GO:0000422~mitophagy,GO:0001953~negative regulation of cell-matrix adhesion,GO:0006351~transcription, DNA-templated,GO:0006364~rRNA processing,GO:0006469~negative regulation of protein kinase activity,GO:0006915~apoptotic process,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0007050~cell cycle arrest,GO:0007265~Ras protein signal transduction,GO:0008285~negative regulation of cell proliferation,GO:0008637~apoptotic mitochondrial changes,GO:0010389~regulation of G2/M transition of mitotic cell cycle,GO:0016925~protein sumoylation,GO:0030308~negative regulation of cell growth,GO:0030889~negative regulation of B cell proliferation,GO:0031647~regulation of protein stability,GO:0031648~protein destabilization,GO:0032088~negative regulation of NF-kappaB transcription factor activity,GO:0033088~negative regulation of immature T cell proliferation in thymus,GO:0033235~positive regulation of protein sumoylation,GO:0034393~positive regulation of smooth muscle cell apoptotic process,GO:0035986~senescence-associated heterochromatin focus assembly,GO:0042326~negative regulation of phosphorylation,GO:0043065~positive regulation of apoptotic process,GO:0043517~positive regulation of DNA damage response, signal transduction by p53 class mediator,GO:0045736~negative regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046825~regulation of protein export from nucleus,GO:0048103~somatic stem cell division,GO:0050821~protein stabilization,GO:0051444~negative regulation of ubiquitin-protein transferase activity,GO:0051882~mitochondrial depolarization,GO:0070534~protein K63-linked ubiquitination,GO:0071158~positive regulation of cell cycle arrest,GO:0090398~cellular senescence,GO:0090399~replicative senescence,GO:1900182~positive regulation of protein localization to nucleus,GO:1901798~positive regulation of signal transduction by p53 class mediator,GO:1902510~regulation of apoptotic DNA fragmentation,GO:1903051~negative regulation of proteolysis involved in cellular protein catabolic process,GO:1903214~regulation of protein targeting to mitochondrion,GO:2000059~negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,GO:2000111~positive regulation of macrophage apoptotic process,GO:2000774~positive regulation of cellular senescence,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0035985~senescence-associated heterochromatin focus,GO:0043234~protein complex,	GO:0002039~p53 binding,GO:0003677~DNA binding,GO:0004861~cyclin-dependent protein serine/threonine kinase inhibitor activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0016301~kinase activity,GO:0019789~SUMO transferase activity,GO:0019901~protein kinase binding,GO:0044822~poly(A) RNA binding,GO:0051059~NF-kappaB binding,GO:0055105~ubiquitin-protein transferase inhibitor activity,GO:0097371~MDM2/MDM4 family protein binding,	IPR010868:Cyclin-dependent kinase inhibitor 2A,IPR020683:Ankyrin repeat-containing domain,	hsa04110:Cell cycle,hsa04115:p53 signaling pathway,hsa05166:HTLV-I infection,hsa05200:Pathways in cancer,hsa05203:Viral carcinogenesis,hsa05206:MicroRNAs in cancer,hsa05212:Pancreatic cancer,hsa05214:Glioma,hsa05218:Melanoma,hsa05219:Bladder cancer,hsa05220:Chronic myeloid leukemia,hsa05223:Non-small cell lung cancer,	155601~Melanoma, cutaneous malignant, 2,155755~Melanoma and neural system tumor syndrome,606719~Pancreatic cancer/melanoma syndrome,Orolaryngeal cancer, multiple,~Orolaryngeal cancer, multiple,,			3D-structure,Acetylation,Alternative splicing,ANK repeat,Apoptosis,Cell cycle,Complete proteome,Cyclin,Cytoplasm,Disease mutation,DNA-binding,Kinase,Li-Fraumeni syndrome,Mitochondrion,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,rRNA processing,Transcription,Transcription regulation,Transferase,Tumor suppressor,Ubl conjugation,Ubl conjugation pathway,	chain:Cyclin-dependent kinase inhibitor 2A, isoform 4,chain:Cyclin-dependent kinase inhibitor 2A, isoforms 1/2/3,helix,modified residue,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,repeat:ANK 4,sequence conflict,sequence variant,splice variant,strand,turn,
CRIPAK	cysteine rich PAK1 inhibitor(CRIPAK)	Homo sapiens				GO:0006469~negative regulation of protein kinase activity,GO:0033147~negative regulation of intracellular estrogen receptor signaling pathway,GO:0043627~response to estrogen,GO:0051493~regulation of cytoskeleton organization,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005886~plasma membrane,	GO:0005515~protein binding,	IPR003616:Post-SET domain,				SM00508:PostSET,	Complete proteome,Cytoplasm,Membrane,Nucleus,Polymorphism,Reference proteome,Repeat,	chain:Cysteine-rich PAK1 inhibitor,region of interest:Interaction with PAK1,repeat:1,repeat:10,repeat:2,repeat:3,repeat:4,repeat:5,repeat:6,repeat:7,repeat:8,repeat:9,sequence conflict,sequence variant,
DAXX	death domain associated protein(DAXX)	Homo sapiens		h_fasPathway:FAS signaling pathway ( CD95 ),h_hivnefPathway:HIV-I Nef: negative effector of Fas and TNF,h_hsp27Pathway:Stress Induction of HSP Regulation,h_keratinocytePathway:Keratinocyte Differentiation,h_mapkPathway:MAPKinase Signaling Pathway,h_p38mapkPathway:p38 MAPK Signaling Pathway ,h_pmlPathway:Regulation of transcriptional activity by PML,		GO:0001934~positive regulation of protein phosphorylation,GO:0006334~nucleosome assembly,GO:0006338~chromatin remodeling,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006915~apoptotic process,GO:0007257~activation of JUN kinase activity,GO:0008625~extrinsic apoptotic signaling pathway via death domain receptors,GO:0016032~viral process,GO:0016569~covalent chromatin modification,GO:0030521~androgen receptor signaling pathway,GO:0031396~regulation of protein ubiquitination,GO:0045860~positive regulation of protein kinase activity,GO:0045892~negative regulation of transcription, DNA-templated,GO:1901216~positive regulation of neuron death,	GO:0000775~chromosome, centromeric region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016605~PML body,GO:0070603~SWI/SNF superfamily-type complex,	GO:0002039~p53 binding,GO:0003714~transcription corepressor activity,GO:0005057~receptor signaling protein activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0019899~enzyme binding,GO:0019901~protein kinase binding,GO:0030295~protein kinase activator activity,GO:0031072~heat shock protein binding,GO:0031625~ubiquitin protein ligase binding,GO:0042393~histone binding,GO:0042803~protein homodimerization activity,GO:0047485~protein N-terminus binding,GO:0050681~androgen receptor binding,	IPR005012:Daxx protein,	hsa04010:MAPK signaling pathway,hsa05014:Amyotrophic lateral sclerosis (ALS),hsa05168:Herpes simplex infection,				3D-structure,Acetylation,Alternative splicing,Apoptosis,Centromere,Chaperone,Chromatin regulator,Chromosome,Coiled coil,Complete proteome,Cytoplasm,Host-virus interaction,Isopeptide bond,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,Ubl conjugation,	chain:Death domain-associated protein 6,compositionally biased region:Asp/Glu-rich (acidic),compositionally biased region:Poly-Asp,modified residue,mutagenesis site,region of interest:Interaction with MAP3K5,region of interest:Interaction with SPOP,sequence conflict,short sequence motif:Nuclear localization signal,splice variant,
DCP1B	decapping mRNA 1B(DCP1B)	Homo sapiens				GO:0000184~nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,GO:0000290~deadenylation-dependent decapping of nuclear-transcribed mRNA,GO:0031087~deadenylation-independent decapping of nuclear-transcribed mRNA,GO:0043085~positive regulation of catalytic activity,GO:0043928~exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay,	GO:0000932~cytoplasmic mRNA processing body,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016020~membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0003729~mRNA binding,GO:0005515~protein binding,GO:0008047~enzyme activator activity,GO:0016787~hydrolase activity,GO:0030234~enzyme regulator activity,	IPR010334:Dcp1-like decapping,IPR011993:Pleckstrin homology-like domain,	hsa03018:RNA degradation,				Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Hydrolase,Nonsense-mediated mRNA decay,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:mRNA-decapping enzyme 1B,compositionally biased region:Poly-Gln,modified residue,sequence conflict,sequence variant,
DIEXF	digestive organ expansion factor homolog (zebrafish)(DIEXF)	Homo sapiens				GO:0000462~maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0006364~rRNA processing,GO:0007275~multicellular organism development,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0032040~small-subunit processome,	GO:0005515~protein binding,GO:0019843~rRNA binding,GO:0034511~U3 snoRNA binding,GO:0044822~poly(A) RNA binding,	IPR010678:Digestive organ expansion factor, predicted,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					Complete proteome,Developmental protein,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Digestive organ expansion factor homolog,compositionally biased region:Glu-rich,compositionally biased region:Poly-Asp,modified residue,sequence conflict,sequence variant,
ESRP1	epithelial splicing regulatory protein 1(ESRP1)	Homo sapiens				GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0008543~fibroblast growth factor receptor signaling pathway,GO:0043484~regulation of RNA splicing,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003729~mRNA binding,GO:0005515~protein binding,	IPR000504:RNA recognition motif domain,IPR012337:Ribonuclease H-like domain,IPR012677:Nucleotide-binding, alpha-beta plait,				SM00360:RRM,	3D-structure,Alternative splicing,Complete proteome,Methylation,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,RNA-binding,	chain:Epithelial splicing regulatory protein 1,domain:RRM 1,domain:RRM 2,domain:RRM 3,helix,sequence conflict,sequence variant,splice variant,strand,turn,
EPHX4	epoxide hydrolase 4(EPHX4)	Homo sapiens					GO:0016021~integral component of membrane,	GO:0016787~hydrolase activity,	IPR000073:Alpha/beta hydrolase fold-1,IPR000639:Epoxide hydrolase-like,					Complete proteome,Hydrolase,Membrane,Polymorphism,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,	active site:Nucleophile,active site:Proton acceptor,active site:Proton donor,chain:Epoxide hydrolase 4,sequence conflict,sequence variant,transmembrane region,
EIF2AK1	eukaryotic translation initiation factor 2 alpha kinase 1(EIF2AK1)	Homo sapiens		h_eif2Pathway:Regulation of eIF2,		GO:0002526~acute inflammatory response,GO:0006909~phagocytosis,GO:0006950~response to stress,GO:0008285~negative regulation of cell proliferation,GO:0009605~response to external stimulus,GO:0010998~regulation of translational initiation by eIF2 alpha phosphorylation,GO:0010999~regulation of eIF2 alpha phosphorylation by heme,GO:0030225~macrophage differentiation,GO:0045993~negative regulation of translational initiation by iron,GO:0046501~protoporphyrinogen IX metabolic process,GO:0046777~protein autophosphorylation,GO:0046986~negative regulation of hemoglobin biosynthetic process,GO:0055072~iron ion homeostasis,	GO:0005737~cytoplasm,	GO:0003743~translation initiation factor activity,GO:0004694~eukaryotic translation initiation factor 2alpha kinase activity,GO:0005524~ATP binding,GO:0020037~heme binding,GO:0042803~protein homodimerization activity,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,	hsa04141:Protein processing in endoplasmic reticulum,hsa05160:Hepatitis C,hsa05162:Measles,hsa05164:Influenza A,hsa05168:Herpes simplex infection,			SM00220:S_TKc,	Alternative splicing,ATP-binding,Coiled coil,Complete proteome,Cytoplasm,Disulfide bond,Initiation factor,Kinase,Nucleotide-binding,Phosphoprotein,Polymorphism,Protein biosynthesis,Protein synthesis inhibitor,Proteomics identification,Reference proteome,Repeat,Serine/threonine-protein kinase,Signal,Transferase,	active site:Proton acceptor,binding site:ATP,chain:Eukaryotic translation initiation factor 2-alpha kinase 1,domain:Protein kinase,modified residue,nucleotide phosphate-binding region:ATP,repeat:HRM 1,repeat:HRM 2,sequence conflict,sequence variant,splice variant,
FIP1L1	factor interacting with PAPOLA and CPSF1(FIP1L1)	Homo sapiens				GO:0000398~mRNA splicing, via spliceosome,GO:0006369~termination of RNA polymerase II transcription,GO:0006406~mRNA export from nucleus,GO:0031124~mRNA 3'-end processing,	GO:0005654~nucleoplasm,GO:0005847~mRNA cleavage and polyadenylation specificity factor complex,	GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR007854:Pre-mRNA polyadenylation factor Fip1,	hsa03015:mRNA surveillance pathway,				Alternative splicing,Complete proteome,mRNA processing,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,RNA-binding,	chain:Pre-mRNA 3'-end-processing factor FIP1,compositionally biased region:Arg-rich,compositionally biased region:Glu-rich,compositionally biased region:Pro-rich,modified residue,region of interest:Necessary for stimulating PAPOLA activity,region of interest:Sufficient for interaction with CPSF1 and CSTF3,region of interest:Sufficient for interaction with CPSF4,region of interest:Sufficient for interaction with PAPOLA,sequence conflict,site:Breakpoint for interstitial deletion to form the FIP1L1-PDGFRA fusion protein,splice variant,
FAM111B	family with sequence similarity 111 member B(FAM111B)	Homo sapiens						GO:0005515~protein binding,	IPR009003:Trypsin-like cysteine/serine peptidase domain,		615704~Poikiloderma, hereditary fibrosing, with tendon contractures, myopathy, and pulmonary fibrosis,			Acetylation,Alternative splicing,Complete proteome,Disease mutation,Polymorphism,Proteomics identification,Reference proteome,	chain:Protein FAM111B,sequence conflict,sequence variant,splice variant,
FUBP1	far upstream element binding protein 1(FUBP1)	Homo sapiens				GO:0006355~regulation of transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0010628~positive regulation of gene expression,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0003697~single-stranded DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR004087:K Homology domain,IPR004088:K Homology domain, type 1,IPR015096:Domain of unknown function DUF1897,				SM00322:KH,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Direct protein sequencing,DNA-binding,Methylation,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Ubl conjugation,	chain:Far upstream element-binding protein 1,compositionally biased region:Gly-rich,compositionally biased region:Pro-rich,domain:KH 1,domain:KH 2,domain:KH 3,domain:KH 4,helix,modified residue,sequence conflict,sequence variant,splice variant,strand,turn,
FNIP1	folliculin interacting protein 1(FNIP1)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001932~regulation of protein phosphorylation,GO:0001934~positive regulation of protein phosphorylation,GO:0002327~immature B cell differentiation,GO:0002904~positive regulation of B cell apoptotic process,GO:0009267~cellular response to starvation,GO:0031334~positive regulation of protein complex assembly,GO:0031929~TOR signaling,GO:0032007~negative regulation of TOR signaling,GO:0033138~positive regulation of peptidyl-serine phosphorylation,GO:0043154~negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0043547~positive regulation of GTPase activity,GO:2000973~regulation of pro-B cell differentiation,	GO:0005737~cytoplasm,	GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005515~protein binding,GO:0042030~ATPase inhibitor activity,GO:0051087~chaperone binding,	IPR026156:Folliculin-interacting protein family,					Alternative splicing,Complete proteome,Cytoplasm,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Folliculin-interacting protein 1,compositionally biased region:Poly-Ser,modified residue,sequence variant,splice variant,
FOXP4	forkhead box P4(FOXP4)	Homo sapiens			Transcription,	GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,	GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0043565~sequence-specific DNA binding,GO:0046872~metal ion binding,	IPR001766:Transcription factor, fork head,IPR011991:Winged helix-turn-helix DNA-binding domain,				SM00339:FH,	Alternative splicing,Complete proteome,DNA-binding,Isopeptide bond,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,Ubl conjugation,Zinc,Zinc-finger,	chain:Forkhead box protein P4,compositionally biased region:Gln-rich,DNA-binding region:Fork-head,domain:Leucine-zipper,modified residue,sequence variant,zinc finger region:C2H2-type,
GRIK2	glutamate ionotropic receptor kainate type subunit 2(GRIK2)	Homo sapiens				GO:0001662~behavioral fear response,GO:0006810~transport,GO:0006874~cellular calcium ion homeostasis,GO:0006886~intracellular protein transport,GO:0007215~glutamate receptor signaling pathway,GO:0007268~chemical synaptic transmission,GO:0019228~neuronal action potential,GO:0034220~ion transmembrane transport,GO:0035235~ionotropic glutamate receptor signaling pathway,GO:0035249~synaptic transmission, glutamatergic,GO:0043113~receptor clustering,GO:0043524~negative regulation of neuron apoptotic process,GO:0043525~positive regulation of neuron apoptotic process,GO:0046328~regulation of JNK cascade,GO:0048169~regulation of long-term neuronal synaptic plasticity,GO:0048172~regulation of short-term neuronal synaptic plasticity,GO:0050804~modulation of synaptic transmission,GO:0050806~positive regulation of synaptic transmission,GO:0051402~neuron apoptotic process,GO:0051967~negative regulation of synaptic transmission, glutamatergic,GO:0060079~excitatory postsynaptic potential,GO:0060080~inhibitory postsynaptic potential,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0014069~postsynaptic density,GO:0016021~integral component of membrane,GO:0030054~cell junction,GO:0032839~dendrite cytoplasm,GO:0032983~kainate selective glutamate receptor complex,GO:0042734~presynaptic membrane,GO:0043195~terminal bouton,GO:0043204~perikaryon,GO:0045211~postsynaptic membrane,	GO:0004970~ionotropic glutamate receptor activity,GO:0005234~extracellular-glutamate-gated ion channel activity,GO:0015276~ligand-gated ion channel activity,GO:0015277~kainate selective glutamate receptor activity,GO:0030165~PDZ domain binding,GO:0031624~ubiquitin conjugating enzyme binding,GO:0031625~ubiquitin protein ligase binding,GO:0042803~protein homodimerization activity,	IPR001320:Ionotropic glutamate receptor,IPR001508:NMDA receptor,IPR001828:Extracellular ligand-binding receptor,IPR019594:Glutamate receptor, L-glutamate/glycine-binding,	hsa04080:Neuroactive ligand-receptor interaction,hsa04724:Glutamatergic synapse,	611092~Mental retardation, autosomal recessive, 6,		SM00079:PBPe,SM00918:SM00918,	3D-structure,Alternative splicing,Cell junction,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,Ion channel,Ion transport,Isopeptide bond,Ligand-gated ion channel,Membrane,Mental retardation,Phosphoprotein,Polymorphism,Postsynaptic cell membrane,Proteomics identification,Receptor,Reference proteome,RNA editing,Signal,Synapse,Transmembrane,Transmembrane helix,Transport,Ubl conjugation,	binding site:Glutamate,chain:Glutamate receptor, ionotropic kainate 2,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO-1),glycosylation site:N-linked (GlcNAc...),region of interest:Glutamate binding,sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
GPC3	glypican 3(GPC3)	Homo sapiens				GO:0001523~retinoid metabolic process,GO:0001658~branching involved in ureteric bud morphogenesis,GO:0006024~glycosaminoglycan biosynthetic process,GO:0006027~glycosaminoglycan catabolic process,GO:0009653~anatomical structure morphogenesis,GO:0009948~anterior/posterior axis specification,GO:0010171~body morphogenesis,GO:0010466~negative regulation of peptidase activity,GO:0030203~glycosaminoglycan metabolic process,GO:0030282~bone mineralization,GO:0030316~osteoclast differentiation,GO:0030324~lung development,GO:0030513~positive regulation of BMP signaling pathway,GO:0035116~embryonic hindlimb morphogenesis,GO:0045732~positive regulation of protein catabolic process,GO:0045807~positive regulation of endocytosis,GO:0045879~negative regulation of smoothened signaling pathway,GO:0045880~positive regulation of smoothened signaling pathway,GO:0045926~negative regulation of growth,GO:0046326~positive regulation of glucose import,GO:0050680~negative regulation of epithelial cell proliferation,GO:0060976~coronary vasculature development,GO:0072138~mesenchymal cell proliferation involved in ureteric bud development,GO:0072180~mesonephric duct morphogenesis,GO:0072203~cell proliferation involved in metanephros development,GO:0090090~negative regulation of canonical Wnt signaling pathway,GO:2000096~positive regulation of Wnt signaling pathway, planar cell polarity pathway,	GO:0005578~proteinaceous extracellular matrix,GO:0005615~extracellular space,GO:0005796~Golgi lumen,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0031225~anchored component of membrane,GO:0043202~lysosomal lumen,GO:0046658~anchored component of plasma membrane,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0043395~heparan sulfate proteoglycan binding,GO:0060422~peptidyl-dipeptidase inhibitor activity,	IPR001863:Glypican,IPR015501:Glypican-3,IPR019803:Glypican, conserved site,	hsa05205:Proteoglycans in cancer,	194070~Wilms tumor, somatic,312870~Simpson-Golabi-Behmel syndrome, type 1,			Alternative splicing,Cell membrane,Complete proteome,Disease mutation,Glycoprotein,GPI-anchor,Heparan sulfate,Lipoprotein,Membrane,Phosphoprotein,Protease inhibitor,Proteoglycan,Proteomics identification,Reference proteome,Secreted,Signal,	chain:Glypican-3,chain:Secreted glypican-3,glycosylation site:N-linked (GlcNAc...),glycosylation site:O-linked (Xyl...) (heparan sulfate),propeptide:Removed in mature form,sequence variant,signal peptide,
GOLGA2	golgin A2(GOLGA2)	Homo sapiens				GO:0006486~protein glycosylation,GO:0006888~ER to Golgi vesicle-mediated transport,GO:0007020~microtubule nucleation,GO:0008356~asymmetric cell division,GO:0010507~negative regulation of autophagy,GO:0032091~negative regulation of protein binding,GO:0048208~COPII vesicle coating,GO:0051225~spindle assembly,GO:0051289~protein homotetramerization,GO:0051297~centrosome organization,GO:0060050~positive regulation of protein glycosylation,GO:0090161~Golgi ribbon formation,GO:0090166~Golgi disassembly,GO:0090306~spindle assembly involved in meiosis,GO:0090307~mitotic spindle assembly,GO:0098609~cell-cell adhesion,	GO:0000137~Golgi cis cisterna,GO:0000139~Golgi membrane,GO:0000922~spindle pole,GO:0005634~nucleus,GO:0005794~Golgi apparatus,GO:0005801~cis-Golgi network,GO:0005874~microtubule,GO:0005913~cell-cell adherens junction,GO:0030134~ER to Golgi transport vesicle,GO:0032580~Golgi cisterna membrane,GO:0033116~endoplasmic reticulum-Golgi intermediate compartment membrane,GO:0072686~mitotic spindle,	GO:0005515~protein binding,GO:0008017~microtubule binding,GO:0019901~protein kinase binding,GO:0019905~syntaxin binding,GO:0061676~importin-alpha family protein binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR024858:Golgin subfamily A,					3D-structure,Alternative splicing,Cell cycle,Cell division,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Golgi apparatus,Membrane,Methylation,Microtubule,Mitosis,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Golgin subfamily A member 2,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Lys,compositionally biased region:Poly-Pro,modified residue,sequence conflict,sequence variant,splice variant,
GON4L	gon-4 like(GON4L)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0030183~B cell differentiation,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0003714~transcription corepressor activity,	IPR003822:Paired amphipathic helix,IPR009057:Homeodomain-like,IPR017877:Myb-like domain,					Alternative splicing,Complete proteome,Isopeptide bond,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,	chain:GON-4-like protein,chain:YY1-associated protein 1,compositionally biased region:Asp-rich,compositionally biased region:Glu-rich,compositionally biased region:Poly-Lys,compositionally biased region:Poly-Pro,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),domain:Myb-like,modified residue,repeat:PAH 1,repeat:PAH 2,sequence conflict,sequence variant,splice variant,
HDAC2	histone deacetylase 2(HDAC2)	Homo sapiens		h_carm-erPathway:CARM1 and Regulation of the Estrogen Receptor,h_etsPathway:METS affect on Macrophage Differentiation,h_mef2dPathway:Role of MEF2D in T-cell Apoptosis,h_prc2Pathway:The PRC2 Complex Sets Long-term Gene Silencing Through Modification of Histone Tails,	Chromatin structure and dynamics / Secondary metabolites biosynthesis, transport, and catabolism,	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001975~response to amphetamine,GO:0003300~cardiac muscle hypertrophy,GO:0006338~chromatin remodeling,GO:0006344~maintenance of chromatin silencing,GO:0006351~transcription, DNA-templated,GO:0007596~blood coagulation,GO:0008284~positive regulation of cell proliferation,GO:0009913~epidermal cell differentiation,GO:0010718~positive regulation of epithelial to mesenchymal transition,GO:0010870~positive regulation of receptor biosynthetic process,GO:0010977~negative regulation of neuron projection development,GO:0016358~dendrite development,GO:0016575~histone deacetylation,GO:0031000~response to caffeine,GO:0032496~response to lipopolysaccharide,GO:0032732~positive regulation of interleukin-1 production,GO:0032760~positive regulation of tumor necrosis factor production,GO:0032922~circadian regulation of gene expression,GO:0032967~positive regulation of collagen biosynthetic process,GO:0034605~cellular response to heat,GO:0035094~response to nicotine,GO:0042220~response to cocaine,GO:0042475~odontogenesis of dentin-containing tooth,GO:0042493~response to drug,GO:0042517~positive regulation of tyrosine phosphorylation of Stat3 protein,GO:0042733~embryonic digit morphogenesis,GO:0043044~ATP-dependent chromatin remodeling,GO:0043066~negative regulation of apoptotic process,GO:0043392~negative regulation of DNA binding,GO:0043433~negative regulation of sequence-specific DNA binding transcription factor activity,GO:0045347~negative regulation of MHC class II biosynthetic process,GO:0045862~positive regulation of proteolysis,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048149~behavioral response to ethanol,GO:0048714~positive regulation of oligodendrocyte differentiation,GO:0055093~response to hyperoxia,GO:0060789~hair follicle placode formation,GO:0061000~negative regulation of dendritic spine development,GO:0061029~eyelid development in camera-type eye,GO:0061198~fungiform papilla formation,GO:0070301~cellular response to hydrogen peroxide,GO:0070932~histone H3 deacetylation,GO:0070933~histone H4 deacetylation,GO:0071300~cellular response to retinoic acid,GO:0071560~cellular response to transforming growth factor beta stimulus,GO:1901796~regulation of signal transduction by p53 class mediator,GO:1903351~cellular response to dopamine,GO:2000757~negative regulation of peptidyl-lysine acetylation,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016021~integral component of membrane,GO:0016580~Sin3 complex,GO:0016581~NuRD complex,GO:0035098~ESC/E(Z) complex,GO:0043234~protein complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000980~RNA polymerase II distal enhancer sequence-specific DNA binding,GO:0001047~core promoter binding,GO:0001103~RNA polymerase II repressing transcription factor binding,GO:0003682~chromatin binding,GO:0004407~histone deacetylase activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0019213~deacetylase activity,GO:0019899~enzyme binding,GO:0031072~heat shock protein binding,GO:0031492~nucleosomal DNA binding,GO:0032041~NAD-dependent histone deacetylase activity (H3-K14 specific),GO:0033558~protein deacetylase activity,GO:0043565~sequence-specific DNA binding,GO:0044822~poly(A) RNA binding,GO:0051059~NF-kappaB binding,	IPR000286:Histone deacetylase superfamily,IPR003084:Histone deacetylase,IPR023801:Histone deacetylase domain,	hsa04110:Cell cycle,hsa04330:Notch signaling pathway,hsa04919:Thyroid hormone signaling pathway,hsa05016:Huntington's disease,hsa05034:Alcoholism,hsa05169:Epstein-Barr virus infection,hsa05200:Pathways in cancer,hsa05202:Transcriptional misregulation in cancer,hsa05203:Viral carcinogenesis,hsa05220:Chronic myeloid leukemia,		PIRSF037913:histone deacetylase class I, eukaryotic type,		3D-structure,Acetylation,Alternative splicing,Biological rhythms,Chromatin regulator,Complete proteome,Cytoplasm,Hydrolase,Isopeptide bond,Membrane,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repressor,S-nitrosylation,Transcription,Transcription regulation,Transmembrane,Transmembrane helix,Ubl conjugation,	chain:Histone deacetylase 2,compositionally biased region:Poly-Gly,modified residue,region of interest:Histone deacetylase,sequence conflict,sequence variant,splice variant,
ID3	inhibitor of DNA binding 3, HLH protein(ID3)	Homo sapiens	71.Id_proteins_G0-to-S_cell_cycle,			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001656~metanephros development,GO:0006275~regulation of DNA replication,GO:0006351~transcription, DNA-templated,GO:0007275~multicellular organism development,GO:0007417~central nervous system development,GO:0007507~heart development,GO:0007517~muscle organ development,GO:0007623~circadian rhythm,GO:0009611~response to wounding,GO:0030182~neuron differentiation,GO:0030855~epithelial cell differentiation,GO:0030903~notochord development,GO:0042476~odontogenesis,GO:0043065~positive regulation of apoptotic process,GO:0043433~negative regulation of sequence-specific DNA binding transcription factor activity,GO:0045662~negative regulation of myoblast differentiation,GO:0045668~negative regulation of osteoblast differentiation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0051726~regulation of cell cycle,GO:0072750~cellular response to leptomycin B,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0015630~microtubule cytoskeleton,	GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0019904~protein domain specific binding,GO:0046983~protein dimerization activity,GO:1901707~leptomycin B binding,	IPR011598:Myc-type, basic helix-loop-helix (bHLH) domain,IPR026052:DNA-binding protein inhibitor,	hsa04350:TGF-beta signaling pathway,hsa04550:Signaling pathways regulating pluripotency of stem cells,			SM00353:HLH,	3D-structure,Biological rhythms,Complete proteome,Myogenesis,Nucleus,Polymorphism,Reference proteome,Repressor,Transcription,Transcription regulation,	chain:DNA-binding protein inhibitor ID-3,domain:Helix-loop-helix motif,sequence variant,
ING1	inhibitor of growth family member 1(ING1)	Homo sapiens				GO:0006325~chromatin organization,GO:0006606~protein import into nucleus,GO:0007049~cell cycle,GO:0008285~negative regulation of cell proliferation,GO:0010941~regulation of cell death,GO:0016569~covalent chromatin modification,GO:0030308~negative regulation of cell growth,GO:0045893~positive regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0035064~methylated histone binding,	IPR001965:Zinc finger, PHD-type,IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR019786:Zinc finger, PHD-type, conserved site,IPR019787:Zinc finger, PHD-finger,IPR024610:Inhibitor of growth protein, N-terminal,		275355~Squamous cell carcinoma, head and neck, somatic,		SM00249:PHD,SM01408:SM01408,	3D-structure,Alternative splicing,Cell cycle,Chromatin regulator,Complete proteome,Disease mutation,Metal-binding,Nucleus,Proteomics identification,Reference proteome,Tumor suppressor,Zinc,Zinc-finger,	chain:Inhibitor of growth protein 1,sequence conflict,sequence variant,splice variant,turn,zinc finger region:PHD-type,
IFI16	interferon gamma inducible protein 16(IFI16)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001819~positive regulation of cytokine production,GO:0002218~activation of innate immune response,GO:0006351~transcription, DNA-templated,GO:0006914~autophagy,GO:0006954~inflammatory response,GO:0008283~cell proliferation,GO:0010506~regulation of autophagy,GO:0030097~hemopoiesis,GO:0030099~myeloid cell differentiation,GO:0030224~monocyte differentiation,GO:0032481~positive regulation of type I interferon production,GO:0032731~positive regulation of interleukin-1 beta production,GO:0040029~regulation of gene expression, epigenetic,GO:0042149~cellular response to glucose starvation,GO:0042771~intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,GO:0043392~negative regulation of DNA binding,GO:0045071~negative regulation of viral genome replication,GO:0045087~innate immune response,GO:0045824~negative regulation of innate immune response,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051607~defense response to virus,GO:0071479~cellular response to ionizing radiation,GO:0072332~intrinsic apoptotic signaling pathway by p53 class mediator,GO:0097202~activation of cysteine-type endopeptidase activity,GO:2000117~negative regulation of cysteine-type endopeptidase activity,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016020~membrane,GO:0016607~nuclear speck,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001047~core promoter binding,GO:0001078~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003690~double-stranded DNA binding,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0044822~poly(A) RNA binding,	IPR004020:DAPIN domain,IPR004021:HIN-200/IF120x,IPR011029:Death-like domain,				SM01289:SM01289,	3D-structure,Acetylation,Activator,Alternative splicing,Apoptosis,Autophagy,Complete proteome,Cytoplasm,DNA-binding,Immunity,Inflammatory response,Innate immunity,Isopeptide bond,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,Ubl conjugation,	chain:Gamma-interferon-inducible protein 16,compositionally biased region:Lys-rich,compositionally biased region:Poly-Ile,domain:DAPIN,domain:HIN-200 1,domain:HIN-200 2,helix,modified residue,sequence conflict,sequence variant,short sequence motif:Nuclear localization signal,splice variant,strand,turn,
IFNGR1	interferon gamma receptor 1(IFNGR1)	Homo sapiens		h_ifngPathway:IFN gamma signaling pathway ,h_nktPathway:Selective expression of chemokine receptors during T-cell polarization,h_th1th2Pathway:Th1/Th2 Differentiation,h_tidPathway:Chaperones modulate interferon Signaling Pathway,		GO:0007165~signal transduction,GO:0009615~response to virus,GO:0060333~interferon-gamma-mediated signaling pathway,GO:0060334~regulation of interferon-gamma-mediated signaling pathway,	GO:0005783~endoplasmic reticulum,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0014069~postsynaptic density,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030425~dendrite,GO:0031982~vesicle,	GO:0004906~interferon-gamma receptor activity,GO:0005515~protein binding,GO:0042015~interleukin-20 binding,	IPR003961:Fibronectin, type III,IPR008355:Interferon gamma receptor alpha subunit,IPR013783:Immunoglobulin-like fold,IPR021126:Interferon gamma receptor, poxvirus/mammal,	hsa04060:Cytokine-cytokine receptor interaction,hsa04066:HIF-1 signaling pathway,hsa04380:Osteoclast differentiation,hsa04630:Jak-STAT signaling pathway,hsa04650:Natural killer cell mediated cytotoxicity,hsa05132:Salmonella infection,hsa05140:Leishmaniasis,hsa05142:Chagas disease (American trypanosomiasis),hsa05145:Toxoplasmosis,hsa05152:Tuberculosis,hsa05162:Measles,hsa05164:Influenza A,hsa05168:Herpes simplex infection,hsa05321:Inflammatory bowel disease (IBD),	209950~Immunodeficiency 27A, mycobacteriosis, AR,600263~H. pylori infection, susceptibility to,607948~Tuberculosis infection, protection against,607948~Tuberculosis, susceptibility to,610424~Hepatitis B virus infection, susceptibility to,615978~Immunodeficiency 27B, mycobacteriosis, AD,			3D-structure,Alternative splicing,Cell membrane,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Interferon-gamma receptor 1,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,modified residue,sequence variant,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
JPH4	junctophilin 4(JPH4)	Homo sapiens			Function unknown,	GO:0007612~learning,GO:0048167~regulation of synaptic plasticity,GO:0050885~neuromuscular process controlling balance,GO:0060314~regulation of ryanodine-sensitive calcium-release channel activity,GO:0060402~calcium ion transport into cytosol,	GO:0005790~smooth endoplasmic reticulum,GO:0005886~plasma membrane,GO:0014701~junctional sarcoplasmic reticulum membrane,GO:0016021~integral component of membrane,GO:0030314~junctional membrane complex,GO:0043198~dendritic shaft,		IPR003409:MORN motif,IPR017191:Junctophilin,			PIRSF037387:junctophilin,	SM00698:MORN,	Cell membrane,Complete proteome,Endoplasmic reticulum,Membrane,Reference proteome,Repeat,Transmembrane,Transmembrane helix,	chain:Junctophilin-4,compositionally biased region:Poly-Pro,repeat:MORN 1,repeat:MORN 2,repeat:MORN 3,repeat:MORN 4,repeat:MORN 5,repeat:MORN 6,repeat:MORN 7,repeat:MORN 8,sequence conflict,topological domain:Cytoplasmic,transmembrane region,
KBTBD4	kelch repeat and BTB domain containing 4(KBTBD4)	Homo sapiens				GO:0030162~regulation of proteolysis,GO:0042787~protein ubiquitination involved in ubiquitin-dependent protein catabolic process,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,	GO:0005737~cytoplasm,GO:0019005~SCF ubiquitin ligase complex,	GO:0031625~ubiquitin protein ligase binding,	IPR000210:BTB/POZ-like,IPR011333:BTB/POZ fold,IPR011705:BTB/Kelch-associated,IPR015915:Kelch-type beta propeller,				SM00225:BTB,SM00875:SM00875,	3D-structure,Alternative splicing,Complete proteome,Kelch repeat,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:Kelch repeat and BTB domain-containing protein 4,domain:BACK,domain:BTB,helix,repeat:Kelch 1,repeat:Kelch 2,repeat:Kelch 3,repeat:Kelch 4,repeat:Kelch 5,sequence conflict,sequence variant,strand,turn,
KRT4	keratin 4(KRT4)	Homo sapiens				GO:0007010~cytoskeleton organization,GO:0030855~epithelial cell differentiation,GO:0050680~negative regulation of epithelial cell proliferation,	GO:0005634~nucleus,GO:0005882~intermediate filament,GO:0009986~cell surface,GO:0045095~keratin filament,GO:0045111~intermediate filament cytoskeleton,	GO:0005198~structural molecule activity,GO:0005515~protein binding,	IPR001664:Intermediate filament protein,IPR003054:Type II keratin,IPR018039:Intermediate filament protein, conserved site,		193900~White sponge nevus 1,		SM01391:SM01391,	Coiled coil,Complete proteome,Disease mutation,Intermediate filament,Keratin,Methylation,Polymorphism,Proteomics identification,Reference proteome,	chain:Keratin, type II cytoskeletal 4,compositionally biased region:Gly-rich,compositionally biased region:Ser-rich,modified residue,region of interest:Coil 1A,region of interest:Coil 1B,region of interest:Coil 2,region of interest:Head,region of interest:Linker 1,region of interest:Linker 12,region of interest:Rod,region of interest:Tail,sequence conflict,sequence variant,site:Stutter,
LATS1	large tumor suppressor kinase 1(LATS1)	Homo sapiens				GO:0000082~G1/S transition of mitotic cell cycle,GO:0000086~G2/M transition of mitotic cell cycle,GO:0000819~sister chromatid segregation,GO:0001827~inner cell mass cell fate commitment,GO:0001828~inner cell mass cellular morphogenesis,GO:0006468~protein phosphorylation,GO:0007067~mitotic nuclear division,GO:0009755~hormone-mediated signaling pathway,GO:0030216~keratinocyte differentiation,GO:0030833~regulation of actin filament polymerization,GO:0033138~positive regulation of peptidyl-serine phosphorylation,GO:0035329~hippo signaling,GO:0043065~positive regulation of apoptotic process,GO:0043254~regulation of protein complex assembly,GO:0045736~negative regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0046620~regulation of organ growth,GO:0051220~cytoplasmic sequestering of protein,GO:0051301~cell division,GO:0090090~negative regulation of canonical Wnt signaling pathway,	GO:0000922~spindle pole,GO:0005622~intracellular,GO:0005815~microtubule organizing center,GO:0005829~cytosol,	GO:0000287~magnesium ion binding,GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0019901~protein kinase binding,	IPR000719:Protein kinase, catalytic domain,IPR000961:AGC-kinase, C-terminal,IPR008271:Serine/threonine-protein kinase, active site,IPR009060:UBA-like,IPR011009:Protein kinase-like domain,IPR015940:Ubiquitin-associated/translation elongation factor EF1B, N-terminal, eukaryote,	hsa04390:Hippo signaling pathway,			SM00220:S_TKc,	3D-structure,Alternative splicing,ATP-binding,Cell cycle,Cell division,Complete proteome,Cytoplasm,Cytoskeleton,Kinase,Magnesium,Metal-binding,Mitosis,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transferase,Tumor suppressor,	active site:Proton acceptor,binding site:ATP,chain:Serine/threonine-protein kinase LATS1,domain:AGC-kinase C-terminal,domain:Protein kinase,domain:UBA,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence variant,splice variant,
LMAN1	lectin, mannose binding 1(LMAN1)	Homo sapiens				GO:0006457~protein folding,GO:0006888~ER to Golgi vesicle-mediated transport,GO:0007029~endoplasmic reticulum organization,GO:0007030~Golgi organization,GO:0007596~blood coagulation,GO:0010638~positive regulation of organelle organization,GO:0015031~protein transport,GO:0018279~protein N-linked glycosylation via asparagine,GO:0032527~protein exit from endoplasmic reticulum,GO:0034498~early endosome to Golgi transport,GO:0048208~COPII vesicle coating,	GO:0000139~Golgi membrane,GO:0005737~cytoplasm,GO:0005789~endoplasmic reticulum membrane,GO:0005793~endoplasmic reticulum-Golgi intermediate compartment,GO:0005794~Golgi apparatus,GO:0012507~ER to Golgi transport vesicle membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030017~sarcomere,GO:0030134~ER to Golgi transport vesicle,GO:0033116~endoplasmic reticulum-Golgi intermediate compartment membrane,GO:0044220~host cell perinuclear region of cytoplasm,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0005537~mannose binding,GO:0046872~metal ion binding,GO:0051082~unfolded protein binding,	IPR005052:Legume-like lectin,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,	hsa04141:Protein processing in endoplasmic reticulum,	227300~Combined factor V and VIII deficiency,			3D-structure,Coiled coil,Complete proteome,Direct protein sequencing,Disulfide bond,Endoplasmic reticulum,ER-Golgi transport,Golgi apparatus,Lectin,Membrane,Metal-binding,Phosphoprotein,Polymorphism,Protein transport,Reference proteome,Signal,Transmembrane,Transmembrane helix,Transport,	chain:Protein ERGIC-53,disulfide bond,domain:L-type lectin-like,sequence conflict,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
LRRIQ3	leucine rich repeats and IQ motif containing 3(LRRIQ3)	Homo sapiens						GO:0005515~protein binding,	IPR000048:IQ motif, EF-hand binding site,IPR001611:Leucine-rich repeat,IPR025875:Leucine rich repeat 4,					Alternative splicing,Coiled coil,Complete proteome,Leucine-rich repeat,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:Leucine-rich repeat and IQ domain- containing protein 3,domain:IQ,repeat:LRR 1,repeat:LRR 2,sequence conflict,sequence variant,splice variant,
LTN1	listerin E3 ubiquitin protein ligase 1(LTN1)	Homo sapiens			General function prediction only,	GO:0051865~protein autoubiquitination,		GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0061630~ubiquitin protein ligase activity,	IPR001841:Zinc finger, RING-type,IPR011016:Zinc finger, RING-CH-type,IPR011989:Armadillo-like helical,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR016024:Armadillo-type fold,				SM00744:RINGv,	3D-structure,Alternative splicing,Complete proteome,Ligase,Metal-binding,Polymorphism,Proteomics identification,Reference proteome,Repeat,Ubl conjugation,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:RING finger protein 160,modified residue,sequence conflict,sequence variant,zinc finger region:RING-type,
KDM2B	lysine demethylase 2B(KDM2B)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0007283~spermatogenesis,GO:0021555~midbrain-hindbrain boundary morphogenesis,GO:0021592~fourth ventricle development,GO:0021670~lateral ventricle development,GO:0021678~third ventricle development,GO:0021993~initiation of neural tube closure,GO:0030307~positive regulation of cell growth,GO:0030900~forebrain development,GO:0030901~midbrain development,GO:0030902~hindbrain development,GO:0035518~histone H2A monoubiquitination,GO:0043524~negative regulation of neuron apoptotic process,GO:0048596~embryonic camera-type eye morphogenesis,GO:0055114~oxidation-reduction process,GO:0070544~histone H3-K36 demethylation,GO:1902459~positive regulation of stem cell population maintenance,GO:2000178~negative regulation of neural precursor cell proliferation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0031519~PcG protein complex,	GO:0000979~RNA polymerase II core promoter sequence-specific DNA binding,GO:0003677~DNA binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0019843~rRNA binding,GO:0032452~histone demethylase activity,GO:0051864~histone demethylase activity (H3-K36 specific),	IPR001810:F-box domain, cyclin-like,IPR001965:Zinc finger, PHD-type,IPR002857:Zinc finger, CXXC-type,IPR003347:JmjC domain,IPR006553:Leucine-rich repeat, cysteine-containing subtype,IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR019787:Zinc finger, PHD-finger,				SM00249:PHD,SM00367:LRR_CC,SM00558:JmjC,	3D-structure,Alternative splicing,Chromatin regulator,Coiled coil,Complete proteome,Dioxygenase,Iron,Isopeptide bond,Leucine-rich repeat,Metal-binding,Nucleus,Oxidoreductase,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Repressor,RNA-binding,rRNA-binding,Transcription,Transcription regulation,Ubl conjugation,Ubl conjugation pathway,Zinc,Zinc-finger,	binding site:Substrate,chain:Lysine-specific demethylase 2B,compositionally biased region:Glu-rich,compositionally biased region:Pro-rich,domain:F-box,domain:JmjC,metal ion-binding site:Iron; catalytic,modified residue,repeat:LRR 1,repeat:LRR 2,repeat:LRR 3,repeat:LRR 4,sequence conflict,splice variant,zinc finger region:CXXC-type,zinc finger region:PHD-type,
KDM5C	lysine demethylase 5C(KDM5C)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0034720~histone H3-K4 demethylation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0048511~rhythmic process,GO:0055114~oxidation-reduction process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0016706~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors,GO:0032452~histone demethylase activity,GO:0032453~histone demethylase activity (H3-K4 specific),	IPR001606:ARID/BRIGHT DNA-binding domain,IPR001965:Zinc finger, PHD-type,IPR003347:JmjC domain,IPR003349:Transcription factor jumonji, JmjN,IPR004198:Zinc finger, C5HC2-type,IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR013637:Lysine-specific demethylase-like domain,IPR019786:Zinc finger, PHD-type, conserved site,IPR019787:Zinc finger, PHD-finger,		300534~Mental retardation, X-linked, syndromic, Claes-Jensen type,		SM00249:PHD,SM00501:BRIGHT,SM00545:JmjN,SM00558:JmjC,	3D-structure,Alternative splicing,Biological rhythms,Chromatin regulator,Complete proteome,Dioxygenase,Disease mutation,Iron,Mental retardation,Metal-binding,Nucleus,Oxidoreductase,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Lysine-specific demethylase 5C,domain:ARID,domain:JmjC,domain:JmjN,helix,modified residue,mutagenesis site,sequence conflict,sequence variant,splice variant,turn,zinc finger region:PHD-type 1,zinc finger region:PHD-type 2,
KDM6A	lysine demethylase 6A(KDM6A)	Homo sapiens				GO:0001701~in utero embryonic development,GO:0001843~neural tube closure,GO:0003007~heart morphogenesis,GO:0003016~respiratory system process,GO:0010628~positive regulation of gene expression,GO:0032525~somite rostral/caudal axis specification,GO:0035264~multicellular organism growth,GO:0048333~mesodermal cell differentiation,GO:0048570~notochord morphogenesis,GO:0051568~histone H3-K4 methylation,GO:0055114~oxidation-reduction process,GO:0060070~canonical Wnt signaling pathway,GO:0071557~histone H3-K27 demethylation,GO:0072358~cardiovascular system development,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0035097~histone methyltransferase complex,GO:0044666~MLL3/4 complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0031490~chromatin DNA binding,GO:0032452~histone demethylase activity,GO:0042802~identical protein binding,GO:0046872~metal ion binding,GO:0051213~dioxygenase activity,GO:0071558~histone demethylase activity (H3-K27 specific),	IPR001440:Tetratricopeptide TPR-1,IPR003347:JmjC domain,IPR011990:Tetratricopeptide-like helical,IPR013026:Tetratricopeptide repeat-containing domain,IPR019734:Tetratricopeptide repeat,	hsa05202:Transcriptional misregulation in cancer,	300867~Kabuki syndrome 2,		SM00028:TPR,SM00558:JmjC,	3D-structure,Chromatin regulator,Complete proteome,Dioxygenase,Iron,Mental retardation,Metal-binding,Methylation,Nucleus,Oxidoreductase,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,TPR repeat,Zinc,	chain:Lysine-specific demethylase 6A,compositionally biased region:Poly-Ala,domain:JmjC,modified residue,mutagenesis site,repeat:TPR 1,repeat:TPR 2,repeat:TPR 3,repeat:TPR 4,repeat:TPR 5,repeat:TPR 6,repeat:TPR 7,repeat:TPR 8,sequence conflict,sequence variant,
KMT2D	lysine methyltransferase 2D(KMT2D)	Homo sapiens			General function prediction only,	GO:0001555~oocyte growth,GO:0006342~chromatin silencing,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0008284~positive regulation of cell proliferation,GO:0033148~positive regulation of intracellular estrogen receptor signaling pathway,GO:0043627~response to estrogen,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048477~oogenesis,GO:0051568~histone H3-K4 methylation,GO:1904837~beta-catenin-TCF complex assembly,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0035097~histone methyltransferase complex,GO:0044666~MLL3/4 complex,	GO:0003677~DNA binding,GO:0005515~protein binding,GO:0008168~methyltransferase activity,GO:0008270~zinc ion binding,GO:0018024~histone-lysine N-methyltransferase activity,GO:0042800~histone methyltransferase activity (H3-K4 specific),GO:0044212~transcription regulatory region DNA binding,	IPR001214:SET domain,IPR001841:Zinc finger, RING-type,IPR001965:Zinc finger, PHD-type,IPR003616:Post-SET domain,IPR003888:FY-rich, N-terminal,IPR003889:FY-rich, C-terminal,IPR009071:High mobility group (HMG) box domain,IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR019787:Zinc finger, PHD-finger,	hsa00310:Lysine degradation,	147920~Kabuki syndrome 1,		SM00184:RING,SM00249:PHD,SM00317:SET,SM00398:HMG,SM00508:PostSET,SM00541:FYRN,SM00542:FYRC,	3D-structure,Acetylation,Alternative splicing,Chromatin regulator,Coiled coil,Complete proteome,Disease mutation,Isopeptide bond,Mental retardation,Metal-binding,Methylation,Methyltransferase,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,S-adenosyl-L-methionine,Transcription,Transcription regulation,Transferase,Ubl conjugation,Zinc,Zinc-finger,	binding site:S-adenosyl-L-methionine,chain:Histone-lysine N-methyltransferase MLL2,compositionally biased region:Arg-rich,compositionally biased region:Cys-rich,compositionally biased region:Gln-rich,compositionally biased region:Pro-rich,domain:Post-SET,domain:SET,metal ion-binding site:Zinc,modified residue,region of interest:15 X 5 AA repeats of S/P-P-P-E/P-E/A,region of interest:S-adenosyl-L-methionine binding,repeat:1,repeat:10,repeat:11,repeat:12,repeat:13,repeat:14,repeat:15,repeat:2,repeat:3,repeat:4,repeat:5,repeat:6,repeat:7,repeat:8,repeat:9,sequence variant,short sequence motif:LXXLL motif 1,short sequence motif:LXXLL motif 2,short sequence motif:LXXLL motif 3,short sequence motif:LXXLL motif 4,short sequence motif:LXXLL motif 5,short sequence motif:LXXLL motif 6,splice variant,zinc finger region:PHD-type 1,zinc finger region:PHD-type 2,zinc finger region:PHD-type 3,zinc finger region:PHD-type 4,zinc finger region:PHD-type 5,zinc finger region:RING-type,
HLA-A	major histocompatibility complex, class I, A(HLA-A)	Homo sapiens	70.Signal_peptides_(MHC)_class_I_molecules,	h_ctlPathway:CTL mediated immune response against target cells ,h_mhcPathway:Antigen Processing and Presentation,h_nkcellsPathway:Ras-Independent pathway in NK cell-mediated cytotoxicity,		GO:0001916~positive regulation of T cell mediated cytotoxicity,GO:0002474~antigen processing and presentation of peptide antigen via MHC class I,GO:0002479~antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,GO:0002480~antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent,GO:0002486~antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent,GO:0002726~positive regulation of T cell cytokine production,GO:0006955~immune response,GO:0016032~viral process,GO:0016045~detection of bacterium,GO:0019731~antibacterial humoral response,GO:0019882~antigen processing and presentation,GO:0019885~antigen processing and presentation of endogenous peptide antigen via MHC class I,GO:0032729~positive regulation of interferon-gamma production,GO:0042270~protection from natural killer cell mediated cytotoxicity,GO:0050690~regulation of defense response to virus by virus,GO:0050776~regulation of immune response,GO:0050830~defense response to Gram-positive bacterium,GO:0060333~interferon-gamma-mediated signaling pathway,GO:0060337~type I interferon signaling pathway,GO:2000566~positive regulation of CD8-positive, alpha-beta T cell proliferation,GO:2000568~positive regulation of memory T cell activation,GO:2001187~positive regulation of CD8-positive, alpha-beta T cell activation,	GO:0000139~Golgi membrane,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005797~Golgi medial cisterna,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0012507~ER to Golgi transport vesicle membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030670~phagocytic vesicle membrane,GO:0031901~early endosome membrane,GO:0042612~MHC class I protein complex,GO:0042613~MHC class II protein complex,GO:0070062~extracellular exosome,GO:0070971~endoplasmic reticulum exit site,GO:0071556~integral component of lumenal side of endoplasmic reticulum membrane,	GO:0005102~receptor binding,GO:0005515~protein binding,GO:0030881~beta-2-microglobulin binding,GO:0042605~peptide antigen binding,GO:0042608~T cell receptor binding,GO:0044822~poly(A) RNA binding,GO:0046977~TAP binding,	IPR000353:MHC class II, beta chain, N-terminal,IPR001039:MHC class I, alpha chain, alpha1/alpha2,IPR003006:Immunoglobulin/major histocompatibility complex, conserved site,IPR003597:Immunoglobulin C1-set,IPR007110:Immunoglobulin-like domain,IPR010579:MHC class I, alpha chain, C-terminal,IPR011161:MHC class I-like antigen recognition,IPR011162:MHC classes I/II-like antigen recognition protein,IPR013783:Immunoglobulin-like fold,IPR014745:MHC class II, alpha/beta chain, N-terminal,	hsa04144:Endocytosis,hsa04145:Phagosome,hsa04514:Cell adhesion molecules (CAMs),hsa04612:Antigen processing and presentation,hsa04940:Type I diabetes mellitus,hsa05166:HTLV-I infection,hsa05168:Herpes simplex infection,hsa05169:Epstein-Barr virus infection,hsa05203:Viral carcinogenesis,hsa05320:Autoimmune thyroid disease,hsa05330:Allograft rejection,hsa05332:Graft-versus-host disease,hsa05416:Viral myocarditis,	608579~Hypersensitivity syndrome, carbamazepine-induced, susceptibility to,		SM00407:IGc1,SM00921:SM00921,	3D-structure,Alternative splicing,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Host-virus interaction,Immunity,Immunoglobulin domain,Membrane,MHC I,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Signal,Sulfation,Transmembrane,Transmembrane helix,Ubl conjugation,	chain:HLA class I histocompatibility antigen, A-1 alpha chain,chain:HLA class I histocompatibility antigen, A-11 alpha chain,chain:HLA class I histocompatibility antigen, A-2 alpha chain,chain:HLA class I histocompatibility antigen, A-23 alpha chain,chain:HLA class I histocompatibility antigen, A-24 alpha chain,chain:HLA class I histocompatibility antigen, A-25 alpha chain,chain:HLA class I histocompatibility antigen, A-26 alpha chain,chain:HLA class I histocompatibility antigen, A-29 alpha chain,chain:HLA class I histocompatibility antigen, A-3 alpha chain,chain:HLA class I histocompatibility antigen, A-31 alpha chain,chain:HLA class I histocompatibility antigen, A-32 alpha chain,chain:HLA class I histocompatibility antigen, A-34 alpha chain,chain:HLA class I histocompatibility antigen, A-36 alpha chain,chain:HLA class I histocompatibility antigen, A-43 alpha chain,chain:HLA class I histocompatibility antigen, A-66 alpha chain,chain:HLA class I histocompatibility antigen, A-68 alpha chain,chain:HLA class I histocompatibility antigen, A-69 alpha chain,chain:HLA class I histocompatibility antigen, A-80 alpha chain,chain:MHC class I antigen,disulfide bond,domain:Ig-like C1-type,glycosylation site:N-linked (GlcNAc...),helix,modified residue,region of interest:Alpha-1,region of interest:Alpha-2,region of interest:Alpha-3,region of interest:Connecting peptide,sequence conflict,sequence variant,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
MED23	mediator complex subunit 23(MED23)	Homo sapiens				GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006367~transcription initiation from RNA polymerase II promoter,	GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,	GO:0003713~transcription coactivator activity,GO:0005515~protein binding,	IPR021629:Mediator complex, subunit Med23,		614249~Mental retardation, autosomal recessive 18,			Activator,Alternative splicing,Complete proteome,Direct protein sequencing,Disease mutation,Mental retardation,Nucleus,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:Mediator of RNA polymerase II transcription subunit 23,modified residue,sequence conflict,splice variant,
MBD2	methyl-CpG binding domain protein 2(MBD2)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000183~chromatin silencing at rDNA,GO:0006346~methylation-dependent chromatin silencing,GO:0006351~transcription, DNA-templated,GO:0007507~heart development,GO:0007568~aging,GO:0009612~response to mechanical stimulus,GO:0030177~positive regulation of Wnt signaling pathway,GO:0031667~response to nutrient levels,GO:0032355~response to estradiol,GO:0035563~positive regulation of chromatin binding,GO:0042127~regulation of cell proliferation,GO:0042711~maternal behavior,GO:0043044~ATP-dependent chromatin remodeling,GO:0043623~cellular protein complex assembly,GO:0044030~regulation of DNA methylation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0048568~embryonic organ development,GO:0071407~cellular response to organic cyclic compound,	GO:0000118~histone deacetylase complex,GO:0000790~nuclear chromatin,GO:0000792~heterochromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0043234~protein complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000980~RNA polymerase II distal enhancer sequence-specific DNA binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003696~satellite DNA binding,GO:0003729~mRNA binding,GO:0005515~protein binding,GO:0008327~methyl-CpG binding,GO:0019904~protein domain specific binding,GO:0031492~nucleosomal DNA binding,GO:0035197~siRNA binding,GO:0070742~C2H2 zinc finger domain binding,	IPR001739:Methyl-CpG DNA binding,IPR016177:DNA-binding, integrase-type,IPR025884:Methyl-CpG binding protein 2/3, C-terminal domain,				SM00391:MBD,	3D-structure,Alternative splicing,Complete proteome,DNA-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:Methyl-CpG-binding domain protein 2,compositionally biased region:Arg-rich,compositionally biased region:Gly-rich,domain:MBD,modified residue,splice variant,
MBD6	methyl-CpG binding domain protein 6(MBD6)	Homo sapiens					GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0010369~chromocenter,	GO:0003677~DNA binding,GO:0003682~chromatin binding,	IPR001739:Methyl-CpG DNA binding,IPR016177:DNA-binding, integrase-type,				SM00391:MBD,	Chromosome,Complete proteome,Nucleus,Proteomics identification,Reference proteome,	chain:Methyl-CpG-binding domain protein 6,compositionally biased region:Pro-rich,domain:MBD,sequence conflict,
MCM7	minichromosome maintenance complex component 7(MCM7)	Homo sapiens		h_mcmPathway:CDK Regulation of DNA Replication,		GO:0000082~G1/S transition of mitotic cell cycle,GO:0006260~DNA replication,GO:0006268~DNA unwinding involved in DNA replication,GO:0006270~DNA replication initiation,GO:0006974~cellular response to DNA damage stimulus,GO:0008283~cell proliferation,GO:0042325~regulation of phosphorylation,GO:0042493~response to drug,GO:0071364~cellular response to epidermal growth factor stimulus,GO:0071466~cellular response to xenobiotic stimulus,	GO:0000784~nuclear chromosome, telomeric region,GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016020~membrane,GO:0042555~MCM complex,	GO:0003677~DNA binding,GO:0003678~DNA helicase activity,GO:0003697~single-stranded DNA binding,GO:0004003~ATP-dependent DNA helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR001208:Mini-chromosome maintenance, DNA-dependent ATPase,IPR003593:AAA+ ATPase domain,IPR008050:DNA replication licensing factor Mcm7,IPR012340:Nucleic acid-binding, OB-fold,IPR018525:Mini-chromosome maintenance, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa03030:DNA replication,hsa04110:Cell cycle,			SM00350:MCM,SM00382:AAA,	Acetylation,Alternative splicing,ATP-binding,Cell cycle,Complete proteome,Direct protein sequencing,DNA replication,DNA-binding,Glycoprotein,Helicase,Hydrolase,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:DNA replication licensing factor mcm7,domain:MCM,modified residue,nucleotide phosphate-binding region:ATP,region of interest:Interaction with ATRIP,region of interest:Interaction with RAD17,sequence conflict,sequence variant,splice variant,
MAP2K4	mitogen-activated protein kinase kinase 4(MAP2K4)	Homo sapiens	100.MAPK_signaling_cascades,77.IkBa_Kinase_JNK_MEKK1,	h_at1rPathway:Angiotensin II mediated activation of JNK Pathway via Pyk2 dependent signaling,h_ceramidePathway:Ceramide Signaling Pathway,h_egfPathway:EGF Signaling Pathway,h_fasPathway:FAS signaling pathway ( CD95 ),h_fcer1Pathway:Fc Epsilon Receptor I Signaling in Mast Cells,h_gleevecPathway:Inhibition of Cellular Proliferation by Gleevec,h_keratinocytePathway:Keratinocyte Differentiation,h_mapkPathway:MAPKinase Signaling Pathway,h_p38mapkPathway:p38 MAPK Signaling Pathway ,h_pdgfPathway:PDGF Signaling Pathway,h_pyk2Pathway:Links between Pyk2 and Map Kinases,h_stressPathway:TNF/Stress Related Signaling,h_tcrPathway:T Cell Receptor Signaling Pathway,h_tnfr1Pathway:TNFR1 Signaling Pathway,h_tollPathway:Toll-Like Receptor Pathway,		GO:0006915~apoptotic process,GO:0007165~signal transduction,GO:0007254~JNK cascade,GO:0007257~activation of JUN kinase activity,GO:0009611~response to wounding,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0034393~positive regulation of smooth muscle cell apoptotic process,GO:0035897~proteolysis in other organism,GO:0038095~Fc-epsilon receptor signaling pathway,GO:0043525~positive regulation of neuron apoptotic process,GO:0045740~positive regulation of DNA replication,GO:0051770~positive regulation of nitric-oxide synthase biosynthetic process,GO:0061049~cell growth involved in cardiac muscle cell development,GO:0071260~cellular response to mechanical stimulus,GO:0072709~cellular response to sorbitol,GO:2000672~negative regulation of motor neuron apoptotic process,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0030424~axon,GO:0032839~dendrite cytoplasm,GO:0043204~perikaryon,	GO:0004672~protein kinase activity,GO:0004702~receptor signaling protein serine/threonine kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008545~JUN kinase kinase activity,GO:0031435~mitogen-activated protein kinase kinase kinase binding,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,	hsa04010:MAPK signaling pathway,hsa04012:ErbB signaling pathway,hsa04620:Toll-like receptor signaling pathway,hsa04664:Fc epsilon RI signaling pathway,hsa04668:TNF signaling pathway,hsa04912:GnRH signaling pathway,hsa05120:Epithelial cell signaling in Helicobacter pylori infection,hsa05142:Chagas disease (American trypanosomiasis),hsa05161:Hepatitis B,hsa05164:Influenza A,hsa05166:HTLV-I infection,hsa05169:Epstein-Barr virus infection,			SM00220:S_TKc,	3D-structure,Acetylation,Alternative splicing,Apoptosis,ATP-binding,Complete proteome,Cytoplasm,Kinase,Methylation,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Stress response,Transferase,Tyrosine-protein kinase,	active site:Proton acceptor,binding site:ATP,chain:Dual specificity mitogen-activated protein kinase kinase 4,compositionally biased region:Gly/Ser-rich,domain:Protein kinase,modified residue,nucleotide phosphate-binding region:ATP,sequence variant,site:Cleavage; by anthrax lethal factor,
MAP3K1	mitogen-activated protein kinase kinase kinase 1(MAP3K1)	Homo sapiens	100.MAPK_signaling_cascades,102.Cholesterol_Stress_Response,158.14-3-3_signal_transduction,159.14-3-3_Apoptosis,68.Mitogen_signaling_in_growth_control,77.IkBa_Kinase_JNK_MEKK1,	h_41BBPathway:The 4-1BB-dependent immune response,h_at1rPathway:Angiotensin II mediated activation of JNK Pathway via Pyk2 dependent signaling,h_bcrPathway:BCR Signaling Pathway,h_cd40Pathway:CD40L Signaling Pathway,h_ceramidePathway:Ceramide Signaling Pathway,h_egfPathway:EGF Signaling Pathway,h_egfr_smrtePathway:Map Kinase Inactivation of SMRT Corepressor,h_fasPathway:FAS signaling pathway ( CD95 ),h_fcer1Pathway:Fc Epsilon Receptor I Signaling in Mast Cells,h_fmlpPathway:fMLP induced chemokine gene expression in HMC-1 cells,h_gleevecPathway:Inhibition of Cellular Proliferation by Gleevec,h_hcmvPathway:Human Cytomegalovirus and Map Kinase Pathways,h_hivnefPathway:HIV-I Nef: negative effector of Fas and TNF,h_il1rPathway:Signal transduction through IL1R,h_keratinocytePathway:Keratinocyte Differentiation,h_malPathway:Role of MAL in Rho-Mediated Activation of SRF,h_mapkPathway:MAPKinase Signaling Pathway,h_nfkbPathway:NF-kB Signaling Pathway,h_p38mapkPathway:p38 MAPK Signaling Pathway ,h_pdgfPathway:PDGF Signaling Pathway,h_pyk2Pathway:Links between Pyk2 and Map Kinases,h_rac1Pathway:Rac 1 cell motility signaling pathway,h_stressPathway:TNF/Stress Related Signaling,h_tcrPathway:T Cell Receptor Signaling Pathway,h_tnfr1Pathway:TNFR1 Signaling Pathway,h_tnfr2Pathway:TNFR2 Signaling Pathway,h_tollPathway:Toll-Like Receptor Pathway,h_vipPathway:Neuropeptides VIP and PACAP inhibit the apoptosis of activated T cells,	General function prediction only,	GO:0000165~MAPK cascade,GO:0000186~activation of MAPKK activity,GO:0002755~MyD88-dependent toll-like receptor signaling pathway,GO:0006468~protein phosphorylation,GO:0006915~apoptotic process,GO:0038095~Fc-epsilon receptor signaling pathway,GO:0071260~cellular response to mechanical stimulus,	GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004702~receptor signaling protein serine/threonine kinase activity,GO:0004709~MAP kinase kinase kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008270~zinc ion binding,GO:0019901~protein kinase binding,	IPR000719:Protein kinase, catalytic domain,IPR001841:Zinc finger, RING-type,IPR007527:Zinc finger, SWIM-type,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR016024:Armadillo-type fold,IPR017441:Protein kinase, ATP binding site,	hsa04010:MAPK signaling pathway,hsa04120:Ubiquitin mediated proteolysis,hsa04622:RIG-I-like receptor signaling pathway,hsa04722:Neurotrophin signaling pathway,hsa04912:GnRH signaling pathway,hsa05161:Hepatitis B,hsa05166:HTLV-I infection,	613762~46XY sex reversal 6,		SM00220:S_TKc,	Acetylation,ATP-binding,Complete proteome,Kinase,Magnesium,Metal-binding,Nucleotide-binding,Phosphoprotein,Polymorphism,Reference proteome,Serine/threonine-protein kinase,Transferase,Zinc,Zinc-finger,	active site:Proton acceptor,binding site:ATP,chain:Mitogen-activated protein kinase kinase kinase 1,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Gly,compositionally biased region:Poly-Ile,compositionally biased region:Poly-Ser,compositionally biased region:Poly-Thr,domain:Protein kinase,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,zinc finger region:RING-type,zinc finger region:SWIM-type,
MBNL1	muscleblind like splicing regulator 1(MBNL1)	Homo sapiens				GO:0001701~in utero embryonic development,GO:0006397~mRNA processing,GO:0007399~nervous system development,GO:0008380~RNA splicing,GO:0030326~embryonic limb morphogenesis,GO:0043484~regulation of RNA splicing,GO:0045445~myoblast differentiation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0010494~cytoplasmic stress granule,	GO:0001069~regulatory region RNA binding,GO:0003723~RNA binding,GO:0003725~double-stranded RNA binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR000571:Zinc finger, CCCH-type,				SM00356:ZnF_C3H1,	3D-structure,Alternative splicing,Complete proteome,Corneal dystrophy,Cytoplasm,Disease mutation,Metal-binding,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,RNA-binding,Zinc,Zinc-finger,	chain:Muscleblind-like protein 1,helix,splice variant,strand,turn,zinc finger region:C3H1-type 1,zinc finger region:C3H1-type 2,zinc finger region:C3H1-type 3,zinc finger region:C3H1-type 4,
MSH3	mutS homolog 3(MSH3)	Homo sapiens			DNA replication, recombination, and repair,	GO:0000710~meiotic mismatch repair,GO:0006281~DNA repair,GO:0006298~mismatch repair,GO:0007131~reciprocal meiotic recombination,GO:0043570~maintenance of DNA repeat elements,GO:0045910~negative regulation of DNA recombination,GO:0051096~positive regulation of helicase activity,	GO:0000228~nuclear chromosome,GO:0005654~nucleoplasm,GO:0016020~membrane,GO:0032302~MutSbeta complex,	GO:0003684~damaged DNA binding,GO:0003697~single-stranded DNA binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0019899~enzyme binding,GO:0030983~mismatched DNA binding,GO:0032137~guanine/thymine mispair binding,GO:0032139~dinucleotide insertion or deletion binding,GO:0032142~single guanine insertion binding,GO:0032181~dinucleotide repeat insertion binding,GO:0032357~oxidized purine DNA binding,GO:0042803~protein homodimerization activity,	IPR000432:DNA mismatch repair protein MutS, C-terminal,IPR007695:DNA mismatch repair protein MutS-like, N-terminal,IPR007696:DNA mismatch repair protein MutS, core,IPR007860:DNA mismatch repair protein MutS, connector domain,IPR016151:DNA mismatch repair protein MutS, N-terminal,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa03430:Mismatch repair,hsa05200:Pathways in cancer,hsa05210:Colorectal cancer,	608089~Endometrial carcinoma, somatic,		SM00533:MUTSd,SM00534:MUTSac,	3D-structure,ATP-binding,Complete proteome,DNA damage,DNA repair,DNA-binding,Nucleotide-binding,Phosphoprotein,Polymorphism,Reference proteome,	chain:DNA mismatch repair protein Msh3,compositionally biased region:Poly-Ala,modified residue,nucleotide phosphate-binding region:ATP,region of interest:Interaction with EXO1,sequence conflict,sequence variant,
NRXN1	neurexin 1(NRXN1)	Homo sapiens				GO:0001525~angiogenesis,GO:0007157~heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,GO:0007158~neuron cell-cell adhesion,GO:0007165~signal transduction,GO:0007268~chemical synaptic transmission,GO:0007269~neurotransmitter secretion,GO:0007411~axon guidance,GO:0007416~synapse assembly,GO:0007612~learning,GO:0016339~calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,GO:0021707~cerebellar granule cell differentiation,GO:0023041~neuronal signal transduction,GO:0030534~adult behavior,GO:0035176~social behavior,GO:0035418~protein localization to synapse,GO:0042297~vocal learning,GO:0045184~establishment of protein localization,GO:0050885~neuromuscular process controlling balance,GO:0051490~negative regulation of filopodium assembly,GO:0051965~positive regulation of synapse assembly,GO:0051968~positive regulation of synaptic transmission, glutamatergic,GO:0060134~prepulse inhibition,GO:0061178~regulation of insulin secretion involved in cellular response to glucose stimulus,GO:0071625~vocalization behavior,GO:0090004~positive regulation of establishment of protein localization to plasma membrane,GO:0090126~protein complex assembly involved in synapse maturation,GO:0090129~positive regulation of synapse maturation,GO:0097091~synaptic vesicle clustering,GO:0097104~postsynaptic membrane assembly,GO:0097105~presynaptic membrane assembly,GO:0097112~gamma-aminobutyric acid receptor clustering,GO:0097114~NMDA glutamate receptor clustering,GO:0097116~gephyrin clustering involved in postsynaptic density assembly,GO:0097117~guanylate kinase-associated protein clustering,GO:0097118~neuroligin clustering involved in postsynaptic membrane assembly,GO:0097119~postsynaptic density protein 95 clustering,GO:0097120~receptor localization to synapse,GO:2000310~regulation of N-methyl-D-aspartate selective glutamate receptor activity,GO:2000311~regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity,GO:2000463~positive regulation of excitatory postsynaptic potential,GO:2000821~regulation of grooming behavior,	GO:0005783~endoplasmic reticulum,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0030054~cell junction,GO:0030139~endocytic vesicle,GO:0031965~nuclear membrane,GO:0031982~vesicle,GO:0042734~presynaptic membrane,GO:0043025~neuronal cell body,GO:0043234~protein complex,GO:0044295~axonal growth cone,GO:0098793~presynapse,	GO:0004872~receptor activity,GO:0004888~transmembrane signaling receptor activity,GO:0005102~receptor binding,GO:0005246~calcium channel regulator activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0033130~acetylcholine receptor binding,GO:0046872~metal ion binding,GO:0048306~calcium-dependent protein binding,GO:0050839~cell adhesion molecule binding,GO:0097109~neuroligin family protein binding,	IPR000152:EGF-type aspartate/asparagine hydroxylation site,IPR000742:Epidermal growth factor-like domain,IPR001791:Laminin G domain,IPR003585:Neurexin/syndecan/glycophorin C,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,IPR027158:Neurexin-1-alpha,	hsa04514:Cell adhesion molecules (CAMs),	614325~Pitt-Hopkins-like syndrome 2,614332~Schizophrenia, susceptibility to, 17,		SM00181:EGF,SM00282:LamG,SM00294:4.1m,	3D-structure,Alternative promoter usage,Alternative splicing,Angiogenesis,Calcium,Cell adhesion,Cell junction,Cell membrane,Complete proteome,Disulfide bond,EGF-like domain,Glycoprotein,Membrane,Metal-binding,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,Synapse,Transmembrane,Transmembrane helix,	chain:Neurexin-1-alpha,chain:Neurexin-1-beta,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Thr,disulfide bond,domain:EGF-like 1,domain:EGF-like 2,domain:EGF-like 3,domain:Laminin G-like,domain:Laminin G-like 1,domain:Laminin G-like 2,domain:Laminin G-like 3,domain:Laminin G-like 4,domain:Laminin G-like 5,domain:Laminin G-like 6,glycosylation site:N-linked (GlcNAc...),helix,metal ion-binding site:Calcium,metal ion-binding site:Calcium; via carbonyl oxygen,sequence conflict,sequence variant,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
NF1	neurofibromin 1(NF1)	Homo sapiens		h_hSWI-SNFpathway:Chromatin Remodeling by hSWI/SNF ATP-dependent Complexes,		GO:0000165~MAPK cascade,GO:0001649~osteoblast differentiation,GO:0001656~metanephros development,GO:0001666~response to hypoxia,GO:0001889~liver development,GO:0001937~negative regulation of endothelial cell proliferation,GO:0001938~positive regulation of endothelial cell proliferation,GO:0001952~regulation of cell-matrix adhesion,GO:0001953~negative regulation of cell-matrix adhesion,GO:0006469~negative regulation of protein kinase activity,GO:0007154~cell communication,GO:0007165~signal transduction,GO:0007265~Ras protein signal transduction,GO:0007406~negative regulation of neuroblast proliferation,GO:0007420~brain development,GO:0007422~peripheral nervous system development,GO:0007507~heart development,GO:0007519~skeletal muscle tissue development,GO:0008542~visual learning,GO:0008625~extrinsic apoptotic signaling pathway via death domain receptors,GO:0010468~regulation of gene expression,GO:0014044~Schwann cell development,GO:0014065~phosphatidylinositol 3-kinase signaling,GO:0016525~negative regulation of angiogenesis,GO:0021510~spinal cord development,GO:0021764~amygdala development,GO:0021897~forebrain astrocyte development,GO:0021915~neural tube development,GO:0021987~cerebral cortex development,GO:0022011~myelination in peripheral nervous system,GO:0030036~actin cytoskeleton organization,GO:0030198~extracellular matrix organization,GO:0030199~collagen fibril organization,GO:0030325~adrenal gland development,GO:0030336~negative regulation of cell migration,GO:0032228~regulation of synaptic transmission, GABAergic,GO:0034605~cellular response to heat,GO:0035021~negative regulation of Rac protein signal transduction,GO:0042060~wound healing,GO:0042992~negative regulation of transcription factor import into nucleus,GO:0043065~positive regulation of apoptotic process,GO:0043087~regulation of GTPase activity,GO:0043407~negative regulation of MAP kinase activity,GO:0043409~negative regulation of MAPK cascade,GO:0043473~pigmentation,GO:0043525~positive regulation of neuron apoptotic process,GO:0043535~regulation of blood vessel endothelial cell migration,GO:0043547~positive regulation of GTPase activity,GO:0045124~regulation of bone resorption,GO:0045671~negative regulation of osteoclast differentiation,GO:0045685~regulation of glial cell differentiation,GO:0045762~positive regulation of adenylate cyclase activity,GO:0045765~regulation of angiogenesis,GO:0046580~negative regulation of Ras protein signal transduction,GO:0046929~negative regulation of neurotransmitter secretion,GO:0048147~negative regulation of fibroblast proliferation,GO:0048169~regulation of long-term neuronal synaptic plasticity,GO:0048485~sympathetic nervous system development,GO:0048593~camera-type eye morphogenesis,GO:0048712~negative regulation of astrocyte differentiation,GO:0048715~negative regulation of oligodendrocyte differentiation,GO:0048745~smooth muscle tissue development,GO:0048844~artery morphogenesis,GO:0048853~forebrain morphogenesis,GO:0050890~cognition,GO:0061534~gamma-aminobutyric acid secretion, neurotransmission,GO:0061535~glutamate secretion, neurotransmission,GO:0098597~observational learning,GO:1900271~regulation of long-term synaptic potentiation,GO:1902043~positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,GO:2001241~positive regulation of extrinsic apoptotic signaling pathway in absence of ligand,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016020~membrane,GO:0030424~axon,GO:0030425~dendrite,GO:0031235~intrinsic component of the cytoplasmic side of the plasma membrane,GO:0098793~presynapse,	GO:0005096~GTPase activator activity,GO:0005515~protein binding,GO:0008429~phosphatidylethanolamine binding,GO:0031210~phosphatidylcholine binding,	IPR001251:CRAL-TRIO domain,IPR001936:Ras GTPase-activating protein,IPR008936:Rho GTPase activation protein,IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,IPR023152:Ras GTPase-activating protein, conserved site,	hsa04010:MAPK signaling pathway,hsa04014:Ras signaling pathway,	162200~Neurofibromatosis, type 1,162210~Neurofibromatosis, familial spinal,193520~Watson syndrome,601321~Neurofibromatosis-Noonan syndrome,607785~Leukemia, juvenile myelomonocytic,		SM00323:RasGAP,SM00516:SEC14,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Disease mutation,GTPase activation,Lipid-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,RNA editing,Tumor suppressor,	chain:Neurofibromin,chain:Neurofibromin truncated,compositionally biased region:Poly-Ser,domain:CRAL-TRIO,domain:Ras-GAP,helix,modified residue,sequence conflict,sequence variant,splice variant,strand,turn,
NF2	neurofibromin 2(NF2)	Homo sapiens				GO:0001707~mesoderm formation,GO:0001953~negative regulation of cell-matrix adhesion,GO:0006469~negative regulation of protein kinase activity,GO:0007398~ectoderm development,GO:0008156~negative regulation of DNA replication,GO:0008285~negative regulation of cell proliferation,GO:0014010~Schwann cell proliferation,GO:0014013~regulation of gliogenesis,GO:0021766~hippocampus development,GO:0022408~negative regulation of cell-cell adhesion,GO:0030036~actin cytoskeleton organization,GO:0030336~negative regulation of cell migration,GO:0031647~regulation of protein stability,GO:0035330~regulation of hippo signaling,GO:0042475~odontogenesis of dentin-containing tooth,GO:0042518~negative regulation of tyrosine phosphorylation of Stat3 protein,GO:0042524~negative regulation of tyrosine phosphorylation of Stat5 protein,GO:0043409~negative regulation of MAPK cascade,GO:0045216~cell-cell junction organization,GO:0045597~positive regulation of cell differentiation,GO:0046426~negative regulation of JAK-STAT cascade,GO:0051496~positive regulation of stress fiber assembly,GO:0070306~lens fiber cell differentiation,GO:0072091~regulation of stem cell proliferation,GO:1900180~regulation of protein localization to nucleus,GO:2000177~regulation of neural precursor cell proliferation,	GO:0001726~ruffle,GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005769~early endosome,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005912~adherens junction,GO:0016020~membrane,GO:0019898~extrinsic component of membrane,GO:0030027~lamellipodium,GO:0030175~filopodium,GO:0030864~cortical actin cytoskeleton,GO:0031527~filopodium membrane,GO:0032154~cleavage furrow,GO:0032587~ruffle membrane,GO:0043005~neuron projection,GO:0044297~cell body,GO:0045177~apical part of cell,GO:0048471~perinuclear region of cytoplasm,	GO:0003779~actin binding,GO:0005515~protein binding,	IPR000299:FERM domain,IPR000798:Ezrin/radixin/moesin like,IPR008954:Moesin,IPR011174:Ezrin/radixin/moesin,IPR011259:Ezrin/radixin/moesin, C-terminal,IPR011993:Pleckstrin homology-like domain,IPR014352:FERM/acyl-CoA-binding protein, 3-helical bundle,IPR018979:FERM, N-terminal,IPR018980:FERM, C-terminal PH-like domain,IPR019747:FERM conserved site,IPR019748:FERM central domain,IPR019749:Band 4.1 domain,	hsa04390:Hippo signaling pathway,	101000~Neurofibromatosis, type 2,162091~Schwannomatosis,607174~Meningioma, NF2-related, somatic,	PIRSF002305:ezrin/radixin/moesin,	SM00295:B41,SM01196:SM01196,	3D-structure,Alternative splicing,Cell membrane,Cell projection,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Deafness,Disease mutation,Membrane,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Tumor suppressor,Ubl conjugation,	chain:Merlin,compositionally biased region:Glu-rich,domain:FERM,helix,modified residue,mutagenesis site,sequence conflict,sequence variant,splice variant,strand,turn,
NIPA2	non imprinted in Prader-Willi/Angelman syndrome 2(NIPA2)	Homo sapiens				GO:0015693~magnesium ion transport,GO:1903830~magnesium ion transmembrane transport,	GO:0005769~early endosome,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0015095~magnesium ion transmembrane transporter activity,	IPR008521:Magnesium transporter NIPA,					Alternative splicing,Cell membrane,Complete proteome,Endosome,Ion transport,Magnesium,Membrane,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:Magnesium transporter NIPA2,sequence conflict,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
NOTCH1	notch 1(NOTCH1)	Homo sapiens		h_hesPathway:Segmentation Clock,h_notchPathway:Proteolysis and Signaling Pathway of Notch ,h_ps1Pathway:Presenilin action in Notch and Wnt signaling,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001701~in utero embryonic development,GO:0001708~cell fate specification,GO:0001837~epithelial to mesenchymal transition,GO:0001889~liver development,GO:0001947~heart looping,GO:0002040~sprouting angiogenesis,GO:0002052~positive regulation of neuroblast proliferation,GO:0002437~inflammatory response to antigenic stimulus,GO:0003157~endocardium development,GO:0003160~endocardium morphogenesis,GO:0003162~atrioventricular node development,GO:0003169~coronary vein morphogenesis,GO:0003180~aortic valve morphogenesis,GO:0003181~atrioventricular valve morphogenesis,GO:0003184~pulmonary valve morphogenesis,GO:0003192~mitral valve formation,GO:0003198~epithelial to mesenchymal transition involved in endocardial cushion formation,GO:0003203~endocardial cushion morphogenesis,GO:0003207~cardiac chamber formation,GO:0003208~cardiac ventricle morphogenesis,GO:0003209~cardiac atrium morphogenesis,GO:0003213~cardiac right atrium morphogenesis,GO:0003214~cardiac left ventricle morphogenesis,GO:0003219~cardiac right ventricle formation,GO:0003222~ventricular trabecula myocardium morphogenesis,GO:0003241~growth involved in heart morphogenesis,GO:0003256~regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,GO:0003270~Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation,GO:0003273~cell migration involved in endocardial cushion formation,GO:0003344~pericardium morphogenesis,GO:0006355~regulation of transcription, DNA-templated,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0006955~immune response,GO:0006959~humoral immune response,GO:0007219~Notch signaling pathway,GO:0007221~positive regulation of transcription of Notch receptor target,GO:0007275~multicellular organism development,GO:0007283~spermatogenesis,GO:0007368~determination of left/right symmetry,GO:0007386~compartment pattern specification,GO:0007409~axonogenesis,GO:0007440~foregut morphogenesis,GO:0007492~endoderm development,GO:0007507~heart development,GO:0008284~positive regulation of cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0009912~auditory receptor cell fate commitment,GO:0010718~positive regulation of epithelial to mesenchymal transition,GO:0010812~negative regulation of cell-substrate adhesion,GO:0010832~negative regulation of myotube differentiation,GO:0014031~mesenchymal cell development,GO:0014807~regulation of somitogenesis,GO:0021515~cell differentiation in spinal cord,GO:0021915~neural tube development,GO:0030154~cell differentiation,GO:0030216~keratinocyte differentiation,GO:0030279~negative regulation of ossification,GO:0030324~lung development,GO:0030335~positive regulation of cell migration,GO:0030513~positive regulation of BMP signaling pathway,GO:0030514~negative regulation of BMP signaling pathway,GO:0030900~forebrain development,GO:0031069~hair follicle morphogenesis,GO:0031100~organ regeneration,GO:0031960~response to corticosteroid,GO:0032495~response to muramyl dipeptide,GO:0032496~response to lipopolysaccharide,GO:0035116~embryonic hindlimb morphogenesis,GO:0035148~tube formation,GO:0035914~skeletal muscle cell differentiation,GO:0035924~cellular response to vascular endothelial growth factor stimulus,GO:0042246~tissue regeneration,GO:0043065~positive regulation of apoptotic process,GO:0043086~negative regulation of catalytic activity,GO:0045070~positive regulation of viral genome replication,GO:0045603~positive regulation of endothelial cell differentiation,GO:0045608~negative regulation of auditory receptor cell differentiation,GO:0045618~positive regulation of keratinocyte differentiation,GO:0045662~negative regulation of myoblast differentiation,GO:0045668~negative regulation of osteoblast differentiation,GO:0045747~positive regulation of Notch signaling pathway,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0045955~negative regulation of calcium ion-dependent exocytosis,GO:0046427~positive regulation of JAK-STAT cascade,GO:0046533~negative regulation of photoreceptor cell differentiation,GO:0048103~somatic stem cell division,GO:0048708~astrocyte differentiation,GO:0048709~oligodendrocyte differentiation,GO:0048711~positive regulation of astrocyte differentiation,GO:0048715~negative regulation of oligodendrocyte differentiation,GO:0048754~branching morphogenesis of an epithelial tube,GO:0050434~positive regulation of viral transcription,GO:0050679~positive regulation of epithelial cell proliferation,GO:0050768~negative regulation of neurogenesis,GO:0055008~cardiac muscle tissue morphogenesis,GO:0060038~cardiac muscle cell proliferation,GO:0060045~positive regulation of cardiac muscle cell proliferation,GO:0060253~negative regulation of glial cell proliferation,GO:0060271~cilium morphogenesis,GO:0060317~cardiac epithelial to mesenchymal transition,GO:0060411~cardiac septum morphogenesis,GO:0060412~ventricular septum morphogenesis,GO:0060528~secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development,GO:0060740~prostate gland epithelium morphogenesis,GO:0060768~regulation of epithelial cell proliferation involved in prostate gland development,GO:0060842~arterial endothelial cell differentiation,GO:0060843~venous endothelial cell differentiation,GO:0060948~cardiac vascular smooth muscle cell development,GO:0060956~endocardial cell differentiation,GO:0060979~vasculogenesis involved in coronary vascular morphogenesis,GO:0060982~coronary artery morphogenesis,GO:0061314~Notch signaling involved in heart development,GO:0061384~heart trabecula morphogenesis,GO:0061419~positive regulation of transcription from RNA polymerase II promoter in response to hypoxia,GO:0070986~left/right axis specification,GO:0071372~cellular response to follicle-stimulating hormone stimulus,GO:0072017~distal tubule development,GO:0072044~collecting duct development,GO:0072144~glomerular mesangial cell development,GO:0072602~interleukin-4 secretion,GO:0090051~negative regulation of cell migration involved in sprouting angiogenesis,GO:0090090~negative regulation of canonical Wnt signaling pathway,GO:0097150~neuronal stem cell population maintenance,GO:1901201~regulation of extracellular matrix assembly,GO:1902263~apoptotic process involved in embryonic digit morphogenesis,GO:1903849~positive regulation of aorta morphogenesis,GO:2000737~negative regulation of stem cell differentiation,GO:2000811~negative regulation of anoikis,GO:2000974~negative regulation of pro-B cell differentiation,GO:2001027~negative regulation of endothelial cell chemotaxis,	GO:0000139~Golgi membrane,GO:0001669~acrosomal vesicle,GO:0002193~MAML1-RBP-Jkappa- ICN1 complex,GO:0005576~extracellular region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005789~endoplasmic reticulum membrane,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005912~adherens junction,GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0016324~apical plasma membrane,GO:0043235~receptor complex,	GO:0001047~core promoter binding,GO:0001190~transcriptional activator activity, RNA polymerase II transcription factor binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0004857~enzyme inhibitor activity,GO:0004872~receptor activity,GO:0005112~Notch binding,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0019899~enzyme binding,GO:0031490~chromatin DNA binding,GO:0043565~sequence-specific DNA binding,GO:0046982~protein heterodimerization activity,	IPR000152:EGF-type aspartate/asparagine hydroxylation site,IPR000742:Epidermal growth factor-like domain,IPR000800:Notch domain,IPR001881:EGF-like calcium-binding,IPR002110:Ankyrin repeat,IPR008297:Notch,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR010660:Notch, NOD domain,IPR011656:Notch, NODP domain,IPR013032:EGF-like, conserved site,IPR018097:EGF-like calcium-binding, conserved site,IPR020683:Ankyrin repeat-containing domain,IPR022362:Neurogenic locus Notch 1,IPR024600:Domain of unknown function DUF3454, notch,	hsa04320:Dorso-ventral axis formation,hsa04330:Notch signaling pathway,hsa04919:Thyroid hormone signaling pathway,hsa05020:Prion diseases,hsa05206:MicroRNAs in cancer,	109730~Aortic valve disease 1,616028~Adams-Oliver syndrome 5,	PIRSF002279:notch protein,	SM00004:NL,SM00179:EGF_CA,SM00181:EGF,SM00248:ANK,SM01334:SM01334,SM01338:SM01338,SM01339:SM01339,	3D-structure,Activator,Angiogenesis,ANK repeat,Calcium,Cell membrane,Complete proteome,Developmental protein,Differentiation,Direct protein sequencing,Disease mutation,Disulfide bond,EGF-like domain,Glycoprotein,Hydroxylation,Isopeptide bond,Membrane,Metal-binding,Notch signaling pathway,Nucleus,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Repeat,Signal,Transcription,Transcription regulation,Transmembrane,Transmembrane helix,Ubl conjugation,	chain:Neurogenic locus notch homolog protein 1,chain:Notch 1 extracellular truncation,chain:Notch 1 intracellular domain,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Arg,compositionally biased region:Poly-Gln,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Gly,compositionally biased region:Poly-Pro,compositionally biased region:Poly-Ser,compositionally biased region:Poly-Val,disulfide bond,domain:EGF-like 1,domain:EGF-like 10,domain:EGF-like 11; calcium-binding,domain:EGF-like 12; calcium-binding,domain:EGF-like 13; calcium-binding,domain:EGF-like 14; calcium-binding,domain:EGF-like 15; calcium-binding,domain:EGF-like 16; calcium-binding,domain:EGF-like 17; calcium-binding,domain:EGF-like 18; calcium-binding,domain:EGF-like 19; calcium-binding,domain:EGF-like 2,domain:EGF-like 20,domain:EGF-like 21; calcium-binding,domain:EGF-like 22,domain:EGF-like 23; calcium-binding,domain:EGF-like 24,domain:EGF-like 25; calcium-binding,domain:EGF-like 26,domain:EGF-like 27,domain:EGF-like 28,domain:EGF-like 29,domain:EGF-like 3,domain:EGF-like 30,domain:EGF-like 31; calcium-binding,domain:EGF-like 32; calcium-binding,domain:EGF-like 33,domain:EGF-like 34,domain:EGF-like 35,domain:EGF-like 36,domain:EGF-like 4,domain:EGF-like 5; calcium-binding,domain:EGF-like 6,domain:EGF-like 7; calcium-binding,domain:EGF-like 8; calcium-binding,domain:EGF-like 9; calcium-binding,glycosylation site:N-linked (GlcNAc...),helix,metal ion-binding site:Calcium,metal ion-binding site:Calcium; via carbonyl oxygen,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,repeat:ANK 4,repeat:ANK 5,repeat:LNR 1,repeat:LNR 2,repeat:LNR 3,sequence conflict,sequence variant,signal peptide,site:Cleavage; by furin-like protease,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
NOTCH2	notch 2(NOTCH2)	Homo sapiens		h_hesPathway:Segmentation Clock,		GO:0001709~cell fate determination,GO:0002315~marginal zone B cell differentiation,GO:0003184~pulmonary valve morphogenesis,GO:0006355~regulation of transcription, DNA-templated,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0006915~apoptotic process,GO:0007050~cell cycle arrest,GO:0007219~Notch signaling pathway,GO:0007275~multicellular organism development,GO:0007399~nervous system development,GO:0008285~negative regulation of cell proliferation,GO:0009887~organ morphogenesis,GO:0016049~cell growth,GO:0019827~stem cell population maintenance,GO:0030097~hemopoiesis,GO:0030522~intracellular receptor signaling pathway,GO:0043066~negative regulation of apoptotic process,GO:0046579~positive regulation of Ras protein signal transduction,GO:0046849~bone remodeling,GO:0050793~regulation of developmental process,GO:0060413~atrial septum morphogenesis,GO:0061314~Notch signaling involved in heart development,	GO:0000139~Golgi membrane,GO:0005576~extracellular region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,GO:0043235~receptor complex,	GO:0004872~receptor activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0038049~transcription factor activity, ligand-activated RNA polymerase II transcription factor binding,	IPR000152:EGF-type aspartate/asparagine hydroxylation site,IPR000742:Epidermal growth factor-like domain,IPR000800:Notch domain,IPR001881:EGF-like calcium-binding,IPR002110:Ankyrin repeat,IPR008297:Notch,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR010660:Notch, NOD domain,IPR011656:Notch, NODP domain,IPR013032:EGF-like, conserved site,IPR018097:EGF-like calcium-binding, conserved site,IPR020683:Ankyrin repeat-containing domain,IPR022336:Neurogenic locus Notch 2,IPR024600:Domain of unknown function DUF3454, notch,	hsa04320:Dorso-ventral axis formation,hsa04330:Notch signaling pathway,hsa04919:Thyroid hormone signaling pathway,hsa05206:MicroRNAs in cancer,	102500~Hajdu-Cheney syndrome,610205~Alagille syndrome 2,	PIRSF002279:notch protein,	SM00004:NL,SM00179:EGF_CA,SM00181:EGF,SM00248:ANK,SM01334:SM01334,SM01338:SM01338,SM01339:SM01339,	3D-structure,Activator,ANK repeat,Calcium,Cell membrane,Complete proteome,Cytoplasm,Developmental protein,Differentiation,Disease mutation,Disulfide bond,EGF-like domain,Glycoprotein,Membrane,Notch signaling pathway,Nucleus,Phosphoprotein,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Transcription,Transcription regulation,Transmembrane,Transmembrane helix,	chain:Neurogenic locus notch homolog protein 2,chain:Notch 2 extracellular truncation,chain:Notch 2 intracellular domain,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Leu,compositionally biased region:Poly-Ser,disulfide bond,domain:EGF-like 1,domain:EGF-like 10,domain:EGF-like 11; calcium-binding,domain:EGF-like 12; calcium-binding,domain:EGF-like 13; calcium-binding,domain:EGF-like 14; calcium-binding,domain:EGF-like 15; calcium-binding,domain:EGF-like 16; calcium-binding,domain:EGF-like 17; calcium-binding,domain:EGF-like 18; calcium-binding,domain:EGF-like 19,domain:EGF-like 2,domain:EGF-like 20; calcium-binding,domain:EGF-like 21; calcium-binding,domain:EGF-like 22,domain:EGF-like 23; calcium-binding,domain:EGF-like 24; calcium-binding,domain:EGF-like 25; calcium-binding,domain:EGF-like 26; calcium-binding,domain:EGF-like 27; calcium-binding,domain:EGF-like 28,domain:EGF-like 29,domain:EGF-like 3,domain:EGF-like 30; calcium-binding,domain:EGF-like 31; calcium-binding,domain:EGF-like 32; calcium-binding,domain:EGF-like 33,domain:EGF-like 34,domain:EGF-like 35,domain:EGF-like 4,domain:EGF-like 5; calcium-binding,domain:EGF-like 6,domain:EGF-like 7; calcium-binding,domain:EGF-like 8; calcium-binding,domain:EGF-like 9; calcium-binding,glycosylation site:N-linked (GlcNAc...),helix,modified residue,region of interest:Negative regulatory region (NRR),repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,repeat:ANK 4,repeat:ANK 5,repeat:ANK 6,repeat:LNR 1,repeat:LNR 2,repeat:LNR 3,sequence conflict,sequence variant,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
NXF1	nuclear RNA export factor 1(NXF1)	Homo sapiens				GO:0006405~RNA export from nucleus,GO:0006406~mRNA export from nucleus,GO:0016032~viral process,GO:0016973~poly(A)+ mRNA export from nucleus,GO:0051028~mRNA transport,	GO:0000346~transcription export complex,GO:0005634~nucleus,GO:0005643~nuclear pore,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016607~nuclear speck,GO:0042405~nuclear inclusion body,	GO:0000166~nucleotide binding,GO:0003723~RNA binding,GO:0003727~single-stranded RNA binding,GO:0003729~mRNA binding,GO:0005487~nucleocytoplasmic transporter activity,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR001611:Leucine-rich repeat,IPR002075:Nuclear transport factor 2,IPR005637:TAP C-terminal (TAP-C) domain,IPR009060:UBA-like,IPR012677:Nucleotide-binding, alpha-beta plait,IPR015245:Nuclear RNA export factor Tap, RNA-binding domain,IPR018222:Nuclear transport factor 2, Eukaryote,	hsa03008:Ribosome biogenesis in eukaryotes,hsa03013:RNA transport,hsa03015:mRNA surveillance pathway,hsa05164:Influenza A,hsa05168:Herpes simplex infection,			SM00804:TAP_C,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Host-virus interaction,Leucine-rich repeat,Methylation,mRNA transport,Nitration,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,RNA-binding,Transport,	chain:Nuclear RNA export factor 1,compositionally biased region:Pro-rich,domain:NTF2,domain:RRM,domain:TAP-C,helix,modified residue,mutagenesis site,region of interest:Interaction with THOC4,repeat:LRR 1,repeat:LRR 2,repeat:LRR 3,repeat:LRR 4,sequence conflict,short sequence motif:Nuclear export signal,short sequence motif:Nuclear localization signal,strand,turn,
NFATC4	nuclear factor of activated T-cells 4(NFATC4)	Homo sapiens		h_bcrPathway:BCR Signaling Pathway,h_calcineurinPathway:Effects of calcineurin in Keratinocyte Differentiation,h_fcer1Pathway:Fc Epsilon Receptor I Signaling in Mast Cells,h_fmlpPathway:fMLP induced chemokine gene expression in HMC-1 cells,h_gpcrPathway:Signaling Pathway from G-Protein Families,h_nfatPathway:NFAT and Hypertrophy of the heart (Transcription in the broken heart),h_tcrPathway:T Cell Receptor Signaling Pathway,		GO:0001569~patterning of blood vessels,GO:0006366~transcription from RNA polymerase II promoter,GO:0006954~inflammatory response,GO:0007507~heart development,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0030178~negative regulation of Wnt signaling pathway,GO:0032091~negative regulation of protein binding,GO:0032760~positive regulation of tumor necrosis factor production,GO:0033173~calcineurin-NFAT signaling cascade,GO:0034644~cellular response to UV,GO:0035562~negative regulation of chromatin binding,GO:0045333~cellular respiration,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048167~regulation of synaptic plasticity,GO:0050774~negative regulation of dendrite morphogenesis,GO:0051145~smooth muscle cell differentiation,GO:0055001~muscle cell development,GO:0071285~cellular response to lithium ion,GO:1902894~negative regulation of pri-miRNA transcription from RNA polymerase II promoter,GO:2000297~negative regulation of synapse maturation,GO:2001235~positive regulation of apoptotic signaling pathway,	GO:0005634~nucleus,GO:0005667~transcription factor complex,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0045111~intermediate filament cytoskeleton,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001078~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001227~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003713~transcription coactivator activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0042975~peroxisome proliferator activated receptor binding,	IPR002909:Cell surface receptor IPT/TIG,IPR008366:Nuclear factor of activated T cells (NFAT),IPR008967:p53-like transcription factor, DNA-binding,IPR011539:Rel homology domain,IPR013783:Immunoglobulin-like fold,IPR014756:Immunoglobulin E-set,	hsa04022:cGMP-PKG signaling pathway,hsa04310:Wnt signaling pathway,hsa04360:Axon guidance,hsa04921:Oxytocin signaling pathway,hsa05161:Hepatitis B,hsa05166:HTLV-I infection,			SM00429:IPT,	3D-structure,Activator,Alternative splicing,Complete proteome,Cytoplasm,Differentiation,DNA-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Ubl conjugation,	chain:Nuclear factor of activated T-cells, cytoplasmic 4,compositionally biased region:Pro-rich,domain:IPT/TIG,domain:RHD,modified residue,mutagenesis site,region of interest:2 approximate SP repeats,region of interest:Calcineurin-binding,repeat:SP 1,repeat:SP 2; approximate,sequence conflict,sequence variant,short sequence motif:Nuclear localization signal,splice variant,strand,turn,
NCOR1	nuclear receptor corepressor 1(NCOR1)	Homo sapiens		h_PparaPathway:Mechanism of Gene Regulation by Peroxisome Proliferators via PPARa(alpha),h_vdrPathway:Control of Gene Expression by Vitamin D Receptor,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0007623~circadian rhythm,GO:0016569~covalent chromatin modification,GO:0044255~cellular lipid metabolic process,GO:0046329~negative regulation of JNK cascade,GO:0051225~spindle assembly,GO:0072362~regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter,GO:0072368~regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter,GO:1903799~negative regulation of production of miRNAs involved in gene silencing by miRNA,GO:2000191~regulation of fatty acid transport,	GO:0000118~histone deacetylase complex,GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005876~spindle microtubule,GO:0016020~membrane,GO:0016580~Sin3 complex,GO:0017053~transcriptional repressor complex,	GO:0001102~RNA polymerase II activating transcription factor binding,GO:0003677~DNA binding,GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0016922~ligand-dependent nuclear receptor binding,GO:0035257~nuclear hormone receptor binding,GO:0042826~histone deacetylase binding,GO:0044212~transcription regulatory region DNA binding,GO:0046966~thyroid hormone receptor binding,	IPR001005:SANT/Myb domain,IPR009057:Homeodomain-like,IPR017884:SANT domain,	hsa04919:Thyroid hormone signaling pathway,hsa05202:Transcriptional misregulation in cancer,			SM00717:SANT,	3D-structure,Acetylation,Alternative splicing,Chromatin regulator,Coiled coil,Complete proteome,DNA-binding,Isopeptide bond,Nucleus,Phosphoprotein,Proteomics identification,Receptor,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,Ubl conjugation,	chain:Nuclear receptor corepressor 1,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Gln,compositionally biased region:Poly-Pro,compositionally biased region:Poly-Ser,compositionally biased region:Pro-rich,domain:SANT 1,domain:SANT 2,helix,modified residue,region of interest:ID1,region of interest:ID2,region of interest:Interaction with C1D,region of interest:Interaction with ETO,region of interest:Interaction with SIN3A/B,region of interest:Interaction with ZBTB33 and HEXIM1,sequence conflict,short sequence motif:CORNR box 1,short sequence motif:CORNR box 2,short sequence motif:CORNR box 3,splice variant,
OR2V2	olfactory receptor family 2 subfamily V member 2(OR2V2)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0007608~sensory perception of smell,GO:0050911~detection of chemical stimulus involved in sensory perception of smell,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,GO:0004984~olfactory receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000725:Olfactory receptor,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04740:Olfactory transduction,				Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Olfaction,Polymorphism,Receptor,Reference proteome,Sensory transduction,Transducer,Transmembrane,Transmembrane helix,	chain:Olfactory receptor 2V2,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
PTCH1	patched 1(PTCH1)	Homo sapiens		h_ptc1Pathway:Sonic Hedgehog (SHH) Receptor Ptc1 Regulates cell cycle,h_shhPathway:Sonic Hedgehog (Shh) Pathway,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001658~branching involved in ureteric bud morphogenesis,GO:0001701~in utero embryonic development,GO:0001709~cell fate determination,GO:0001843~neural tube closure,GO:0003007~heart morphogenesis,GO:0007224~smoothened signaling pathway,GO:0007346~regulation of mitotic cell cycle,GO:0007420~brain development,GO:0008589~regulation of smoothened signaling pathway,GO:0009612~response to mechanical stimulus,GO:0009887~organ morphogenesis,GO:0009953~dorsal/ventral pattern formation,GO:0009957~epidermal cell fate specification,GO:0010157~response to chlorate,GO:0010875~positive regulation of cholesterol efflux,GO:0016485~protein processing,GO:0021522~spinal cord motor neuron differentiation,GO:0021532~neural tube patterning,GO:0021997~neural plate axis specification,GO:0030326~embryonic limb morphogenesis,GO:0032355~response to estradiol,GO:0032526~response to retinoic acid,GO:0032880~regulation of protein localization,GO:0035108~limb morphogenesis,GO:0035137~hindlimb morphogenesis,GO:0040015~negative regulation of multicellular organism growth,GO:0042493~response to drug,GO:0042593~glucose homeostasis,GO:0043433~negative regulation of sequence-specific DNA binding transcription factor activity,GO:0043616~keratinocyte proliferation,GO:0045606~positive regulation of epidermal cell differentiation,GO:0045668~negative regulation of osteoblast differentiation,GO:0045879~negative regulation of smoothened signaling pathway,GO:0045893~positive regulation of transcription, DNA-templated,GO:0048568~embryonic organ development,GO:0050680~negative regulation of epithelial cell proliferation,GO:0051782~negative regulation of cell division,GO:0060037~pharyngeal system development,GO:0060603~mammary gland duct morphogenesis,GO:0060644~mammary gland epithelial cell differentiation,GO:0060831~smoothened signaling pathway involved in dorsal/ventral neural tube patterning,GO:0061005~cell differentiation involved in kidney development,GO:0061053~somite development,GO:0071397~cellular response to cholesterol,GO:0072001~renal system development,GO:0072203~cell proliferation involved in metanephros development,GO:0072661~protein targeting to plasma membrane,	GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0005901~caveola,GO:0014069~postsynaptic density,GO:0016021~integral component of membrane,GO:0030496~midbody,GO:0030666~endocytic vesicle membrane,GO:0043231~intracellular membrane-bounded organelle,GO:0044294~dendritic growth cone,GO:0044295~axonal growth cone,GO:0048471~perinuclear region of cytoplasm,GO:0060170~ciliary membrane,GO:0072372~primary cilium,	GO:0005113~patched binding,GO:0005119~smoothened binding,GO:0005515~protein binding,GO:0008158~hedgehog receptor activity,GO:0008201~heparin binding,GO:0015485~cholesterol binding,GO:0030332~cyclin binding,GO:0032403~protein complex binding,GO:0097108~hedgehog family protein binding,	IPR000731:Sterol-sensing domain,IPR003392:Patched,IPR004766:Transmembrane receptor, patched,	hsa04024:cAMP signaling pathway,hsa04340:Hedgehog signaling pathway,hsa05200:Pathways in cancer,hsa05205:Proteoglycans in cancer,hsa05217:Basal cell carcinoma,	109400~Basal cell nevus syndrome,605462~Basal cell carcinoma, somatic,610828~Holoprosencephaly-7,			Alternative splicing,Complete proteome,Disease mutation,Glycoprotein,Holoprosencephaly,Isopeptide bond,Membrane,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Transmembrane,Transmembrane helix,Tumor suppressor,Ubl conjugation,	chain:Protein patched homolog 1,compositionally biased region:Gly-rich,domain:SSD,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
PDE4DIP	phosphodiesterase 4D interacting protein(PDE4DIP)	Homo sapiens				GO:0030036~actin cytoskeleton organization,GO:0043623~cellular protein complex assembly,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005813~centrosome,GO:0005815~microtubule organizing center,GO:0030016~myofibril,	GO:0005515~protein binding,GO:0019899~enzyme binding,	IPR005454:Profilin, chordates,IPR005455:Profilin,IPR010630:Neuroblastoma breakpoint family (NBPF) domain,IPR012943:Spindle associated,				SM01148:SM01148,	Alternative splicing,Chromosomal rearrangement,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Golgi apparatus,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Myomegalin,domain:NBPF,sequence conflict,sequence variant,site:Breakpoint for insertion to form PDE4DIP- PDGFRB fusion protein,splice variant,
PIK3R1	phosphoinositide-3-kinase regulatory subunit 1(PIK3R1)	Homo sapiens	104.Insulin_signaling,105.Signaling_glucose_uptake,106.Glycogen_synthase-synthesis,107.mRNA_translation-protein_synthesis,2.Cytokine_Receptors,37.Akt-PKB_Effector_of_P13K_in_Vivo,63.LAT_couples_T-cell_receptor,	h_achPathway:Role of nicotinic acetylcholine receptors in the regulation of apoptosis,h_aktPathway:AKT Signaling Pathway,h_arfPathway:Tumor Suppressor Arf Inhibits Ribosomal Biogenesis,h_badPathway:Regulation of BAD phosphorylation,h_bcellsurvivalPathway:B Cell Survival Pathway,h_cdc42racPathway:Role of PI3K subunit p85 in regulation of Actin Organization and Cell Migration,h_crebPathway:Transcription factor CREB and its extracellular signals,h_ctcfPathway:CTCF: First Multivalent Nuclear Factor,h_ctla4Pathway:The Co-Stimulatory Signal During T-cell Activation,h_cxcr4Pathway:CXCR4 Signaling Pathway,h_ecmPathway:Erk and PI-3 Kinase Are Necessary for Collagen Binding in Corneal Epithelia,h_edg1Pathway:Phospholipids as signalling intermediaries,h_egfPathway:EGF Signaling Pathway,h_eif4Pathway:Regulation of eIF4e and p70 S6 Kinase,h_erk5Pathway:Role of Erk5 in Neuronal Survival,h_fcer1Pathway:Fc Epsilon Receptor I Signaling in Mast Cells,h_gcrpathway:Corticosteroids and cardioprotection,h_ghPathway:Growth Hormone Signaling Pathway,h_gleevecPathway:Inhibition of Cellular Proliferation by Gleevec,H_gsk3Pathway:Inactivation of Gsk3 by AKT causes accumulation of b-catenin in Alveolar Macrophages,h_hcmvPathway:Human Cytomegalovirus and Map Kinase Pathways,h_hdacPathway:Control of skeletal myogenesis by HDAC & calcium/calmodulin-dependent kinase (CaMK),h_her2Pathway:Role of ERBB2 in Signal Transduction and Oncology,h_igf1mtorPathway:Skeletal muscle hypertrophy is regulated via AKT/mTOR pathway,h_igf1Pathway:IGF-1 Signaling Pathway,h_igf1rPathway:Multiple antiapoptotic pathways from IGF-1R signaling lead to BAD phosphorylation,h_il2rbPathway:IL-2 Receptor Beta Chain in T cell Activation,h_il7Pathway:IL-7 Signal Transduction,h_insulinPathway:Insulin Signaling Pathway,h_longevityPathway:The IGF-1 Receptor and Longevity,h_metPathway:Signaling of Hepatocyte Growth Factor Receptor,h_mtorPathway:mTOR Signaling Pathway,h_nfatPathway:NFAT and Hypertrophy of the heart (Transcription in the broken heart),h_ngfPathway:Nerve growth factor pathway (NGF),h_nkcellsPathway:Ras-Independent pathway in NK cell-mediated cytotoxicity,h_par1pathway:Thrombin signaling and protease-activated receptors,h_pdgfPathway:PDGF Signaling Pathway,h_plcPathway:Phospholipase C Signaling Pathway,h_PparaPathway:Mechanism of Gene Regulation by Peroxisome Proliferators via PPARa(alpha),h_ptenPathway:PTEN dependent cell cycle arrest and apoptosis,h_rac1Pathway:Rac 1 cell motility signaling pathway,h_raccycdPathway:Influence of Ras and Rho proteins on G1 to S Transition,h_rasPathway:Ras Signaling Pathway,h_tcrPathway:T Cell Receptor Signaling Pathway,h_tffPathway:Trefoil Factors Initiate  Mucosal Healing,h_tpoPathway:TPO Signaling Pathway,h_trkaPathway:Trka Receptor Signaling Pathway,h_vegfPathway:VEGF, Hypoxia, and Angiogenesis,	Cell division and chromosome partitioning,	GO:0001678~cellular glucose homeostasis,GO:0001953~negative regulation of cell-matrix adhesion,GO:0006468~protein phosphorylation,GO:0006661~phosphatidylinositol biosynthetic process,GO:0007165~signal transduction,GO:0007173~epidermal growth factor receptor signaling pathway,GO:0008286~insulin receptor signaling pathway,GO:0008625~extrinsic apoptotic signaling pathway via death domain receptors,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0014065~phosphatidylinositol 3-kinase signaling,GO:0014066~regulation of phosphatidylinositol 3-kinase signaling,GO:0016032~viral process,GO:0030168~platelet activation,GO:0030183~B cell differentiation,GO:0030335~positive regulation of cell migration,GO:0031295~T cell costimulation,GO:0032760~positive regulation of tumor necrosis factor production,GO:0032869~cellular response to insulin stimulus,GO:0033120~positive regulation of RNA splicing,GO:0034644~cellular response to UV,GO:0034976~response to endoplasmic reticulum stress,GO:0036092~phosphatidylinositol-3-phosphate biosynthetic process,GO:0038095~Fc-epsilon receptor signaling pathway,GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis,GO:0038128~ERBB2 signaling pathway,GO:0042993~positive regulation of transcription factor import into nucleus,GO:0043066~negative regulation of apoptotic process,GO:0043551~regulation of phosphatidylinositol 3-kinase activity,GO:0045671~negative regulation of osteoclast differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046326~positive regulation of glucose import,GO:0046854~phosphatidylinositol phosphorylation,GO:0048009~insulin-like growth factor receptor signaling pathway,GO:0048010~vascular endothelial growth factor receptor signaling pathway,GO:0048015~phosphatidylinositol-mediated signaling,GO:0050821~protein stabilization,GO:0050852~T cell receptor signaling pathway,GO:0050900~leukocyte migration,GO:0051492~regulation of stress fiber assembly,GO:0051531~NFAT protein import into nucleus,GO:0060396~growth hormone receptor signaling pathway,GO:0090004~positive regulation of establishment of protein localization to plasma membrane,GO:1900103~positive regulation of endoplasmic reticulum unfolded protein response,GO:2001275~positive regulation of glucose import in response to insulin stimulus,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005801~cis-Golgi network,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0005942~phosphatidylinositol 3-kinase complex,GO:0005943~phosphatidylinositol 3-kinase complex, class IA,GO:0016020~membrane,GO:1990578~perinuclear endoplasmic reticulum membrane,	GO:0005068~transmembrane receptor protein tyrosine kinase adaptor activity,GO:0005158~insulin receptor binding,GO:0005159~insulin-like growth factor receptor binding,GO:0005168~neurotrophin TRKA receptor binding,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0016301~kinase activity,GO:0016303~1-phosphatidylinositol-3-kinase activity,GO:0019903~protein phosphatase binding,GO:0035014~phosphatidylinositol 3-kinase regulator activity,GO:0036312~phosphatidylinositol 3-kinase regulatory subunit binding,GO:0043125~ErbB-3 class receptor binding,GO:0043548~phosphatidylinositol 3-kinase binding,GO:0043559~insulin binding,GO:0043560~insulin receptor substrate binding,GO:0046934~phosphatidylinositol-4,5-bisphosphate 3-kinase activity,GO:0046935~1-phosphatidylinositol-3-kinase regulator activity,GO:0046982~protein heterodimerization activity,	IPR000198:Rho GTPase-activating protein domain,IPR000980:SH2 domain,IPR001452:Src homology-3 domain,IPR001720:PI3 kinase, P85 regulatory subunit,IPR008936:Rho GTPase activation protein,	hsa04012:ErbB signaling pathway,hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa04024:cAMP signaling pathway,hsa04062:Chemokine signaling pathway,hsa04066:HIF-1 signaling pathway,hsa04068:FoxO signaling pathway,hsa04070:Phosphatidylinositol signaling system,hsa04071:Sphingolipid signaling pathway,hsa04150:mTOR signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04152:AMPK signaling pathway,hsa04210:Apoptosis,hsa04370:VEGF signaling pathway,hsa04380:Osteoclast differentiation,hsa04510:Focal adhesion,hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa04611:Platelet activation,hsa04620:Toll-like receptor signaling pathway,hsa04630:Jak-STAT signaling pathway,hsa04650:Natural killer cell mediated cytotoxicity,hsa04660:T cell receptor signaling pathway,hsa04662:B cell receptor signaling pathway,hsa04664:Fc epsilon RI signaling pathway,hsa04666:Fc gamma R-mediated phagocytosis,hsa04668:TNF signaling pathway,hsa04670:Leukocyte transendothelial migration,hsa04722:Neurotrophin signaling pathway,hsa04725:Cholinergic synapse,hsa04750:Inflammatory mediator regulation of TRP channels,hsa04810:Regulation of actin cytoskeleton,hsa04910:Insulin signaling pathway,hsa04914:Progesterone-mediated oocyte maturation,hsa04915:Estrogen signaling pathway,hsa04917:Prolactin signaling pathway,hsa04919:Thyroid hormone signaling pathway,hsa04923:Regulation of lipolysis in adipocytes,hsa04930:Type II diabetes mellitus,hsa04931:Insulin resistance,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa04960:Aldosterone-regulated sodium reabsorption,hsa04973:Carbohydrate digestion and absorption,hsa05100:Bacterial invasion of epithelial cells,hsa05142:Chagas disease (American trypanosomiasis),hsa05146:Amoebiasis,hsa05160:Hepatitis C,hsa05161:Hepatitis B,hsa05162:Measles,hsa05164:Influenza A,hsa05166:HTLV-I infection,hsa05169:Epstein-Barr virus infection,hsa05200:Pathways in cancer,hsa05203:Viral carcinogenesis,hsa05205:Proteoglycans in cancer,hsa05210:Colorectal cancer,hsa05211:Renal cell carcinoma,hsa05212:Pancreatic cancer,hsa05213:Endometrial cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05218:Melanoma,hsa05220:Chronic myeloid leukemia,hsa05221:Acute myeloid leukemia,hsa05222:Small cell lung cancer,hsa05223:Non-small cell lung cancer,hsa05230:Central carbon metabolism in cancer,hsa05231:Choline metabolism in cancer,	269880~SHORT syndrome,615214~Agammaglobulinemia 7, autosomal recessive,616005~Immunodeficiency 36,		SM00252:SH2,SM00324:RhoGAP,SM00326:SH3,	3D-structure,Acetylation,Alternative splicing,Coiled coil,Complete proteome,Disease mutation,Dwarfism,Host-virus interaction,Kinase,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Repeat,SH2 domain,SH3 domain,Stress response,Transferase,Transport,Ubl conjugation,	chain:Phosphatidylinositol 3-kinase regulatory subunit alpha,domain:Rho-GAP,domain:SH2 1,domain:SH2 2,domain:SH3,helix,modified residue,sequence conflict,sequence variant,splice variant,strand,turn,
PLK2	polo like kinase 2(PLK2)	Homo sapiens				GO:0000082~G1/S transition of mitotic cell cycle,GO:0006468~protein phosphorylation,GO:0006977~DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,GO:0007052~mitotic spindle organization,GO:0007093~mitotic cell cycle checkpoint,GO:0007265~Ras protein signal transduction,GO:0007613~memory,GO:0010508~positive regulation of autophagy,GO:0018105~peptidyl-serine phosphorylation,GO:0032092~positive regulation of protein binding,GO:0032436~positive regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0032486~Rap protein signal transduction,GO:0043066~negative regulation of apoptotic process,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0045732~positive regulation of protein catabolic process,GO:0046599~regulation of centriole replication,GO:0048167~regulation of synaptic plasticity,GO:0060291~long-term synaptic potentiation,GO:0060292~long term synaptic depression,GO:0061000~negative regulation of dendritic spine development,	GO:0000785~chromatin,GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005814~centriole,GO:0005829~cytosol,GO:0030425~dendrite,	GO:0004674~protein serine/threonine kinase activity,GO:0004871~signal transducer activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0032403~protein complex binding,GO:0043008~ATP-dependent protein binding,	IPR000719:Protein kinase, catalytic domain,IPR000959:POLO box duplicated domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,	hsa04068:FoxO signaling pathway,			SM00220:S_TKc,	3D-structure,ATP-binding,Cell projection,Complete proteome,Cytoplasm,Cytoskeleton,Kinase,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Serine/threonine-protein kinase,Transferase,Tumor suppressor,	active site:Proton acceptor,binding site:ATP,chain:Serine/threonine-protein kinase PLK2,compositionally biased region:Poly-His,domain:POLO box 1,domain:POLO box 2,domain:Protein kinase,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,
PAPD7	poly(A) RNA polymerase D7, non-canonical(PAPD7)	Homo sapiens				GO:0006302~double-strand break repair,GO:0007062~sister chromatid cohesion,GO:0007076~mitotic chromosome condensation,GO:0042493~response to drug,GO:0051301~cell division,GO:0071897~DNA biosynthetic process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0003677~DNA binding,GO:0003887~DNA-directed DNA polymerase activity,GO:0004652~polynucleotide adenylyltransferase activity,GO:0016779~nucleotidyltransferase activity,GO:0043221~SMC family protein binding,GO:0046872~metal ion binding,	IPR002058:PAP/25A-associated,IPR002934:Nucleotidyl transferase domain,	hsa03018:RNA degradation,				Alternative splicing,Cell cycle,Cell division,Complete proteome,Cytoplasm,DNA-binding,DNA-directed DNA polymerase,Magnesium,Manganese,Metal-binding,Mitosis,Nucleotidyltransferase,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Transferase,	chain:DNA polymerase sigma,compositionally biased region:Ser-rich,sequence variant,
PBRM1	polybromo 1(PBRM1)	Homo sapiens			Chromatin structure and dynamics / Transcription,	GO:0006338~chromatin remodeling,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007067~mitotic nuclear division,GO:0008285~negative regulation of cell proliferation,GO:0016569~covalent chromatin modification,	GO:0000228~nuclear chromosome,GO:0005654~nucleoplasm,GO:0090544~BAF-type complex,	GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0005515~protein binding,	IPR001025:Bromo adjacent homology (BAH) domain,IPR001487:Bromodomain,IPR009071:High mobility group (HMG) box domain,IPR018359:Bromodomain, conserved site,				SM00297:BROMO,SM00398:HMG,SM00439:BAH,	3D-structure,Acetylation,Alternative splicing,Bromodomain,Chromatin regulator,Complete proteome,DNA-binding,Isopeptide bond,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Tumor suppressor,Ubl conjugation,	chain:Protein polybromo-1,compositionally biased region:Poly-Asp,compositionally biased region:Pro-rich,DNA-binding region:HMG box,domain:BAH 1,domain:BAH 2,domain:Bromo 1,domain:Bromo 2,domain:Bromo 3,domain:Bromo 4,domain:Bromo 5,domain:Bromo 6,helix,modified residue,sequence conflict,splice variant,turn,
PKD1L2	polycystin 1 like 2 (gene/pseudogene)(PKD1L2)	Homo sapiens				GO:0050982~detection of mechanical stimulus,GO:0070588~calcium ion transmembrane transport,	GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0005262~calcium channel activity,GO:0005509~calcium ion binding,GO:0030246~carbohydrate binding,	IPR000203:GPS domain,IPR000922:D-galactoside/L-rhamnose binding SUEL lectin domain,IPR001024:Lipoxygenase, LH2,IPR001304:C-type lectin,IPR002859:PKD/REJ-like protein,IPR003915:Polycystic kidney disease type 2 protein,IPR013122:Polycystin cation channel, PKD1/PKD2,IPR014010:Egg jelly receptor, REJ-like,IPR016186:C-type lectin-like,IPR016187:C-type lectin fold,				SM00034:CLECT,SM00303:GPS,SM00308:LH2,	Alternative splicing,Complete proteome,Disulfide bond,Glycoprotein,Ion channel,Ion transport,Lectin,Membrane,Polymorphism,Reference proteome,Signal,Transmembrane,Transmembrane helix,Transport,	chain:Polycystic kidney disease protein 1-like 2,disulfide bond,domain:C-type lectin,domain:GPS,domain:PLAT,domain:REJ,domain:SUEL-type lectin,glycosylation site:N-linked (GlcNAc...),region of interest:Channel pore-region,region of interest:Interaction with GNAS and GNAI1,sequence conflict,sequence variant,short sequence motif:Polycystin motif,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
PRPF38B	pre-mRNA processing factor 38B(PRPF38B)	Homo sapiens				GO:0006397~mRNA processing,GO:0008380~RNA splicing,	GO:0071011~precatalytic spliceosome,	GO:0044822~poly(A) RNA binding,	IPR005037:Pre-mRNA-splicing factor 38,	hsa03040:Spliceosome,				Acetylation,Alternative splicing,Coiled coil,Complete proteome,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Spliceosome,	chain:Pre-mRNA-splicing factor 38B,compositionally biased region:Arg-rich,modified residue,sequence conflict,splice variant,
RGS12	regulator of G-protein signaling 12(RGS12)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0007165~signal transduction,GO:0008277~regulation of G-protein coupled receptor protein signaling pathway,GO:0009968~negative regulation of signal transduction,GO:0043547~positive regulation of GTPase activity,	GO:0000794~condensed nuclear chromosome,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0016363~nuclear matrix,GO:0030054~cell junction,GO:0030425~dendrite,GO:0045202~synapse,	GO:0005057~receptor signaling protein activity,GO:0005096~GTPase activator activity,GO:0030695~GTPase regulator activity,	IPR001478:PDZ domain,IPR003109:GoLoco motif,IPR003116:Raf-like Ras-binding,IPR006020:Phosphotyrosine interaction domain,IPR011993:Pleckstrin homology-like domain,IPR016137:Regulator of G protein signalling superfamily,IPR024066:Regulator of G-protein signaling, domain 1,				SM00228:PDZ,SM00315:RGS,SM00390:GoLoco,SM00455:RBD,SM00462:PTB,	3D-structure,Alternative splicing,Cell junction,Cell projection,Complete proteome,Cytoplasm,GTPase activation,Isopeptide bond,Methylation,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Repressor,Signal transduction inhibitor,Synapse,Transcription,	chain:Regulator of G-protein signaling 12,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),domain:GoLoco,domain:PDZ,domain:PID,domain:RBD 1,domain:RBD 2,domain:RGS,helix,modified residue,sequence variant,splice variant,strand,turn,
RMND5B	required for meiotic nuclear division 5 homolog B(RMND5B)	Homo sapiens			General function prediction only,	GO:0042787~protein ubiquitination involved in ubiquitin-dependent protein catabolic process,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0034657~GID complex,	GO:0004842~ubiquitin-protein transferase activity,	IPR006594:LisH dimerisation motif,IPR006595:CTLH, C-terminal LisH motif,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR013144:CRA domain,IPR024964:CTLH/CRA C-terminal to LisH motif domain,				SM00667:LisH,SM00668:CTLH,SM00757:CRA,	Acetylation,Alternative splicing,Complete proteome,Proteomics identification,Reference proteome,	chain:Protein RMD5 homolog B,domain:CTLH,domain:LisH,splice variant,
RTN4	reticulon 4(RTN4)	Homo sapiens				GO:0006915~apoptotic process,GO:0007413~axonal fasciculation,GO:0021801~cerebral cortex radial glia guided migration,GO:0030308~negative regulation of cell growth,GO:0030334~regulation of cell migration,GO:0030517~negative regulation of axon extension,GO:0042981~regulation of apoptotic process,GO:0050771~negative regulation of axonogenesis,GO:0051292~nuclear pore complex assembly,GO:0060317~cardiac epithelial to mesenchymal transition,GO:0071786~endoplasmic reticulum tubular network organization,GO:0071787~endoplasmic reticulum tubular network assembly,GO:0098609~cell-cell adhesion,GO:2000172~regulation of branching morphogenesis of a nerve,	GO:0005622~intracellular,GO:0005635~nuclear envelope,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0005913~cell-cell adherens junction,GO:0014069~postsynaptic density,GO:0016021~integral component of membrane,GO:0030176~integral component of endoplasmic reticulum membrane,GO:0042995~cell projection,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR003388:Reticulon,					3D-structure,Acetylation,Alternative splicing,Coiled coil,Complete proteome,Direct protein sequencing,Endoplasmic reticulum,Membrane,Neurogenesis,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Reticulon-4,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Pro,domain:Reticulon,helix,modified residue,sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
RRH	retinal pigment epithelium-derived rhodopsin homolog(RRH)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0007601~visual perception,GO:0007602~phototransduction,GO:0009584~detection of visible light,GO:0018298~protein-chromophore linkage,GO:0071482~cellular response to light stimulus,	GO:0005887~integral component of plasma membrane,	GO:0004930~G-protein coupled receptor activity,GO:0008020~G-protein coupled photoreceptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR002962:Peropsin,IPR017452:GPCR, rhodopsin-like, 7TM,IPR027430:Visual pigments (opsins) retinal binding site,				SM01381:SM01381,	Chromophore,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Photoreceptor protein,Receptor,Reference proteome,Retinal protein,Sensory transduction,Transducer,Transmembrane,Transmembrane helix,	chain:Visual pigment-like receptor peropsin,disulfide bond,glycosylation site:N-linked (GlcNAc...),modified residue,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
RTKN2	rhotekin 2(RTKN2)	Homo sapiens				GO:0007165~signal transduction,GO:0030097~hemopoiesis,			IPR001849:Pleckstrin homology domain,IPR011072:HR1 rho-binding repeat,IPR011993:Pleckstrin homology-like domain,IPR012966:Domain of unknown function DUF1709,				SM00233:PH,SM00742:Hr1,	Alternative splicing,Coiled coil,Complete proteome,Polymorphism,Proteomics identification,Reference proteome,	chain:Rhotekin-2,domain:PH,sequence variant,splice variant,
RPS6KA3	ribosomal protein S6 kinase A3(RPS6KA3)	Homo sapiens		h_gpcrPathway:Signaling Pathway from G-Protein Families,h_mapkPathway:MAPKinase Signaling Pathway,		GO:0001501~skeletal system development,GO:0002224~toll-like receptor signaling pathway,GO:0006468~protein phosphorylation,GO:0006915~apoptotic process,GO:0007049~cell cycle,GO:0007165~signal transduction,GO:0007417~central nervous system development,GO:0030307~positive regulation of cell growth,GO:0032496~response to lipopolysaccharide,GO:0035556~intracellular signal transduction,GO:0043066~negative regulation of apoptotic process,GO:0043154~negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0043555~regulation of translation in response to stress,GO:0043620~regulation of DNA-templated transcription in response to stress,GO:0045597~positive regulation of cell differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005840~ribosome,	GO:0000287~magnesium ion binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0019901~protein kinase binding,GO:0043027~cysteine-type endopeptidase inhibitor activity involved in apoptotic process,	IPR000719:Protein kinase, catalytic domain,IPR000961:AGC-kinase, C-terminal,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR016239:Ribosomal protein S6 kinase II,IPR017441:Protein kinase, ATP binding site,IPR017892:Protein kinase, C-terminal,	hsa04010:MAPK signaling pathway,hsa04114:Oocyte meiosis,hsa04150:mTOR signaling pathway,hsa04720:Long-term potentiation,hsa04722:Neurotrophin signaling pathway,hsa04914:Progesterone-mediated oocyte maturation,hsa04931:Insulin resistance,	300844~Mental retardation, X-linked 19,303600~Coffin-Lowry syndrome,	PIRSF000606:ribosomal protein S6 kinase II,	SM00133:S_TK_X,SM00220:S_TKc,	3D-structure,ATP-binding,Cell cycle,Complete proteome,Cytoplasm,Disease mutation,Kinase,Magnesium,Mental retardation,Metal-binding,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Ribonucleoprotein,Ribosomal protein,Serine/threonine-protein kinase,Stress response,Transferase,	active site:Proton acceptor,binding site:ATP,chain:Ribosomal protein S6 kinase alpha-3,domain:AGC-kinase C-terminal,domain:Protein kinase 1,domain:Protein kinase 2,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,
RNF111	ring finger protein 111(RNF111)	Homo sapiens				GO:0000209~protein polyubiquitination,GO:0007389~pattern specification process,GO:0016567~protein ubiquitination,GO:0030511~positive regulation of transforming growth factor beta receptor signaling pathway,GO:0030579~ubiquitin-dependent SMAD protein catabolic process,GO:0031398~positive regulation of protein ubiquitination,GO:0042787~protein ubiquitination involved in ubiquitin-dependent protein catabolic process,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0070911~global genome nucleotide-excision repair,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0043234~protein complex,	GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0032184~SUMO polymer binding,GO:0046332~SMAD binding,GO:0061630~ubiquitin protein ligase activity,	IPR001841:Zinc finger, RING-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,				SM00184:RING,	3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Developmental protein,Isopeptide bond,Ligase,Metal-binding,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:E3 ubiquitin-protein ligase Arkadia,compositionally biased region:His-rich,compositionally biased region:Pro-rich,compositionally biased region:Ser-rich,region of interest:Interaction with AXIN1,sequence conflict,sequence variant,splice variant,zinc finger region:RING-type; atypical,
RNF6	ring finger protein 6(RNF6)	Homo sapiens				GO:0006355~regulation of transcription, DNA-templated,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0030517~negative regulation of axon extension,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0044314~protein K27-linked ubiquitination,GO:0045893~positive regulation of transcription, DNA-templated,GO:0060765~regulation of androgen receptor signaling pathway,GO:0070936~protein K48-linked ubiquitination,GO:0085020~protein K6-linked ubiquitination,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016605~PML body,GO:0030424~axon,GO:0031965~nuclear membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0003677~DNA binding,GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0050681~androgen receptor binding,GO:0061630~ubiquitin protein ligase activity,	IPR001841:Zinc finger, RING-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,		133239~Esophageal carcinoma, somatic,		SM00184:RING,	Alternative splicing,Cell projection,Complete proteome,Cytoplasm,Ligase,Metal-binding,Nucleus,Polymorphism,Reference proteome,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:RING finger protein 6,compositionally biased region:Arg-rich,compositionally biased region:Poly-Asp,sequence variant,zinc finger region:RING-type,
ROBO2	roundabout guidance receptor 2(ROBO2)	Homo sapiens				GO:0001656~metanephros development,GO:0001657~ureteric bud development,GO:0001822~kidney development,GO:0007155~cell adhesion,GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,GO:0007411~axon guidance,GO:0007417~central nervous system development,GO:0007420~brain development,GO:0016199~axon midline choice point recognition,GO:0021510~spinal cord development,GO:0021891~olfactory bulb interneuron development,GO:0031290~retinal ganglion cell axon guidance,GO:0032870~cellular response to hormone stimulus,GO:0035385~Roundabout signaling pathway,GO:0050772~positive regulation of axonogenesis,GO:0050925~negative regulation of negative chemotaxis,GO:0051964~negative regulation of synapse assembly,GO:0061364~apoptotic process involved in luteolysis,	GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0030673~axolemma,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0008046~axon guidance receptor activity,GO:0042802~identical protein binding,	IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR003961:Fibronectin, type III,IPR007110:Immunoglobulin-like domain,IPR009138:Neural cell adhesion,IPR013098:Immunoglobulin I-set,IPR013106:Immunoglobulin V-set,IPR013783:Immunoglobulin-like fold,	hsa04360:Axon guidance,	610878~Vesicoureteral reflux 2,		SM00060:FN3,SM00406:IGv,SM00408:IGc2,SM00409:IG,	3D-structure,Alternative splicing,Chemotaxis,Chromosomal rearrangement,Complete proteome,Developmental protein,Differentiation,Disease mutation,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Neurogenesis,Phosphoprotein,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Roundabout homolog 2,disulfide bond,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Fibronectin type-III 3,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,domain:Ig-like C2-type 4,domain:Ig-like C2-type 5,glycosylation site:N-linked (GlcNAc...),helix,sequence conflict,sequence variant,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
RUNX1	runt related transcription factor 1(RUNX1)	Homo sapiens				GO:0001503~ossification,GO:0002062~chondrocyte differentiation,GO:0006366~transcription from RNA polymerase II promoter,GO:0007165~signal transduction,GO:0030097~hemopoiesis,GO:0030099~myeloid cell differentiation,GO:0030853~negative regulation of granulocyte differentiation,GO:0030854~positive regulation of granulocyte differentiation,GO:0032743~positive regulation of interleukin-2 production,GO:0045766~positive regulation of angiogenesis,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048935~peripheral nervous system neuron development,GO:0071425~hematopoietic stem cell proliferation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016021~integral component of membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0000975~regulatory region DNA binding,GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0001047~core promoter binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003714~transcription corepressor activity,GO:0004114~3',5'-cyclic-nucleotide phosphodiesterase activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008134~transcription factor binding,GO:0042803~protein homodimerization activity,GO:0046872~metal ion binding,GO:0046982~protein heterodimerization activity,	IPR000040:Acute myeloid leukemia 1 protein (AML1)/Runt,IPR002073:3'5'-cyclic nucleotide phosphodiesterase, catalytic domain,IPR002893:Zinc finger, MYND-type,IPR008967:p53-like transcription factor, DNA-binding,IPR012346:p53/RUNT-type transcription factor, DNA-binding domain,IPR013289:Eight-Twenty-One,IPR013290:Myeloid transforming gene on chromosome 8 (MTG8),IPR013524:Runt domain,IPR013711:Runx, C-terminal  domain,IPR014896:NHR2-like,IPR016554:Runt-related transcription factor RUNX,IPR027384:Runx, central domain,	hsa05200:Pathways in cancer,hsa05202:Transcriptional misregulation in cancer,hsa05220:Chronic myeloid leukemia,hsa05221:Acute myeloid leukemia,	601399~Platelet disorder, familial, with associated myeloid malignancy,601626~Leukemia, acute myeloid,	PIRSF009374:runt-related transcription factor RUNX,		3D-structure,Acetylation,Activator,Alternative splicing,Chloride,Chromosomal rearrangement,Coiled coil,Complete proteome,Disease mutation,DNA-binding,Membrane,Metal-binding,Methylation,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Proto-oncogene,Reference proteome,Repressor,Transcription,Transcription regulation,Transmembrane,Zinc,Zinc-finger,	binding site:Chloride 1,binding site:Chloride 1; via amide nitrogen,binding site:Chloride 2,binding site:Chloride 2; via amide nitrogen,chain:Runt-related transcription factor 1,compositionally biased region:Pro/Ser/Thr-rich,domain:Runt,modified residue,mutagenesis site,region of interest:Interaction with DNA,region of interest:Interaction with MYST3,region of interest:Interaction with MYST4,sequence conflict,sequence variant,site:Breakpoint for translocation to form AML1-EAP in T-MDS and CML and to form type II MACROD1-RUNX1 fusion protein,site:Breakpoint for translocation to form AML1-EMV-1 (or AML1-EAP) in CML and T- MDS, to form AML1-MTG8 (ETO) in AML-M2, to form AML1-CBFA2T3 in therapy-related myeloid malignancies, to form AML1-MECOM in CML and to form type I MACROD1-RUNX1 fusion protein,splice variant,strand,
SSBP1	single stranded DNA binding protein 1(SSBP1)	Homo sapiens				GO:0006260~DNA replication,GO:0007005~mitochondrion organization,GO:0051096~positive regulation of helicase activity,GO:0070584~mitochondrion morphogenesis,	GO:0005634~nucleus,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0042645~mitochondrial nucleoid,GO:0070062~extracellular exosome,	GO:0003682~chromatin binding,GO:0003697~single-stranded DNA binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR000424:Primosome PriB/single-strand DNA-binding,IPR011344:Single-strand DNA-binding,IPR012340:Nucleic acid-binding, OB-fold,	hsa03030:DNA replication,hsa03430:Mismatch repair,hsa03440:Homologous recombination,		PIRSF002070:single-strand binding protein,		3D-structure,Acetylation,Complete proteome,Direct protein sequencing,DNA replication,DNA-binding,Mitochondrion,Mitochondrion nucleoid,Phosphoprotein,Proteomics identification,Reference proteome,Transit peptide,	chain:Single-stranded DNA-binding protein, mitochondrial,domain:SSB,helix,modified residue,strand,transit peptide:Mitochondrion,
SCLT1	sodium channel and clathrin linker 1(SCLT1)	Homo sapiens				GO:0042384~cilium assembly,GO:0045162~clustering of voltage-gated sodium channels,GO:0060271~cilium morphogenesis,	GO:0005813~centrosome,GO:0005814~centriole,GO:0005829~cytosol,GO:0070062~extracellular exosome,GO:0071439~clathrin complex,GO:0097539~ciliary transition fiber,	GO:0008022~protein C-terminus binding,GO:0017080~sodium channel regulator activity,GO:0030276~clathrin binding,						Acetylation,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Sodium channel and clathrin linker 1,modified residue,sequence variant,splice variant,
SLC16A1	solute carrier family 16 member 1(SLC16A1)	Homo sapiens				GO:0006090~pyruvate metabolic process,GO:0006629~lipid metabolic process,GO:0015718~monocarboxylic acid transport,GO:0015728~mevalonate transport,GO:0032094~response to food,GO:0035879~plasma membrane lactate transport,GO:0042593~glucose homeostasis,GO:0050796~regulation of insulin secretion,GO:0050900~leukocyte migration,GO:0051297~centrosome organization,GO:0051780~behavioral response to nutrient,GO:0071407~cellular response to organic cyclic compound,	GO:0005739~mitochondrion,GO:0005813~centrosome,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0008028~monocarboxylic acid transmembrane transporter activity,GO:0015129~lactate transmembrane transporter activity,GO:0015130~mevalonate transmembrane transporter activity,GO:0015293~symporter activity,GO:0042803~protein homodimerization activity,GO:0097159~organic cyclic compound binding,	IPR004743:Monocarboxylate transporter,IPR011701:Major facilitator superfamily,IPR020846:Major facilitator superfamily domain,		245340~Erythrocyte lactate transporter defect,610021~Hyperinsulinemic hypoglycemia, familial, 7,616095~Monocarboxylate transporter 1 deficiency,			Alternative splicing,Cell membrane,Complete proteome,Disease mutation,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Symport,Transmembrane,Transmembrane helix,Transport,	chain:Monocarboxylate transporter 1,modified residue,sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
SLC2A5	solute carrier family 2 member 5(SLC2A5)	Homo sapiens				GO:0003044~regulation of systemic arterial blood pressure mediated by a chemical signal,GO:0005975~carbohydrate metabolic process,GO:0008643~carbohydrate transport,GO:0008645~hexose transport,GO:0009750~response to fructose,GO:0015755~fructose transport,GO:0015758~glucose transport,GO:0071332~cellular response to fructose stimulus,GO:1904659~glucose transmembrane transport,GO:1990539~fructose import across plasma membrane,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0016324~apical plasma membrane,GO:0042383~sarcolemma,GO:0070062~extracellular exosome,	GO:0005353~fructose transmembrane transporter activity,GO:0005355~glucose transmembrane transporter activity,GO:0022891~substrate-specific transmembrane transporter activity,GO:0070061~fructose binding,	IPR002442:Fructose transporter, type 5 (GLUT5),IPR003663:Sugar/inositol transporter,IPR005828:General substrate transporter,IPR005829:Sugar transporter, conserved site,IPR020846:Major facilitator superfamily domain,	hsa04973:Carbohydrate digestion and absorption,				3D-structure,Acetylation,Alternative splicing,Cell membrane,Complete proteome,Glycoprotein,Membrane,Proteomics identification,Reference proteome,Sugar transport,Transmembrane,Transmembrane helix,Transport,	chain:Solute carrier family 2, facilitated glucose transporter member 5,glycosylation site:N-linked (GlcNAc...),sequence conflict,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
SLC20A1	solute carrier family 20 member 1(SLC20A1)	Homo sapiens				GO:0006796~phosphate-containing compound metabolic process,GO:0006810~transport,GO:0006811~ion transport,GO:0006817~phosphate ion transport,GO:0007165~signal transduction,GO:0035435~phosphate ion transmembrane transport,GO:0035725~sodium ion transmembrane transport,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0044341~sodium-dependent phosphate transport,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0004871~signal transducer activity,GO:0004872~receptor activity,GO:0005315~inorganic phosphate transmembrane transporter activity,GO:0005316~high-affinity inorganic phosphate:sodium symporter activity,GO:0005436~sodium:phosphate symporter activity,GO:0015319~sodium:inorganic phosphate symporter activity,GO:0015321~sodium-dependent phosphate transmembrane transporter activity,	IPR001204:Phosphate transporter,					Complete proteome,Membrane,Phosphate transport,Phosphoprotein,Proteomics identification,Receptor,Reference proteome,Symport,Transmembrane,Transmembrane helix,Transport,	chain:Sodium-dependent phosphate transporter 1,modified residue,mutagenesis site,region of interest:A,sequence conflict,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
SLC22A4	solute carrier family 22 member 4(SLC22A4)	Homo sapiens				GO:0006641~triglyceride metabolic process,GO:0006814~sodium ion transport,GO:0007589~body fluid secretion,GO:0009437~carnitine metabolic process,GO:0015695~organic cation transport,GO:0015697~quaternary ammonium group transport,GO:0015879~carnitine transport,GO:0098655~cation transmembrane transport,GO:1902603~carnitine transmembrane transport,	GO:0005739~mitochondrion,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0016324~apical plasma membrane,	GO:0000166~nucleotide binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008513~secondary active organic cation transmembrane transporter activity,GO:0015226~carnitine transmembrane transporter activity,GO:0015293~symporter activity,GO:0015491~cation:cation antiporter activity,GO:0015651~quaternary ammonium group transmembrane transporter activity,GO:0030165~PDZ domain binding,	IPR004749:Organic cation transport protein,IPR005828:General substrate transporter,IPR005829:Sugar transporter, conserved site,IPR020846:Major facilitator superfamily domain,	hsa05231:Choline metabolism in cancer,	180300~Rheumatoid arthritis, susceptibility to,			ATP-binding,Complete proteome,Disease mutation,Glycoprotein,Ion transport,Membrane,Nucleotide-binding,Polymorphism,Reference proteome,Sodium,Sodium transport,Symport,Transmembrane,Transmembrane helix,Transport,	chain:Solute carrier family 22 member 4,glycosylation site:N-linked (GlcNAc...),nucleotide phosphate-binding region:ATP,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
SLC22A9	solute carrier family 22 member 9(SLC22A9)	Homo sapiens				GO:0009914~hormone transport,GO:0015698~inorganic anion transport,GO:0015913~short-chain fatty acid import,GO:0043252~sodium-independent organic anion transport,GO:0098656~anion transmembrane transport,	GO:0005887~integral component of plasma membrane,GO:0016323~basolateral plasma membrane,	GO:0005452~inorganic anion exchanger activity,GO:0015301~anion:anion antiporter activity,GO:0015347~sodium-independent organic anion transmembrane transporter activity,GO:0015636~short-chain fatty acid uptake transporter activity,	IPR011701:Major facilitator superfamily,IPR020846:Major facilitator superfamily domain,					Alternative splicing,Cell membrane,Complete proteome,Glycoprotein,Membrane,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:Solute carrier family 22 member 9,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
SLC44A3	solute carrier family 44 member 3(SLC44A3)	Homo sapiens				GO:0006656~phosphatidylcholine biosynthetic process,GO:0015871~choline transport,GO:0055085~transmembrane transport,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0005515~protein binding,GO:0015220~choline transmembrane transporter activity,	IPR007603:Choline transporter-like,	hsa05231:Choline metabolism in cancer,				Alternative splicing,Complete proteome,Glycoprotein,Membrane,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Choline transporter-like protein 3,compositionally biased region:Cys-rich,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,splice variant,transmembrane region,
SPECC1	sperm antigen with calponin homology and coiled-coil domains 1(SPECC1)	Homo sapiens				GO:0000226~microtubule cytoskeleton organization,GO:0030036~actin cytoskeleton organization,	GO:0005634~nucleus,GO:0005815~microtubule organizing center,GO:0016020~membrane,GO:0031941~filamentous actin,		IPR001715:Calponin homology domain,				SM00033:CH,	Alternative splicing,Chromosomal rearrangement,Coiled coil,Complete proteome,Lipoprotein,Membrane,Myristate,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Proto-oncogene,Reference proteome,	chain:Cytospin-B,compositionally biased region:Ser-rich,domain:CH,modified residue,sequence conflict,sequence variant,splice variant,
STAU2	staufen double-stranded RNA binding protein 2(STAU2)	Homo sapiens				GO:0006810~transport,	GO:0005730~nucleolus,GO:0005783~endoplasmic reticulum,GO:0005874~microtubule,GO:0016020~membrane,	GO:0003725~double-stranded RNA binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR014720:Double-stranded RNA-binding-like domain,				SM00358:DSRM,	Alternative splicing,Complete proteome,Cytoplasm,Endoplasmic reticulum,Microtubule,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,RNA-binding,Transport,	chain:Double-stranded RNA-binding protein Staufen homolog 2,domain:DRBM 1,domain:DRBM 2,domain:DRBM 3,domain:DRBM 4,modified residue,region of interest:Required for dendritic transport,sequence conflict,sequence variant,short sequence motif:Nuclear localization signal 1,short sequence motif:Nuclear localization signal 2,splice variant,
STAG2	stromal antigen 2(STAG2)	Homo sapiens			Cell division and chromosome partitioning,	GO:0007062~sister chromatid cohesion,GO:0007067~mitotic nuclear division,GO:0016925~protein sumoylation,GO:0032876~negative regulation of DNA endoreduplication,GO:0051301~cell division,GO:0051321~meiotic cell cycle,	GO:0000775~chromosome, centromeric region,GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0015629~actin cytoskeleton,GO:0016020~membrane,GO:0045111~intermediate filament cytoskeleton,	GO:0005515~protein binding,	IPR013721:STAG,IPR016024:Armadillo-type fold,IPR020839:Stromalin conservative domain,	hsa04110:Cell cycle,				3D-structure,Acetylation,Alternative splicing,Cell cycle,Cell division,Centromere,Chromosome,Chromosome partition,Coiled coil,Complete proteome,Meiosis,Mitosis,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Cohesin subunit SA-2,compositionally biased region:Poly-Ser,domain:SCD,modified residue,sequence conflict,sequence variant,
SMC6	structural maintenance of chromosomes 6(SMC6)	Homo sapiens			Cell division and chromosome partitioning,	GO:0000722~telomere maintenance via recombination,GO:0000724~double-strand break repair via homologous recombination,GO:0006974~cellular response to DNA damage stimulus,GO:0016925~protein sumoylation,GO:0051984~positive regulation of chromosome segregation,GO:0071139~resolution of recombination intermediates,GO:0090398~cellular senescence,	GO:0000781~chromosome, telomeric region,GO:0000803~sex chromosome,GO:0005622~intracellular,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0016605~PML body,GO:0016607~nuclear speck,GO:0030915~Smc5-Smc6 complex,GO:0035061~interchromatin granule,GO:0035861~site of double-strand break,	GO:0005515~protein binding,GO:0005524~ATP binding,GO:0031625~ubiquitin protein ligase binding,	IPR003395:RecF/RecN/SMC,IPR027132:Structural maintenance of chromosomes protein 6,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					Alternative splicing,ATP-binding,Chromosome,Coiled coil,Complete proteome,DNA damage,DNA recombination,DNA repair,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Telomere,Ubl conjugation,	chain:Structural maintenance of chromosomes protein 6,compositionally biased region:Ala/Asp-rich (DA-box),modified residue,nucleotide phosphate-binding region:ATP,region of interest:Flexible hinge,sequence conflict,sequence variant,splice variant,
SULF1	sulfatase 1(SULF1)	Homo sapiens				GO:0001822~kidney development,GO:0001937~negative regulation of endothelial cell proliferation,GO:0002063~chondrocyte development,GO:0003094~glomerular filtration,GO:0006915~apoptotic process,GO:0008152~metabolic process,GO:0010575~positive regulation of vascular endothelial growth factor production,GO:0014846~esophagus smooth muscle contraction,GO:0016525~negative regulation of angiogenesis,GO:0030177~positive regulation of Wnt signaling pathway,GO:0030201~heparan sulfate proteoglycan metabolic process,GO:0030336~negative regulation of cell migration,GO:0030513~positive regulation of BMP signaling pathway,GO:0032836~glomerular basement membrane development,GO:0035860~glial cell-derived neurotrophic factor receptor signaling pathway,GO:0040036~regulation of fibroblast growth factor receptor signaling pathway,GO:0040037~negative regulation of fibroblast growth factor receptor signaling pathway,GO:0048010~vascular endothelial growth factor receptor signaling pathway,GO:0048706~embryonic skeletal system development,GO:0051216~cartilage development,GO:0060348~bone development,GO:0060384~innervation,GO:0060686~negative regulation of prostatic bud formation,	GO:0005615~extracellular space,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005795~Golgi stack,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0045121~membrane raft,	GO:0003824~catalytic activity,GO:0004065~arylsulfatase activity,GO:0005509~calcium ion binding,GO:0008449~N-acetylglucosamine-6-sulfatase activity,GO:0008484~sulfuric ester hydrolase activity,	IPR000917:Sulfatase,IPR014615:Extracellular sulfatase,IPR017849:Alkaline phosphatase-like, alpha/beta/alpha,IPR017850:Alkaline-phosphatase-like, core domain,IPR024607:Sulfatase, conserved site,IPR024609:Extracellular sulfatase, C-terminal,			PIRSF036665:extracellular sulfatase,		Apoptosis,Calcium,Coiled coil,Complete proteome,Endoplasmic reticulum,Glycoprotein,Golgi apparatus,Hydrolase,Metal-binding,Proteomics identification,Reference proteome,Signal,	chain:Extracellular sulfatase Sulf-1,glycosylation site:N-linked (GlcNAc...),metal ion-binding site:Calcium,metal ion-binding site:Calcium; via 3-oxoalanine,modified residue,mutagenesis site,sequence conflict,signal peptide,
SYCP1	synaptonemal complex protein 1(SYCP1)	Homo sapiens				GO:0000711~meiotic DNA repair synthesis,GO:0007129~synapsis,GO:0007130~synaptonemal complex assembly,GO:0007131~reciprocal meiotic recombination,GO:0007283~spermatogenesis,GO:0032880~regulation of protein localization,GO:0035092~sperm chromatin condensation,GO:0051026~chiasma assembly,GO:0051301~cell division,GO:0051878~lateral element assembly,	GO:0000775~chromosome, centromeric region,GO:0000795~synaptonemal complex,GO:0000801~central element,GO:0000802~transverse filament,GO:0001673~male germ cell nucleus,	GO:0003677~DNA binding,	IPR008827:Synaptonemal complex 1,IPR024835:Synaptonemal complex protein 2/protein 2-like,					3D-structure,Cell cycle,Cell division,Centromere,Chromosome,Coiled coil,Complete proteome,DNA-binding,Isopeptide bond,Meiosis,Nucleus,Polymorphism,Proteomics identification,Reference proteome,	chain:Synaptonemal complex protein 1,compositionally biased region:Arg/Lys-rich (basic),compositionally biased region:Asp/Glu-rich (acidic),cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),modified residue,sequence conflict,sequence variant,short sequence motif:Nuclear localization signal,
SYCP2	synaptonemal complex protein 2(SYCP2)	Homo sapiens				GO:0007130~synaptonemal complex assembly,GO:0007140~male meiosis,GO:0007143~female meiotic division,GO:0009566~fertilization,GO:0043066~negative regulation of apoptotic process,GO:0048808~male genitalia morphogenesis,GO:0051301~cell division,	GO:0000795~synaptonemal complex,GO:0000800~lateral element,GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0046982~protein heterodimerization activity,	IPR024832:Synaptonemal complex protein 2,IPR024835:Synaptonemal complex protein 2/protein 2-like,					Cell cycle,Cell division,Chromosome,Complete proteome,DNA-binding,Meiosis,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Synaptonemal complex protein 2,compositionally biased region:Poly-Ser,sequence conflict,sequence variant,
TET2	tet methylcytosine dioxygenase 2(TET2)	Homo sapiens				GO:0001822~kidney development,GO:0002318~myeloid progenitor cell differentiation,GO:0006211~5-methylcytosine catabolic process,GO:0006493~protein O-linked glycosylation,GO:0007049~cell cycle,GO:0009791~post-embryonic development,GO:0014070~response to organic cyclic compound,GO:0019511~peptidyl-proline hydroxylation,GO:0019857~5-methylcytosine metabolic process,GO:0019858~cytosine metabolic process,GO:0020027~hemoglobin metabolic process,GO:0030099~myeloid cell differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048536~spleen development,GO:0061484~hematopoietic stem cell homeostasis,GO:0070989~oxidative demethylation,GO:0072576~liver morphogenesis,GO:0080111~DNA demethylation,GO:0080182~histone H3-K4 trimethylation,	GO:0005634~nucleus,	GO:0000907~sulfonate dioxygenase activity,GO:0003677~DNA binding,GO:0005515~protein binding,GO:0008198~ferrous iron binding,GO:0008270~zinc ion binding,GO:0018602~2,4-dichlorophenoxyacetate alpha-ketoglutarate dioxygenase activity,GO:0019798~procollagen-proline dioxygenase activity,GO:0034792~hypophosphite dioxygenase activity,GO:0043734~DNA-N1-methyladenine dioxygenase activity,GO:0052634~C-19 gibberellin 2-beta-dioxygenase activity,GO:0052635~C-20 gibberellin 2-beta-dioxygenase activity,GO:0070579~methylcytosine dioxygenase activity,	IPR024779:2OGFeDO domain, nucleic acid-modifying type,		614286~Myelodysplastic syndrome, somatic,		SM01333:SM01333,	3D-structure,Alternative splicing,Cell cycle,Chromatin regulator,Complete proteome,Dioxygenase,DNA-binding,Glycoprotein,Iron,Metal-binding,Methylation,Oxidoreductase,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Tumor suppressor,Zinc,	binding site:2-oxoglutarate,chain:Probable methylcytosine dioxygenase TET2,compositionally biased region:Gln-rich,compositionally biased region:Pro-rich,metal ion-binding site:Iron; catalytic,modified residue,sequence conflict,sequence variant,splice variant,
TRIP12	thyroid hormone receptor interactor 12(TRIP12)	Homo sapiens				GO:0000209~protein polyubiquitination,GO:0006281~DNA repair,GO:0006974~cellular response to DNA damage stimulus,GO:0009790~embryo development,GO:0042787~protein ubiquitination involved in ubiquitin-dependent protein catabolic process,GO:1901315~negative regulation of histone H2A K63-linked ubiquitination,GO:2000780~negative regulation of double-strand break repair,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0016874~ligase activity,GO:0046966~thyroid hormone receptor binding,	IPR000569:HECT,IPR004170:WWE domain,IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,	hsa04120:Ubiquitin mediated proteolysis,			SM00119:HECTc,	Acetylation,Alternative splicing,Complete proteome,DNA damage,DNA repair,Nucleus,Phosphoprotein,Proteomics identification,Receptor,Reference proteome,Transferase,Ubl conjugation pathway,	active site:Glycyl thioester intermediate,chain:Probable E3 ubiquitin-protein ligase TRIP12,domain:HECT,domain:WWE,modified residue,region of interest:K-box,sequence conflict,
TCEB3	transcription elongation factor B subunit 3(TCEB3)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0006368~transcription elongation from RNA polymerase II promoter,	GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0016021~integral component of membrane,GO:0070449~elongin complex,	GO:0003677~DNA binding,GO:0003746~translation elongation factor activity,GO:0005515~protein binding,	IPR001810:F-box domain, cyclin-like,IPR003617:Transcription elongation factor, TFIIS/CRSP70, N-terminal, sub-type,IPR010684:RNA polymerase II transcription factor SIII, subunit A,IPR017923:Transcription factor IIS, N-terminal,				SM00509:TFS2N,	3D-structure,Acetylation,Complete proteome,Elongation factor,Nucleus,Phosphoprotein,Polymorphism,Protein biosynthesis,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:Transcription elongation factor B polypeptide 3,domain:F-box,domain:TFIIS N-terminal,modified residue,region of interest:Activation domain,region of interest:Interacting with Elongin BC complex,sequence variant,
TCF7L2	transcription factor 7 like 2(TCF7L2)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001568~blood vessel development,GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007050~cell cycle arrest,GO:0007223~Wnt signaling pathway, calcium modulating pathway,GO:0008283~cell proliferation,GO:0009749~response to glucose,GO:0010909~positive regulation of heparan sulfate proteoglycan biosynthetic process,GO:0016055~Wnt signaling pathway,GO:0031016~pancreas development,GO:0032024~positive regulation of insulin secretion,GO:0032092~positive regulation of protein binding,GO:0032350~regulation of hormone metabolic process,GO:0042593~glucose homeostasis,GO:0043433~negative regulation of sequence-specific DNA binding transcription factor activity,GO:0043570~maintenance of DNA repeat elements,GO:0044334~canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition,GO:0045444~fat cell differentiation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046827~positive regulation of protein export from nucleus,GO:0048625~myoblast fate commitment,GO:0048660~regulation of smooth muscle cell proliferation,GO:0051897~positive regulation of protein kinase B signaling,GO:0060070~canonical Wnt signaling pathway,GO:0090090~negative regulation of canonical Wnt signaling pathway,GO:1904837~beta-catenin-TCF complex assembly,GO:2000675~negative regulation of type B pancreatic cell apoptotic process,GO:2001237~negative regulation of extrinsic apoptotic signaling pathway,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016605~PML body,GO:0032993~protein-DNA complex,GO:0070369~beta-catenin-TCF7L2 complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001103~RNA polymerase II repressing transcription factor binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0008013~beta-catenin binding,GO:0008134~transcription factor binding,GO:0019901~protein kinase binding,GO:0035257~nuclear hormone receptor binding,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,GO:0045295~gamma-catenin binding,GO:0070016~armadillo repeat domain binding,	IPR009071:High mobility group (HMG) box domain,IPR013558:CTNNB1 binding, N-teminal,IPR024940:Transcription factor TCF/LEF,IPR027397:Catenin binding domain,	hsa04310:Wnt signaling pathway,hsa04390:Hippo signaling pathway,hsa04520:Adherens junction,hsa04916:Melanogenesis,hsa05200:Pathways in cancer,hsa05210:Colorectal cancer,hsa05213:Endometrial cancer,hsa05215:Prostate cancer,hsa05216:Thyroid cancer,hsa05217:Basal cell carcinoma,hsa05221:Acute myeloid leukemia,hsa05412:Arrhythmogenic right ventricular cardiomyopathy (ARVC),	125853~Diabetes mellitus, type 2, susceptibility to,		SM00398:HMG,	3D-structure,Activator,Alternative splicing,Complete proteome,Diabetes mellitus,DNA-binding,Isopeptide bond,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,Ubl conjugation,Wnt signaling pathway,	chain:Transcription factor 7-like 2,compositionally biased region:Pro-rich,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),DNA-binding region:HMG box,helix,mutagenesis site,region of interest:CTNNB1-binding,region of interest:Promoter-specific activation domain,sequence conflict,sequence variant,short sequence motif:Nuclear localization signal,splice variant,
TFE3	transcription factor binding to IGHM enhancer 3(TFE3)	Homo sapiens				GO:0002250~adaptive immune response,GO:0006351~transcription, DNA-templated,GO:0006959~humoral immune response,GO:0045670~regulation of osteoclast differentiation,GO:0045785~positive regulation of cell adhesion,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,GO:0046983~protein dimerization activity,	IPR011598:Myc-type, basic helix-loop-helix (bHLH) domain,IPR021802:Basic helix-loop-helix leucine zipper transcrition factor MiT/TFE,IPR024100:Transcription factor E3,	hsa05202:Transcriptional misregulation in cancer,	300854~Renal cell carcinoma, papillary, 1,		SM00353:HLH,	Activator,Adaptive immunity,Alternative splicing,Chromosomal rearrangement,Coiled coil,Complete proteome,DNA-binding,Immunity,Methylation,Nucleus,Phosphoprotein,Polymorphism,Proto-oncogene,Reference proteome,Transcription,Transcription regulation,Ubl conjugation,	chain:Transcription factor E3,DNA-binding region:Basic motif,domain:Helix-loop-helix motif,domain:Leucine-zipper,modified residue,region of interest:Strong transcription activation domain,sequence conflict,sequence variant,site:Breakpoint for translocation to form ASPSCR1-TFE3 oncogene,site:Breakpoint for translocation to form NONO-TFE3, PSF-TFE3 and ASPSCR1-TFE3 oncogenes,site:Breakpoint for translocation to form PRCC-TFE3 oncogene,
TGFBR2	transforming growth factor beta receptor 2(TGFBR2)	Homo sapiens		h_alkPathway:ALK in cardiac myocytes,h_ctcfPathway:CTCF: First Multivalent Nuclear Factor,h_nthiPathway:NFkB activation by Nontypeable Hemophilus influenzae,h_tgfbPathway:TGF beta signaling pathway,h_tob1Pathway:Role of Tob in T-cell activation,		GO:0001568~blood vessel development,GO:0001569~patterning of blood vessels,GO:0001570~vasculogenesis,GO:0001666~response to hypoxia,GO:0001701~in utero embryonic development,GO:0001947~heart looping,GO:0002053~positive regulation of mesenchymal cell proliferation,GO:0002088~lens development in camera-type eye,GO:0002651~positive regulation of tolerance induction to self antigen,GO:0002663~positive regulation of B cell tolerance induction,GO:0002666~positive regulation of T cell tolerance induction,GO:0003148~outflow tract septum morphogenesis,GO:0003149~membranous septum morphogenesis,GO:0003151~outflow tract morphogenesis,GO:0003181~atrioventricular valve morphogenesis,GO:0003186~tricuspid valve morphogenesis,GO:0003214~cardiac left ventricle morphogenesis,GO:0003274~endocardial cushion fusion,GO:0003430~growth plate cartilage chondrocyte growth,GO:0006468~protein phosphorylation,GO:0006898~receptor-mediated endocytosis,GO:0006915~apoptotic process,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0007182~common-partner SMAD protein phosphorylation,GO:0007219~Notch signaling pathway,GO:0007224~smoothened signaling pathway,GO:0007369~gastrulation,GO:0007420~brain development,GO:0007507~heart development,GO:0007566~embryo implantation,GO:0007568~aging,GO:0007584~response to nutrient,GO:0008284~positive regulation of cell proliferation,GO:0009612~response to mechanical stimulus,GO:0009749~response to glucose,GO:0010468~regulation of gene expression,GO:0010634~positive regulation of epithelial cell migration,GO:0010718~positive regulation of epithelial to mesenchymal transition,GO:0018105~peptidyl-serine phosphorylation,GO:0018107~peptidyl-threonine phosphorylation,GO:0023014~signal transduction by protein phosphorylation,GO:0030154~cell differentiation,GO:0030512~negative regulation of transforming growth factor beta receptor signaling pathway,GO:0031100~organ regeneration,GO:0032147~activation of protein kinase activity,GO:0035162~embryonic hemopoiesis,GO:0040008~regulation of growth,GO:0042060~wound healing,GO:0042127~regulation of cell proliferation,GO:0042493~response to drug,GO:0043011~myeloid dendritic cell differentiation,GO:0043415~positive regulation of skeletal muscle tissue regeneration,GO:0043627~response to estrogen,GO:0045766~positive regulation of angiogenesis,GO:0048545~response to steroid hormone,GO:0048565~digestive tract development,GO:0048661~positive regulation of smooth muscle cell proliferation,GO:0048701~embryonic cranial skeleton morphogenesis,GO:0051138~positive regulation of NK T cell differentiation,GO:0060021~palate development,GO:0060044~negative regulation of cardiac muscle cell proliferation,GO:0060389~pathway-restricted SMAD protein phosphorylation,GO:0060412~ventricular septum morphogenesis,GO:0060434~bronchus morphogenesis,GO:0060440~trachea formation,GO:0060443~mammary gland morphogenesis,GO:0060463~lung lobe morphogenesis,GO:0070723~response to cholesterol,GO:1905007~positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,GO:1990086~lens fiber cell apoptotic process,GO:2000379~positive regulation of reactive oxygen species metabolic process,	GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005901~caveola,GO:0009897~external side of plasma membrane,GO:0016021~integral component of membrane,GO:0043235~receptor complex,GO:0045121~membrane raft,GO:0070022~transforming growth factor beta receptor homodimeric complex,	GO:0004675~transmembrane receptor protein serine/threonine kinase activity,GO:0004702~receptor signaling protein serine/threonine kinase activity,GO:0005024~transforming growth factor beta-activated receptor activity,GO:0005026~transforming growth factor beta receptor activity, type II,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0005539~glycosaminoglycan binding,GO:0031435~mitogen-activated protein kinase kinase kinase binding,GO:0034713~type I transforming growth factor beta receptor binding,GO:0034714~type III transforming growth factor beta receptor binding,GO:0046332~SMAD binding,GO:0046872~metal ion binding,GO:0050431~transforming growth factor beta binding,	IPR000333:Activin type II/Transforming growth factor-beta II receptor,IPR000719:Protein kinase, catalytic domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR015013:Transforming growth factor beta receptor 2 ectodomain,IPR017194:Transforming growth factor-beta receptor, type II,IPR017441:Protein kinase, ATP binding site,	hsa04010:MAPK signaling pathway,hsa04060:Cytokine-cytokine receptor interaction,hsa04068:FoxO signaling pathway,hsa04144:Endocytosis,hsa04350:TGF-beta signaling pathway,hsa04380:Osteoclast differentiation,hsa04390:Hippo signaling pathway,hsa04520:Adherens junction,hsa05142:Chagas disease (American trypanosomiasis),hsa05166:HTLV-I infection,hsa05200:Pathways in cancer,hsa05202:Transcriptional misregulation in cancer,hsa05210:Colorectal cancer,hsa05212:Pancreatic cancer,hsa05220:Chronic myeloid leukemia,	133239~Esophageal cancer, somatic,610168~Loeys-Dietz syndrome 2,614331~Colorectal cancer, hereditary nonpolyposis, type 6,	PIRSF037393:transforming growth factor-beta receptor, type II,	SM00220:S_TKc,	3D-structure,Alternative splicing,Aortic aneurysm,Apoptosis,ATP-binding,Cell membrane,Complete proteome,Differentiation,Direct protein sequencing,Disease mutation,Disulfide bond,Glycoprotein,Growth regulation,Hereditary nonpolyposis colorectal cancer,Kinase,Magnesium,Manganese,Membrane,Metal-binding,Nucleotide-binding,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Serine/threonine-protein kinase,Signal,Transferase,Transmembrane,Transmembrane helix,	active site:Proton acceptor,binding site:ATP,chain:TGF-beta receptor type-2,disulfide bond,domain:Protein kinase,glycosylation site:N-linked (GlcNAc...),helix,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
TMBIM4	transmembrane BAX inhibitor motif containing 4(TMBIM4)	Homo sapiens				GO:0006915~apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0050848~regulation of calcium-mediated signaling,	GO:0000139~Golgi membrane,GO:0005795~Golgi stack,GO:0016021~integral component of membrane,	GO:0005515~protein binding,	IPR006214:Bax inhibitor 1-related,					Apoptosis,Complete proteome,Golgi apparatus,Membrane,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,	chain:Transmembrane BAX inhibitor motif- containing protein 4,sequence variant,transmembrane region,
TNRC6B	trinucleotide repeat containing 6B(TNRC6B)	Homo sapiens				GO:0007223~Wnt signaling pathway, calcium modulating pathway,GO:0031047~gene silencing by RNA,GO:0035194~posttranscriptional gene silencing by RNA,GO:0035278~miRNA mediated inhibition of translation,GO:0048015~phosphatidylinositol-mediated signaling,GO:0060213~positive regulation of nuclear-transcribed mRNA poly(A) tail shortening,GO:1900153~positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,	GO:0000932~cytoplasmic mRNA processing body,GO:0005829~cytosol,	GO:0000166~nucleotide binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR012677:Nucleotide-binding, alpha-beta plait,IPR019486:Argonaute hook domain,					Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,RNA-binding,RNA-mediated gene silencing,Translation regulation,	chain:Trinucleotide repeat-containing gene 6B protein,compositionally biased region:Gln-rich,compositionally biased region:Pro-rich,domain:RRM,modified residue,sequence conflict,sequence variant,splice variant,
TRIM17	tripartite motif containing 17(TRIM17)	Homo sapiens				GO:0006914~autophagy,GO:0032880~regulation of protein localization,GO:0051865~protein autoubiquitination,	GO:0005622~intracellular,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0030674~protein binding, bridging,GO:0046872~metal ion binding,	IPR000315:Zinc finger, B-box,IPR001841:Zinc finger, RING-type,IPR001870:B30.2/SPRY domain,IPR003877:SPla/RYanodine receptor SPRY,IPR003879:Butyrophylin-like,IPR006574:SPRY-associated,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,IPR017907:Zinc finger, RING-type, conserved site,IPR027370:RING-type zinc-finger, LisH dimerisation motif,				SM00184:RING,SM00336:BBOX,SM00449:SPRY,SM00589:PRY,	Alternative splicing,Coiled coil,Complete proteome,Ligase,Metal-binding,Proteomics identification,Reference proteome,Ubl conjugation,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:E3 ubiquitin-protein ligase TRIM17,domain:B30.2/SPRY,zinc finger region:B box-type,zinc finger region:RING-type,
TSC2	tuberous sclerosis 2(TSC2)	Homo sapiens		h_mtorPathway:mTOR Signaling Pathway,h_vdrPathway:Control of Gene Expression by Vitamin D Receptor,		GO:0001843~neural tube closure,GO:0006469~negative regulation of protein kinase activity,GO:0006606~protein import into nucleus,GO:0006897~endocytosis,GO:0007050~cell cycle arrest,GO:0007507~heart development,GO:0008104~protein localization,GO:0008285~negative regulation of cell proliferation,GO:0014067~negative regulation of phosphatidylinositol 3-kinase signaling,GO:0016032~viral process,GO:0016192~vesicle-mediated transport,GO:0030100~regulation of endocytosis,GO:0030178~negative regulation of Wnt signaling pathway,GO:0032007~negative regulation of TOR signaling,GO:0043491~protein kinase B signaling,GO:0043547~positive regulation of GTPase activity,GO:0046626~regulation of insulin receptor signaling pathway,GO:0046627~negative regulation of insulin receptor signaling pathway,GO:0048009~insulin-like growth factor receptor signaling pathway,GO:0050918~positive chemotaxis,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0051726~regulation of cell cycle,GO:0051898~negative regulation of protein kinase B signaling,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005764~lysosome,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0016020~membrane,GO:0033596~TSC1-TSC2 complex,GO:0048471~perinuclear region of cytoplasm,	GO:0005096~GTPase activator activity,GO:0005515~protein binding,GO:0019902~phosphatase binding,GO:0031267~small GTPase binding,GO:0042803~protein homodimerization activity,	IPR000331:Rap GTPase activating proteins domain,IPR003913:Tuberin,IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,IPR018515:Tuberin-type domain,IPR024584:Tuberin, N-terminal,	hsa04115:p53 signaling pathway,hsa04150:mTOR signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04152:AMPK signaling pathway,hsa04910:Insulin signaling pathway,hsa04919:Thyroid hormone signaling pathway,hsa05231:Choline metabolism in cancer,	606690~Lymphangioleiomyomatosis, somatic,613254~Tuberous sclerosis-2,			Alternative splicing,Complete proteome,Cytoplasm,Disease mutation,GTPase activation,Host-virus interaction,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Tumor suppressor,Ubl conjugation,	chain:Tuberin,domain:Rap-GAP,modified residue,mutagenesis site,region of interest:Required for interaction with TSC1,sequence conflict,sequence variant,splice variant,
TP53	tumor protein p53(TP53)	Homo sapiens	1.RBphosphoE2F,152.altered_synaptic_signalling-neurodegenerative_disorders,157.14-3-3_Cell_Cycle,38.Cell_cycle_arrest_and_apoptosis_ceramide,94.E2F_transcriptional_activity_cell_cycle,99.NF-kB_activation,	h_arfPathway:Tumor Suppressor Arf Inhibits Ribosomal Biogenesis,h_atmPathway:ATM Signaling Pathway,h_atrbrcaPathway:Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility,h_btg2Pathway:BTG family proteins and cell cycle regulation,h_chemicalPathway:Apoptotic Signaling in Response to DNA Damage,h_ctcfPathway:CTCF: First Multivalent Nuclear Factor,h_EfpPathway:Estrogen-responsive protein Efp controls cell cycle and breast tumors growth,h_g1Pathway:Cell Cycle: G1/S Check Point ,h_g2Pathway:Cell Cycle: G2/M Checkpoint,h_p53hypoxiaPathway:Hypoxia and p53 in the Cardiovascular system,h_p53Pathway:p53 Signaling Pathway,h_plk3Pathway:Regulation of cell cycle progression by Plk3,h_pmlPathway:Regulation of transcriptional activity by PML,h_rbPathway:RB Tumor Suppressor/Checkpoint Signaling in response to DNA damage,h_rnaPathway:Double Stranded RNA Induced Gene Expression,h_telPathway:Telomeres, Telomerase, Cellular Aging, and  Immortality,h_tertPathway:Overview of telomerase protein component gene hTert Transcriptional Regulation ,h_tidPathway:Chaperones modulate interferon Signaling Pathway,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000733~DNA strand renaturation,GO:0006284~base-excision repair,GO:0006289~nucleotide-excision repair,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0006461~protein complex assembly,GO:0006915~apoptotic process,GO:0006974~cellular response to DNA damage stimulus,GO:0006977~DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,GO:0006978~DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,GO:0006983~ER overload response,GO:0007049~cell cycle,GO:0007050~cell cycle arrest,GO:0007265~Ras protein signal transduction,GO:0007275~multicellular organism development,GO:0007569~cell aging,GO:0008104~protein localization,GO:0008283~cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0008340~determination of adult lifespan,GO:0010165~response to X-ray,GO:0010332~response to gamma radiation,GO:0010628~positive regulation of gene expression,GO:0016032~viral process,GO:0016925~protein sumoylation,GO:0030154~cell differentiation,GO:0030308~negative regulation of cell growth,GO:0030330~DNA damage response, signal transduction by p53 class mediator,GO:0031065~positive regulation of histone deacetylation,GO:0031497~chromatin assembly,GO:0031571~mitotic G1 DNA damage checkpoint,GO:0032461~positive regulation of protein oligomerization,GO:0034613~cellular protein localization,GO:0034644~cellular response to UV,GO:0035690~cellular response to drug,GO:0042149~cellular response to glucose starvation,GO:0042771~intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,GO:0042981~regulation of apoptotic process,GO:0043065~positive regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0043153~entrainment of circadian clock by photoperiod,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0043525~positive regulation of neuron apoptotic process,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046677~response to antibiotic,GO:0046827~positive regulation of protein export from nucleus,GO:0046902~regulation of mitochondrial membrane permeability,GO:0048147~negative regulation of fibroblast proliferation,GO:0048512~circadian behavior,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0051097~negative regulation of helicase activity,GO:0051262~protein tetramerization,GO:0051974~negative regulation of telomerase activity,GO:0070245~positive regulation of thymocyte apoptotic process,GO:0071158~positive regulation of cell cycle arrest,GO:0071456~cellular response to hypoxia,GO:0071479~cellular response to ionizing radiation,GO:0072332~intrinsic apoptotic signaling pathway by p53 class mediator,GO:0090200~positive regulation of release of cytochrome c from mitochondria,GO:0090399~replicative senescence,GO:0090403~oxidative stress-induced premature senescence,GO:0097193~intrinsic apoptotic signaling pathway,GO:0097252~oligodendrocyte apoptotic process,GO:1900119~positive regulation of execution phase of apoptosis,GO:1900740~positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,GO:1901796~regulation of signal transduction by p53 class mediator,GO:1902749~regulation of cell cycle G2/M phase transition,GO:1990440~positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,GO:2000379~positive regulation of reactive oxygen species metabolic process,GO:2001244~positive regulation of intrinsic apoptotic signaling pathway,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005657~replication fork,GO:0005669~transcription factor TFIID complex,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0005783~endoplasmic reticulum,GO:0005829~cytosol,GO:0016021~integral component of membrane,GO:0016363~nuclear matrix,GO:0016604~nuclear body,GO:0016605~PML body,GO:0043234~protein complex,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001046~core promoter sequence-specific DNA binding,GO:0001085~RNA polymerase II transcription factor binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0002020~protease binding,GO:0002039~p53 binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003684~damaged DNA binding,GO:0003690~double-stranded DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005507~copper ion binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008134~transcription factor binding,GO:0008270~zinc ion binding,GO:0019899~enzyme binding,GO:0019901~protein kinase binding,GO:0019903~protein phosphatase binding,GO:0030971~receptor tyrosine kinase binding,GO:0031625~ubiquitin protein ligase binding,GO:0035035~histone acetyltransferase binding,GO:0042802~identical protein binding,GO:0043565~sequence-specific DNA binding,GO:0043621~protein self-association,GO:0044212~transcription regulatory region DNA binding,GO:0046872~metal ion binding,GO:0046982~protein heterodimerization activity,GO:0047485~protein N-terminus binding,GO:0051087~chaperone binding,GO:0051721~protein phosphatase 2A binding,	IPR002117:p53 tumour suppressor family,IPR008967:p53-like transcription factor, DNA-binding,IPR010991:p53, tetramerisation domain,IPR011615:p53, DNA-binding domain,IPR012346:p53/RUNT-type transcription factor, DNA-binding domain,IPR013872:p53 transactivation domain,IPR015155:PLAA family ubiquitin binding, PFU,	hsa04010:MAPK signaling pathway,hsa04071:Sphingolipid signaling pathway,hsa04110:Cell cycle,hsa04115:p53 signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04210:Apoptosis,hsa04310:Wnt signaling pathway,hsa04722:Neurotrophin signaling pathway,hsa04919:Thyroid hormone signaling pathway,hsa05014:Amyotrophic lateral sclerosis (ALS),hsa05016:Huntington's disease,hsa05160:Hepatitis C,hsa05161:Hepatitis B,hsa05162:Measles,hsa05166:HTLV-I infection,hsa05168:Herpes simplex infection,hsa05169:Epstein-Barr virus infection,hsa05200:Pathways in cancer,hsa05202:Transcriptional misregulation in cancer,hsa05203:Viral carcinogenesis,hsa05205:Proteoglycans in cancer,hsa05206:MicroRNAs in cancer,hsa05210:Colorectal cancer,hsa05212:Pancreatic cancer,hsa05213:Endometrial cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05216:Thyroid cancer,hsa05217:Basal cell carcinoma,hsa05218:Melanoma,hsa05219:Bladder cancer,hsa05220:Chronic myeloid leukemia,hsa05222:Small cell lung cancer,hsa05223:Non-small cell lung cancer,hsa05230:Central carbon metabolism in cancer,	114480~Breast cancer,114500~Colorectal cancer,114550~Hepatocellular carcinoma,137800~Glioma susceptibility 1,151623~Li-Fraumeni syndrome,202300~Adrenal cortical carcinoma,259500~Osteosarcoma,260350~Pancreatic cancer,260500~Choroid plexus papilloma,607107~Nasopharyngeal carcinoma,614740~Basal cell carcinoma 7,			3D-structure,Acetylation,Activator,Alternative promoter usage,Alternative splicing,Apoptosis,Biological rhythms,Cell cycle,Complete proteome,Cytoplasm,Disease mutation,DNA-binding,Endoplasmic reticulum,Glycoprotein,Host-virus interaction,Isopeptide bond,Li-Fraumeni syndrome,Membrane,Metal-binding,Methylation,Mitochondrion,Necrosis,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repressor,somatic,Transcription,Transcription regulation,Transmembrane,Transmembrane helix,Tumor suppressor,Ubl conjugation,Zinc,ZincFT   VARIANT     247    248       NR -> KW (in sporadic cancers,	chain:Cellular tumor antigen p53,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),helix,metal ion-binding site:Zinc,modified residue,mutagenesis site,region of interest:Basic (repression of DNA-binding),region of interest:Interaction with AXIN1,region of interest:Interaction with CARM1,region of interest:Interaction with E4F1,region of interest:Interaction with HIPK1,region of interest:Interaction with HIPK2,region of interest:Interaction with HRMT1L2,region of interest:Interaction with USP7,region of interest:Interaction with WWOX,region of interest:Interacts with the 53BP2 SH3 domain,region of interest:Oligomerization,region of interest:Required for interaction with FBXO42,region of interest:Transcription activation (acidic),sequence variant,short sequence motif:[KR]-[STA]-K motif,short sequence motif:Bipartite nuclear localization signal,short sequence motif:Nuclear export signal,splice variant,strand,turn,
USP28	ubiquitin specific peptidase 28(USP28)	Homo sapiens				GO:0000077~DNA damage checkpoint,GO:0006281~DNA repair,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0006974~cellular response to DNA damage stimulus,GO:0007265~Ras protein signal transduction,GO:0008283~cell proliferation,GO:0010212~response to ionizing radiation,GO:0016579~protein deubiquitination,GO:0031647~regulation of protein stability,GO:0034644~cellular response to UV,GO:0042771~intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0043234~protein complex,	GO:0004843~thiol-dependent ubiquitin-specific protease activity,GO:0005515~protein binding,GO:0036459~thiol-dependent ubiquitinyl hydrolase activity,	IPR001394:Peptidase C19, ubiquitin carboxyl-terminal hydrolase 2,IPR009060:UBA-like,IPR018200:Peptidase C19, ubiquitin carboxyl-terminal hydrolase 2, conserved site,					3D-structure,Alternative splicing,Coiled coil,Complete proteome,DNA damage,DNA repair,Hydrolase,Nucleus,Phosphoprotein,Protease,Proteomics identification,Reference proteome,Thiol protease,Ubl conjugation pathway,	chain:Ubiquitin carboxyl-terminal hydrolase 28,modified residue,repeat:UIM,sequence conflict,splice variant,
USP35	ubiquitin specific peptidase 35(USP35)	Homo sapiens				GO:0006511~ubiquitin-dependent protein catabolic process,GO:0016579~protein deubiquitination,		GO:0004843~thiol-dependent ubiquitin-specific protease activity,GO:0036459~thiol-dependent ubiquitinyl hydrolase activity,	IPR001394:Peptidase C19, ubiquitin carboxyl-terminal hydrolase 2,IPR016024:Armadillo-type fold,IPR018200:Peptidase C19, ubiquitin carboxyl-terminal hydrolase 2, conserved site,					Alternative splicing,Coiled coil,Complete proteome,Hydrolase,Phosphoprotein,Polymorphism,Protease,Proteomics identification,Reference proteome,Thiol protease,Ubl conjugation pathway,	chain:Ubiquitin carboxyl-terminal hydrolase 35,modified residue,sequence variant,
USP43	ubiquitin specific peptidase 43(USP43)	Homo sapiens				GO:0006511~ubiquitin-dependent protein catabolic process,GO:0016579~protein deubiquitination,GO:0019985~translesion synthesis,	GO:0005654~nucleoplasm,	GO:0019785~ISG15-specific protease activity,GO:0036459~thiol-dependent ubiquitinyl hydrolase activity,	IPR001394:Peptidase C19, ubiquitin carboxyl-terminal hydrolase 2,IPR018200:Peptidase C19, ubiquitin carboxyl-terminal hydrolase 2, conserved site,					Alternative splicing,Complete proteome,Hydrolase,Methylation,Phosphoprotein,Protease,Proteomics identification,Reference proteome,Thiol protease,Ubl conjugation pathway,	chain:Ubiquitin carboxyl-terminal hydrolase 43,modified residue,sequence conflict,splice variant,
USP9X	ubiquitin specific peptidase 9, X-linked(USP9X)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001764~neuron migration,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0007059~chromosome segregation,GO:0007067~mitotic nuclear division,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0007292~female gamete generation,GO:0016579~protein deubiquitination,GO:0030509~BMP signaling pathway,GO:0044267~cellular protein metabolic process,GO:0048675~axon extension,GO:0051301~cell division,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016020~membrane,GO:0030426~growth cone,	GO:0004197~cysteine-type endopeptidase activity,GO:0004843~thiol-dependent ubiquitin-specific protease activity,GO:0005515~protein binding,GO:0008234~cysteine-type peptidase activity,GO:0036459~thiol-dependent ubiquitinyl hydrolase activity,GO:0070410~co-SMAD binding,	IPR001394:Peptidase C19, ubiquitin carboxyl-terminal hydrolase 2,IPR016024:Armadillo-type fold,IPR018200:Peptidase C19, ubiquitin carboxyl-terminal hydrolase 2, conserved site,		300919~Mental retardation, X-linked 99,			Alternative splicing,Cell cycle,Cell division,Cell projection,Chromosome partition,Complete proteome,Cytoplasm,Disease mutation,Hydrolase,Mental retardation,Mitosis,Phosphoprotein,Protease,Reference proteome,Thiol protease,Ubl conjugation pathway,	chain:Probable ubiquitin carboxyl-terminal hydrolase FAF-X,modified residue,sequence conflict,splice variant,
XYLT2	xylosyltransferase 2(XYLT2)	Homo sapiens				GO:0006024~glycosaminoglycan biosynthetic process,GO:0015012~heparan sulfate proteoglycan biosynthetic process,GO:0030206~chondroitin sulfate biosynthetic process,GO:0030210~heparin biosynthetic process,GO:0050650~chondroitin sulfate proteoglycan biosynthetic process,	GO:0000139~Golgi membrane,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0008375~acetylglucosaminyltransferase activity,GO:0030158~protein xylosyltransferase activity,	IPR003406:Glycosyl transferase, family 14,IPR024448:Xylosyltransferase,	hsa00532:Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate,hsa00534:Glycosaminoglycan biosynthesis - heparan sulfate / heparin,hsa01100:Metabolic pathways,	264800~Pseudoxanthoma elasticum, modifier of severity of,605822~Spondyloocular syndrome,			Alternative splicing,Complete proteome,Disease mutation,Disulfide bond,Endoplasmic reticulum,Glycoprotein,Glycosyltransferase,Golgi apparatus,Membrane,Polymorphism,Proteomics identification,Reference proteome,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,	chain:Xylosyltransferase 2,glycosylation site:N-linked (GlcNAc...),sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
ZNRF3	zinc and ring finger 3(ZNRF3)	Homo sapiens				GO:0006511~ubiquitin-dependent protein catabolic process,GO:0016567~protein ubiquitination,GO:0030178~negative regulation of Wnt signaling pathway,GO:0038018~Wnt receptor catabolic process,GO:0060070~canonical Wnt signaling pathway,GO:0060071~Wnt signaling pathway, planar cell polarity pathway,GO:0072089~stem cell proliferation,GO:0090090~negative regulation of canonical Wnt signaling pathway,GO:2000051~negative regulation of non-canonical Wnt signaling pathway,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0004842~ubiquitin-protein transferase activity,GO:0005109~frizzled binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0061630~ubiquitin protein ligase activity,	IPR001841:Zinc finger, RING-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,				SM00184:RING,	Alternative splicing,Cell membrane,Complete proteome,Ligase,Membrane,Metal-binding,Reference proteome,Signal,Transmembrane,Transmembrane helix,Ubl conjugation pathway,Wnt signaling pathway,Zinc,Zinc-finger,	chain:Zinc/RING finger protein 3,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,zinc finger region:RING-type; atypical,
ZC3H11A	zinc finger CCCH-type containing 11A(ZC3H11A)	Homo sapiens				GO:0006369~termination of RNA polymerase II transcription,GO:0006405~RNA export from nucleus,GO:0006406~mRNA export from nucleus,GO:0016973~poly(A)+ mRNA export from nucleus,GO:0031124~mRNA 3'-end processing,	GO:0000346~transcription export complex,GO:0005654~nucleoplasm,	GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR000571:Zinc finger, CCCH-type,				SM00356:ZnF_C3H1,	Acetylation,Coiled coil,Complete proteome,Isopeptide bond,Metal-binding,mRNA transport,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transport,Ubl conjugation,Zinc,Zinc-finger,	chain:Zinc finger CCCH domain-containing protein 11A,compositionally biased region:Poly-Asp,modified residue,sequence conflict,sequence variant,zinc finger region:C3H1-type 1,zinc finger region:C3H1-type 2,zinc finger region:C3H1-type 3,
ZC3H13	zinc finger CCCH-type containing 13(ZC3H13)	Homo sapiens					GO:0005654~nucleoplasm,GO:0016021~integral component of membrane,GO:0016607~nuclear speck,	GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR000571:Zinc finger, CCCH-type,				SM00356:ZnF_C3H1,	Alternative splicing,Coiled coil,Complete proteome,Isopeptide bond,Membrane,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transmembrane,Transmembrane helix,Ubl conjugation,Zinc,Zinc-finger,	chain:Zinc finger CCCH domain-containing protein 13,compositionally biased region:Arg/Glu-rich,compositionally biased region:Arg/Ser-rich,compositionally biased region:Lys-rich,compositionally biased region:Ser-rich,modified residue,sequence conflict,sequence variant,splice variant,zinc finger region:C3H1-type,
ZC3H18	zinc finger CCCH-type containing 18(ZC3H18)	Homo sapiens					GO:0005654~nucleoplasm,	GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR000571:Zinc finger, CCCH-type,				SM00356:ZnF_C3H1,	Acetylation,Alternative splicing,Coiled coil,Complete proteome,Isopeptide bond,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation,Zinc,Zinc-finger,	chain:Zinc finger CCCH domain-containing protein 18,compositionally biased region:Poly-Asp,compositionally biased region:Pro-rich,compositionally biased region:Ser-rich,modified residue,sequence conflict,sequence variant,splice variant,zinc finger region:C3H1-type,
ZMYM3	zinc finger MYM-type containing 3(ZMYM3)	Homo sapiens				GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007010~cytoskeleton organization,GO:0007275~multicellular organism development,GO:0022604~regulation of cell morphogenesis,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003677~DNA binding,GO:0008270~zinc ion binding,	IPR010507:Zinc finger, MYM-type,IPR011017:TRASH domain,IPR021893:Protein of unknown function DUF3504,				SM00746:TRASH,	Alternative splicing,Chromosomal rearrangement,Complete proteome,Metal-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Zinc,Zinc-finger,	chain:Zinc finger MYM-type protein 3,modified residue,splice variant,zinc finger region:MYM-type 1,zinc finger region:MYM-type 2,zinc finger region:MYM-type 3,zinc finger region:MYM-type 4,zinc finger region:MYM-type 5,zinc finger region:MYM-type 6,zinc finger region:MYM-type 7,zinc finger region:MYM-type 8,zinc finger region:MYM-type 9,
ZMYM4	zinc finger MYM-type containing 4(ZMYM4)	Homo sapiens				GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007010~cytoskeleton organization,GO:0007275~multicellular organism development,GO:0022604~regulation of cell morphogenesis,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003677~DNA binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,	IPR010507:Zinc finger, MYM-type,IPR011017:TRASH domain,IPR021893:Protein of unknown function DUF3504,				SM00746:TRASH,	Acetylation,Alternative splicing,Complete proteome,Isopeptide bond,Metal-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Ubl conjugation,Zinc,Zinc-finger,	chain:Zinc finger MYM-type protein 4,modified residue,sequence conflict,sequence variant,splice variant,zinc finger region:MYM-type 1,zinc finger region:MYM-type 2,zinc finger region:MYM-type 3,zinc finger region:MYM-type 4,zinc finger region:MYM-type 5,zinc finger region:MYM-type 6,zinc finger region:MYM-type 7,zinc finger region:MYM-type 8,zinc finger region:MYM-type 9,
ZBTB4	zinc finger and BTB domain containing 4(ZBTB4)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0006974~cellular response to DNA damage stimulus,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005694~chromosome,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0001227~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003676~nucleic acid binding,GO:0005515~protein binding,GO:0008327~methyl-CpG binding,GO:0010428~methyl-CpNpG binding,GO:0019901~protein kinase binding,GO:0042803~protein homodimerization activity,GO:0043565~sequence-specific DNA binding,GO:0046872~metal ion binding,	IPR000210:BTB/POZ-like,IPR007087:Zinc finger, C2H2,IPR011333:BTB/POZ fold,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00225:BTB,SM00355:ZnF_C2H2,	Chromosome,Coiled coil,Complete proteome,DNA-binding,Isopeptide bond,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,Ubl conjugation,Zinc,Zinc-finger,	chain:Zinc finger and BTB domain-containing protein 4,compositionally biased region:Glu-rich,compositionally biased region:Pro-rich,domain:BTB,sequence conflict,sequence variant,zinc finger region:C2H2-type 1; atypical,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,
ZNF14	zinc finger protein 14(ZNF14)	Homo sapiens			General function prediction only,	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0046872~metal ion binding,	IPR001909:Krueppel-associated box,IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00349:KRAB,SM00355:ZnF_C2H2,	Complete proteome,DNA-binding,Metal-binding,Nucleus,Polymorphism,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger protein 14,domain:KRAB,sequence variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 10,zinc finger region:C2H2-type 11,zinc finger region:C2H2-type 12,zinc finger region:C2H2-type 13,zinc finger region:C2H2-type 14,zinc finger region:C2H2-type 15,zinc finger region:C2H2-type 16,zinc finger region:C2H2-type 17,zinc finger region:C2H2-type 18,zinc finger region:C2H2-type 19,zinc finger region:C2H2-type 2; degenerate,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4; atypical,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,zinc finger region:C2H2-type 7,zinc finger region:C2H2-type 8,zinc finger region:C2H2-type 9,
ZNF292	zinc finger protein 292(ZNF292)	Homo sapiens				GO:0006366~transcription from RNA polymerase II promoter,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,	GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,	3D-structure,Acetylation,Alternative splicing,Coiled coil,Complete proteome,DNA-binding,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger protein 292,helix,modified residue,sequence conflict,strand,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,zinc finger region:C2H2-type 7,zinc finger region:C2H2-type 8,zinc finger region:C2H2-type 9,
ZNF318	zinc finger protein 318(ZNF318)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0051321~meiotic cell cycle,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0003676~nucleic acid binding,GO:0008270~zinc ion binding,	IPR003604:Zinc finger, U1-type,				SM00451:ZnF_U1,	Alternative splicing,Coiled coil,Complete proteome,Isopeptide bond,Meiosis,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,Ubl conjugation,Zinc,Zinc-finger,	chain:Zinc finger protein 318,compositionally biased region:Lys-rich,compositionally biased region:Pro-rich,modified residue,sequence conflict,sequence variant,splice variant,zinc finger region:Matrin-type 1,zinc finger region:Matrin-type 2,
ZNF34	zinc finger protein 34(ZNF34)	Homo sapiens			General function prediction only,	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005622~intracellular,GO:0005634~nucleus,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR001909:Krueppel-associated box,IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00349:KRAB,SM00355:ZnF_C2H2,	Complete proteome,DNA-binding,Metal-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger protein 34,domain:KRAB,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 10,zinc finger region:C2H2-type 11,zinc finger region:C2H2-type 12,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,zinc finger region:C2H2-type 7,zinc finger region:C2H2-type 8,zinc finger region:C2H2-type 9,
ZNF365	zinc finger protein 365(ZNF365)	Homo sapiens				GO:0000281~mitotic cytokinesis,GO:0033566~gamma-tubulin complex localization,	GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005815~microtubule organizing center,	GO:0005515~protein binding,GO:0042803~protein homodimerization activity,			605990~Nephrolithiasis, uric acid, susceptibility to,			Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Phosphoprotein,Polymorphism,Reference proteome,	chain:Protein ZNF365,chain:Talanin,modified residue,sequence conflict,sequence variant,splice variant,
ZNF750	zinc finger protein 750(ZNF750)	Homo sapiens				GO:0006366~transcription from RNA polymerase II promoter,GO:0008544~epidermis development,GO:0030154~cell differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0043231~intracellular membrane-bounded organelle,	GO:0001046~core promoter sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0005515~protein binding,GO:0046872~metal ion binding,			610227~Seborrhea-like dermatitis with psoriasiform elements,			Activator,Complete proteome,Differentiation,Metal-binding,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Protein ZNF750,sequence conflict,sequence variant,
ZNF800	zinc finger protein 800(ZNF800)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,	Complete proteome,DNA-binding,Isopeptide bond,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Ubl conjugation,Zinc,Zinc-finger,	chain:Zinc finger protein 800,compositionally biased region:Poly-His,modified residue,sequence variant,zinc finger region:C2H2-type 1; degenerate,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,zinc finger region:C2H2-type 7,
ZFPM1	zinc finger protein, FOG family member 1(ZFPM1)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0002295~T-helper cell lineage commitment,GO:0003151~outflow tract morphogenesis,GO:0003181~atrioventricular valve morphogenesis,GO:0003192~mitral valve formation,GO:0003195~tricuspid valve formation,GO:0006351~transcription, DNA-templated,GO:0007507~heart development,GO:0007596~blood coagulation,GO:0010724~regulation of definitive erythrocyte differentiation,GO:0030218~erythrocyte differentiation,GO:0030219~megakaryocyte differentiation,GO:0030220~platelet formation,GO:0030851~granulocyte differentiation,GO:0032091~negative regulation of protein binding,GO:0032642~regulation of chemokine production,GO:0035162~embryonic hemopoiesis,GO:0035855~megakaryocyte development,GO:0045078~positive regulation of interferon-gamma biosynthetic process,GO:0045403~negative regulation of interleukin-4 biosynthetic process,GO:0045599~negative regulation of fat cell differentiation,GO:0055008~cardiac muscle tissue morphogenesis,GO:0060318~definitive erythrocyte differentiation,GO:0060319~primitive erythrocyte differentiation,GO:0060377~negative regulation of mast cell differentiation,GO:0060412~ventricular septum morphogenesis,GO:0060413~atrial septum morphogenesis,GO:0071733~transcriptional activation by promoter-enhancer looping,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005737~cytoplasm,GO:0017053~transcriptional repressor complex,	GO:0000979~RNA polymerase II core promoter sequence-specific DNA binding,GO:0001078~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001085~RNA polymerase II transcription factor binding,GO:0001102~RNA polymerase II activating transcription factor binding,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,	3D-structure,Activator,Complete proteome,DNA-binding,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger protein ZFPM1,modified residue,region of interest:Interaction with CTBP2,region of interest:Interaction with TACC3,sequence variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2HC-type 1,zinc finger region:C2HC-type 2,zinc finger region:C2HC-type 3,zinc finger region:C2HC-type 4,zinc finger region:C2HC-type 5,
